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LATEX
What is this life if, full of care,
We have no time to stand and stare.
No time to stand beneath the boughs,
And stare as long as sheep or cows.
No time to see, when woods we pass,
Where squirrels hide their nuts in grass.
No time to see, in broad daylight,
Streams full of stars, like skies at night.
No time to turn at Beauty’s glance,
And watch her feet, how they can dance.
No time to wait till her mouth can
Enrich that smile her eyes began.
A poor life this if, full of care,
We have no time to stand and stare.
— W. H. Davies
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Abstract
Pregnancy induces numerous changes in the physiology of the mother as she adapts
to the metabolically demanding fetus developing within her womb. It is during
this period of intense physiological stress that she begins to develop the maternal
behaviours that will ultimately support the nurturing of the offspring after parturi-
tion and protect them from harm. In human pregnancies, women are particularly
susceptible to mood disorders which may reflect an enhanced vulnerability induced
by pregnancy. The placenta is the key organ of pregnancy driving the physiological
and potentially the behavioural changes required for a successful pregnancy. Pla-
cental dysfunction may contribute to maternal mood disorders by mis-programming
maternal behaviour, a relationship that can be explored in a tractable animal model.
Imprinted genes are expressed in the placenta and have been implicated in the
regulation of key endocrine lineage of the mouse placenta. Phlda2 is a maternally
expressed imprinted gene that regulates one such lineage, the Spongiotrophoblast
(SpT), which is a source of placental lactogens and a number of other hormones.
Placental lactogens belong to the same hormone family as prolactin and some
members of this family mediate their action via the Prolactin Receptor (Prlr). Both
prolactin and the Prlr have been directly shown to be required for the establishment
of maternal care behaviour in rodents. This led to the hypothesis that Phlda2 might
modulate maternal care in rodents by regulating the size of the placental endocrine
compartment.
To test this hypothesis, we used three cohorts of Wildtype (WT) dams carrying
fetuses that possessed either a 50% reduction in the SpT, resulting from a double dose
Hugo Creeth Contents
of Phlda2 (Mouseline: Phlda2 +/+ BACx1, TG; 2X) or a 200% increase in the SpT,
resulting from a null dose of Phlda2 (Mouseline: Phlda2 -/+), KO; 0X) or 100% of the
WT size of the SpT, resulting from a single dose of Phlda2 (Mouseline: Phlda2 +/+,
WT; 1X) generated using Recipient Embryo Transfer (RET). Maternal behaviour
was studied postpartum and a biomolecular characterisation was performed during
pregnancy using microarray and Quantitative Polymerase Chain Reaction (qPCR)
to look at changes in maternal gene expression and a histological approach used
to examine maternal neurogenesis in the Sub-ventricular Zone (SVZ) of the lateral
ventricles and Sub-Granular Zone (SGZ) of the hippocampus. Additionally, a study
was made of male offspring carrying the Phlda2 transgene (TG), which were previously
shown to be low birth weight, their non-transgenic litter mates (NON-TG) and a
fully WT cohort of mice to ask whether placental endocrine dysfunction in utero
programmed altered behaviour later in life.
The results of this first study showed distinct changes in pup retrieval, nest building
and the dam’s grooming and licking behaviour with dams exposed to the smaller
endocrine compartment spending less time with their pups. Specific maternal
brain regions showed altered transcriptional profiles at Embryonic Day (E) 16.5 of
pregnancy and there was a significant reduction in neurogenesis. While there were
no differences in anxiety or locomotor activity levels in the offspring cohorts, there
were significant changes in hedonic response in both the TG and NON-TG offspring.
Together, these data provide the first evidence that imprinted genes can influence
both maternal care behaviour and offspring behavioural outcomes via the placental
endocrine compartment. This work has wider implications since human studies have
shown that elevated placental PHLDA2 is a common features of human growth
restricted pregnancies. There is a a co-occurrence of low birth weight and maternal
mood disorders with mothers experiencing prenatal depression having a three-fold
increased risk of a Low Birth Weight (LBW) baby. Aberrant imprinting in the
placenta could account for this co-occurrence.
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1General Introduction
1.1 Pregnancy
We all begin our lives as the products of pregnancy. Events during pregnancy can
influence an individual’s phenotype throughout their life. There are well documented
studies that implicate early life events in utero and the postpartum period on the
life of the offspring. There is less research or at least less understanding about the
short term and lasting effects that pregnancy has upon the mother’s health. The
two are most likely intimately linked as demonstrated by the co-occurrence of IUGR,
LBW and psychiatric illness. Therefore understanding and investigating the novel
origins of the adverse mental health effects during and after pregnancy on both the
mother and the offspring is vital, and is the focus of this research.
The point of conception signifies the beginning of an exceptionally challenging period
of time for a mother. In the human condition the developing embryo becomes known
as a fetus at around 8 weeks gestation. This is the stage when mineralization occurs
and bone marrow forms. At this point numerous changes have already occurred
to the mother’s physiology in order to accommodate for this new metabolically
demanding group of cells (Brunton and Russell, 2008, Grattan, 2011, Shingo, 2003).
These changes continue throughout pregnancy and encompass both physiological
alterations as well as behavioural adaptations (Figure 1.1).
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Figure 1.1: Pregnancy Adaptations. The many adaptations, both physiological and be-
havioural, that take place in a mother during pregnancy. Taken from Grattan (2011)
1.2 Maternal Behaviour and Maternal
Mood Disorders
Maternal behaviour is broadly defined as “the pattern of a mother’s behaviour that
appears to enhance her offspring’s survival and reproductive success” (Saltzman and
Maestripieri, 2011). The natural process of transitioning from being a nulliparous
female to a mother irreversibly alters the motivational and behavioural repertoire of
the female, initiating maternal behaviour. The care given as a result of the initiation
of this maternal behaviour significantly affects the developmental trajectory of her
offspring, thus making these behavioural responses of the mother to her newborn
offspring vital to understand. In humans there are differences in the levels and quality
of maternal behaviour provided to the offspring. These differences are often based on
factors such as: social economic status, lifestyle choices and cultural differences of the
2
Hugo Creeth Maternal Behaviour and Maternal Mood Disorders
mother and her family (Atif et al., 2015). Irrespective of these potentially confounding
factors there is an underlying set of nurturing behaviours that a mother must possess
in order to care for her offspring effectively. The pregnant female has an increased
appetite throughout pregnancy to support the developing fetus (Grattan, 2011). She
will also show increased aggression and reduced anxiety postpartum (Hahn-Holbrook
et al., 2011) (Figure 1.1). These behaviours are evident throughout gestation but
are most obvious after parturition, when direct mother-offspring interactions can
occur. As already mentioned, pregnancy is hugely challenging for any mother due
to the unrelenting physiological and psychological changes that must take place. It
is therefore not surprising that during pregnancy sometimes these basic maternal
behaviours can become disrupted, this combined with the enormous emotional
upheaval associated with this transitioning period to motherhood means that a new
mother is increasingly vulnerable to developing specific psychiatric illnesses.
Mood disorders are a far-reaching class of psychiatric illnesses. They affect between
1 in 4 and 1 in 10 people during their lifetime and are classified clinically as “a
disturbance in a person’s mood” (Somers et al., 2006, Waraich et al., 2004). Originally
known as “affective” disorders the switch to the term “mood” is an effort to more
accurately describe the underlying emotional instability of those suffering from these
disorders (American Psychiatric Association et al., 2013). There are two major
categories of mood disorders that are grouped together based on the presence of
either manic or hypomanic episodes. The two categories are Major Depressive
Disorder (MDD) and Bipolar Disorder (BD). As with most psychiatric illnesses
MDD and BD represent a sliding scale of syndromes with a variety of symptoms and
severities. This mosaic of syndromes and symptoms offers a challenge to clinicians
and researchers alike. In particular when trying to identify the origin and appropriate
treatment for these disorders. It is therefore vital that research into this area is
conducted, so to improve understanding and ultimately lead to the better treatment
of these increasingly prevalent disorders (Gaynes et al., 2005, Musters et al., 2008).
There is a known link between emotionality instability and mental health, specifically
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in relation to mood disorders. The increased plasticity across the body systems of the
mother during pregnancy allows the body systems to adapt to ensure they function
in the optimum ways to provide the ideal conditions for pregnancy. This increased
plasticity of the body systems is thought to be one reason why new mothers are prone
to developing psychiatric disorders (O’Hara and Wisner, 2014, Perani and Slattery,
2014). The increased susceptibility during this period has given rise to a new class
of mood disorders, known collectively as the “Maternal Mood Disorders”. These
are thought to represent a general failure of the mother to undergo the appropriate
behavioural changes associated with motherhood, leading to emotional instability
and psychopathology (American Psychiatric Association et al., 2013).
It has been shown that around 50% of women experience the “baby blues” in the
immediate stages after birth (Gaynes et al., 2005, Harris et al., 1994). Although
the “baby blues” are not considered as clinically relevant, more severe behavioural
disorders, like Postnatal Depression (PND) and Puerperal Psychosis (PP), are. Both
PND and PP are often seen within a large proportion of those mothers impacted
by the “baby blues” (Stewart et al., 2003). The effects of PND and PP can have
detrimental effects to both the mother and the offspring for many years after birth
(Capron et al., 2015). Depression is a common psychiatric disorder that is known
to have substantial morbidity (Cox et al., 1993, Halbreich, 2005, Liu et al., 2012,
Murray, 1992). PND is thought to affect 1 in 10 new mothers with estimates of
prevalence being averaged at 13% (Gaynes et al., 2005, Musters et al., 2008). Some
estimates have been as large as 85%, although this study has since been dismissed
as being indiscriminate in its diagnosis of PND (Henshaw, 2003, Pearlstein et al.,
2009). Symptoms include mood swings, confusion, irritability and fatigue (American
Psychiatric Association et al., 2013). PP, is a more severe condition that can develop
shortly after the woman has given birth. PP occurs in 1 in 1000 women and is
characterised by the emergence of severe hallucinations. PP due to the danger the
condition poses to both the mother and child, is considered a psychiatric emergency
(American Psychiatric Association et al., 2013, Musters et al., 2008). As mentioned
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already PND and PP not only have an affect on the mother’s health, but also
significantly impact upon the development of mother-infant bonds (Dubber et al.,
2015, Stein et al., 1991). It is surprising therefore that despite the evidence linking
maternal mood disorders to a range of other morbidities and adverse outcomes
for mother and child, there is remarkably little known about the causes of these
depressive symptoms.
Historically, research has focussed on the impact prenatal stress during pregnancy,
lifestyle choices or previous susceptibility of a mother to mental health issues has
upon the mother and child (Bale et al., 2010b, Bourke et al., 2013, Hanley et al.,
2013). Prenatal depression and perinatal anxiety is reported to affect between 12-20%
of women during pregnancy (O’Hara and Wisner, 2014). In monetary terms a study
by the London School of Economics (LSE) has estimated the total economic cost
of perinatal anxiety and depression at between £7-8 billion a year (Bauer et al.,
2016). The high prevalence of prenatal and PND and the consequences for the health
of both the mother and her offspring highlight the need to better understand the
origins of maternal mood disorders. Emotional or physiological changes that may
occur during gestation may potentiate existing mental health disorders in vulnerable
women, consistent with the observation that women with BD have a 50% risk of
developing PP (Jones and Craddock, 2001). The baseline female adult population
risk for PP is 1-2/1000; with the risk rising dramatically to 1:7 for women with
just one previous episode of PP (Brockington, 2004, Jones and Craddock, 2001).
Some studies have even suggested the prevalence to increase to 1 in 2 women, within
those that have a history of BD or previous episodes of PP (Munk-Olsen et al., 2012,
Musters et al., 2008). Further work in this area substantiates the importance of these
findings. Jones and Craddock (2001) have showed that PP affects 74% of mothers
with BD and a first-degree relative who had PP, compared with only 30% of BD
women without any family history of PP. Taken together with the increased risk that
maternal lifestyle has upon the mental health outcomes of the mother, this suggests
that epigenetic events during pregnancy may underlie both prenatal depression and
5
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PND (Janssen et al., 2015, 2016).
Similarly, it is known that early life environmental differences can play a vital role
on the developmental trajectory of the offspring as they grow up. In particular it
has been shown that postnatal maternal separation can produce altered emotion-
related behaviour responses, which in humans increases the risk of psychiatric
disorders and anti-social behaviour, such as aggression (Haller et al., 2014, Nishi
et al., 2014, Paksarian et al., 2015). Similarly, early life stress has been linked to
increased risk of schizophrenia and substance abuse (Agid et al., 1999, Kendler
et al., 2000). This early life stress is often associated with neglect. Evidence
from several studies suggests that the effect of early life neglect constitutes one
of the major risk factors for the development and persistence of mental disorders
including depression, Post Traumatic Stress Disorder (PTSD), and Attention Deficit
Hyperactivity Disorder (ADHD) (Famularo et al., 1992, Pelcovitz et al., 1994). The
mechanisms behind what causes these later life pathologies is not well understood in
humans, with preclinical studies suggest that early life stress may be a factor that
results in increased stress responsiveness (Drake, 2014, Nemeroff, 2002, Zeng et al.,
2015).
1.3 IUGR and LBW
IUGR and LBW are both associated with poor perinatal outcomes. Although there
are two types of IUGR, symmetric and asymmetric the accepted definition for the
pathology by the Royal College of Obstetricians and Gynaecologists (RCOG) is “a
fetus that fails to reach its potential growth” (Fiander, 2015). In contrast a LBW
baby, also known as a Small for Gestational Age (SGA) baby, is defined as a baby
having a birth weight below a given 10th percentile for gestational age (Fiander,
2015). The two conditions are not synonymous but are both important clinical
problems which carry complications for both the mother and the offspring during
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pregnancy and into later life.
1.3.1 Maternal Outcomes
LBW has long been used as a measure of overall fetal and maternal health (Halbreich,
2005). Prenatal depression has often been associated with LBW (Glynn and Sandman,
2011, Liu et al., 2012, Monk et al., 2012). In the past studies have focussed primarily
on the social development and outcome of the offspring and not upon the psychiatric
health of the mothers. These studies have helped attribute future adult psychiatric
illness of the offspring to pre-natal stress, drug abuse and other similar lifestyle
choices (see subsection 1.3.2). Very little work has been done to look at the impact
that fetal development has upon the mother’s behaviour and whether there is any
link between LBW and maternal mood disorders. There are reports that indicate the
psychological distress that can occur in mothers of LBW babies (Singer et al., 1999),
including cases of PTSD (Kersting et al., 2004). Another study carried out by Liu
et al. (2012) highlighted a 3-fold increase in depressed mood in mothers with LBW
children. This has previously been reported in a meta analysis study, Grote et al.
(2010) concluded that women with depression during pregnancy are at increased risk
for preterm birth and LBW, although they noted that the magnitude of the effect
varies according to the depression measurement, country location and socioeconomic
status. These studies have often focussed on LBW and IUGR being a direct result of
the maternal depressive state during pregnancy. There is however growing evidence
that these depressive symptoms may originate as a result of the changes brought
about from carrying an IUGR baby.
The placenta is the key organ of pregnancy and plays a nourishing role in the
development of the embryo. This means that placental defects can have severe
consequences for embryonic growth and development. In humans, placental defects
result in complications including pre-eclampsia and IUGR (Szymonowicz and Yu,
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1987, Valero De Bernabé et al., 2004). One study by Evans et al. (2001) of 12,059
women found there to be an increase in reported depressive symptoms in the third
trimester (13.6%) compared to the second trimester (11.8%). The second and third
trimesters are when placental hormones are signalling most strongly (Samaan et al.,
1966). While the general consensus has been that changes in the term placenta
is associated with prenatal depression as a consequence of the condition (Olivier
et al., 2014), it is also possible that placental endocrine dysfunction drives prenatal
depression (Janssen et al., 2016). It follows that these placental differences may
contribute to the pathology of postpartum mood disorders.
1.3.2 Offspring Outcomes
In humans the offspring of mothers with suboptimal in utero environments often have
several bodily systems that are compromised. These include cardiovascular fitness
(Barker, 1995, Lindblom et al., 2015), metabolic function (Entringer, 2013) and
behavioural responses (Bale et al., 2010b). In humans, maternal stress (Weinstock,
2008), poor diet (Brown et al., 2000) and depression (Rice et al., 2007) throughout
pregnancy have been linked to LBW and a subsequent range of physiological and
behavioural outcomes in the offspring. Such as delayed fetal growth, structural
alterations to the neural system, impaired cognitive performance, social abnormalities
and an increased risk of psychiatric illnesses later in life (Sandman et al., 2011). In
particular, prenatal stress in LBW mothers has been related to an increased risk for
major depression in adulthood (Hulshoff Pol et al., 2000). LBW, IUGR and preterm
birth have been linked to behavioural problems, such as hyperactivity during school
(McCormick et al., 1990). In one study, known as the Helsinki study, in which they
followed up very low-birth-weight (VLBW) babies (< 1500 g) into young adulthood
(20 years of age) they highlighted the link between IUGR and risk of depression in
young adulthood (Räikkönen et al., 2008).
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1.4 Pregnancy Hormones
The plethora of changes that are brought about through the pregnant state in humans
and other mammals are predominately initiated and ultimately controlled through
the endocrine system. Maternal and placental hormones act to bring about the
appropriate physiological responses to cope with the developing fetus (Fiander, 2015).
Hormones in the general sense are “chemical signals that serve to communicate
messages to multiple internal sites simultaneously. Hormones are released by a
gland. They are then picked up by receptors at multiple other sites, thereby affecting
them in a way specific to the site” (Gangestad and Grebe, 2016). There are many
hormones that are prevalent throughout pregnancy and after birth. These all act
in distinct ways in order to maintain the pregnant state or prepare the female for
the physiological demands of pregnancy and onward challenges of motherhood. The
hormones that have been most abundantly studied in relation to pregnancy are the
protein hormones and the steroid hormones. There are too many to discuss them all
in detail, but the major hormones are briefly outlined in the following sections and
their functions in humans and rodents summarised in Table 1.1 and Table 1.2.
1.4.1 Steroid Hormones
These hormones are secreted from the gonads, adrenal cortex and placenta. They
include progesterone, a member of the progestins. Progesterone is a key hormone pro-
duced by the corpus luteum up until around 10 weeks of gestation in humans, before
the placenta produces enough progesterone to maintain pregnancy independently
until term (Kumar and Magon, 2012). Progesterone is sometimes referred to as the
hormone of pregnancy, due to its critical role in the maintenance and establishment
of the pregnant state, through the support of the endometrium, which is critical
9
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for the survival of the conceptus and suppression of ovulation (Sonigo et al., 2014,
Wright and Johnson, 2008). Progesterone also helps suppress the smooth muscles
of the myometrium near the end of gestation, however as oestrogen levels rise this
suppression is reduced encouraging parturition.
The other key group of steroid hormones that are found at high levels during
pregnancy are the oestrogens. The levels of oestrogens rise continually throughout
gestation, reaching their maximum at term. The principle effects of oestrogens on
the pregnant state are their antagonising effects upon progesterone at term and the
stimulation of the growth of the myometrium (Pi et al., 2003). Like progesterone the
oestrogens help maintain the pregnant state through suppression of gonadotropin
hormones from the pituitary. Finally oestrogens are amongst the key hormones that
help in mammary gland development (Brisken and O’Malley, 2010).
1.4.2 Protein Hormones
Protein/peptide hormones are extremely abundant during gestation and play a key
role in a number of pregnancy processes. Corticotropin releasing hormone (CRH), is
the main modulator of the Hypothalamic-Pituitary-Adrenal (HPA) axis by acting
upon Adrenocorticotropic hormone (ACTH) and acting in its release into the circu-
lation (Nephew and Murgatroyd, 2013). CRH is released from the Paraventricular
Nucleus (PVN) of the hypothalamus stimulating the pituitary synthesis of ACTH.
ACTH is released in high levels during pregnancy leaving the mother in a state of
hypercortisolism (Mastorakos and Ilias, 2003). Interestingly, oestrogen increases the
sensitivity of the adrenal gland to ACTH, an example how the hormones of pregnancy
often work together for a given outcome, in this case hypercortisolism (Waddell and
Atkinson, 1994). Vasopressin (ADH) is most commonly known for its more general
role in the kidney where it is vital for helping the body regulate the retention of water
(Robertson, 1983). However, it has emerged that ADH is also a critical hormone in
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pregnancy, where it acts in parallel with CRH in mediating the stress response in
mammals during pregnancy and lactation modulating the HPA axis (Goland et al.,
1991, Ma et al., 2005, Mastorakos and Ilias, 2003). Oxytocin (OXT) is secreted from
the posterior pituitary, the PVN of the hypothalamus and the placenta. OXT is
essential for lactation, as it it stimulates milk ejections (Brunton and Russell, 2008,
Russell et al., 2003). It is also important in promoting parturition. It does this
by being released in pulses a few minutes apart, stimulating uterine contractions.
Prolactin is released from the pituitary in humans and placental lactogens from the
placenta. It is most well known for its vital role in lactation and milk production
(Nephew and Murgatroyd, 2013).
1.5 Modelling Maternal Behaviour
In order to further our understanding of the processes that induce and maintain
maternal behaviour, processes that may be disrupted in maternal mood disorders,
rodents can provide a useful tool. Both mice and rats are commonly used in
scientific research for numerous reasons when modelling human disease. They
provide a tractable system that allows the continual monitoring of the behavioural
and biochemical changes occurring during a defined period, as well as allowing
genetic and non-genetic manipulation. Their short gestation and weaning time allows
longitudinal and generational studies to be carried out over a much shorter time frame
than in the human equivalent. Thus it is possible to look at the offsprings development
as a consequence of a compromised in utero and/or early life environment.
Crucially for this study, mice and rats elicit maternal behaviours that are predictable
and testable, making them the ideal choice of animal model for this kind of research
(Bridges et al., 1990). The behaviours that a new dam must exhibit during pregnancy
encompass finding and remembering food stores, water sources, nest sites and danger
zones (Franks et al., 2011). These locations once processed must either be avoided
11
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Table 1.1: Pregnancy Hormones in Humans and their Functions
Hormone/s Tissue/s excreted
from
Function/s Reference/s
Progesterone Gonads/adrenal
glands/placenta
Establishment and
maintenance of
pregnancy. Inhibits
lactogenesis.
Kumar and Magon
(2012), Macias and
Hinck (2012), Sonigo
et al. (2014)
Oestrogens Gonads Antagonising effect
upon progesterone at
parturition.
Stimulates the growth
of the myometrium.
Helps maintain the
pregnant state by
suppressing
gonadotropin
hormones. Promotes
mammary
development.
Brisken and O’Malley
(2010), Macias and
Hinck (2012)
Oxytocin Placenta/hypoth -
alamus/pituitary
Stimulates
contractions of uterus
and cervix. Vital in
lactation and milk
ejection. Helps with
bonding and
emotionality.
Promotes prolactin
production.
Apter-Levi et al.
(2014),
Bachner-Melman and
Ebstein (2014), Dale
(1906)
Corticotropin
releasing hormone
Hypothalamus Determines length of
gestation. Mediates
vasopressin release.
Wadhwa et al. (1998)
Vasopressin Pituitary Increases anxiety and
increases agression.
Heinrichs et al. (2009)
Prolactin Pituitary/placenta Milk production and
lactation. Maternal
metabolism.
Suppression of the
stress response.
Suppresses ovulation
and maintains
pregnancy.
Freeman et al. (2000)
Placental Lactogens Placenta Lactation and milk
production. Maternal
metabolism.
HANDWERGER
(1991), Walker et al.
(1990)
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Table 1.2: Pregnancy Hormones in Rodents and their Functions
Hormone/s Tissue/s excreted
from
Function/s Reference/s
Progesterone Gonads/adrenal
glands/placenta
Helps establish and
maintain pregnancy
and inhibits
lactogenesis.
Bazer (1998),
López-Fontana et al.
(2012)
Oestrogens Gonads Helps establish
implantation and
maintain pregnancy.
Gidley-Baird (1981),
Pi et al. (2003)
Oxytocin Placenta/hypo -
thalamus/pituitary
Initiates parturition
and promotes social
behaviours. Induces
maternal behaviour
Champagne et al.
(2001), Champagne
and Meaney (2006),
Li et al. (1999)
Corticotropin
releasing hormone
Hypothalamus/
placenta
Stimulates the
production of ACTH
and main modulator
of HPA axis. Inhibits
maternal behaviour.
Klampfl et al. (2013),
Pedersen et al. (1991)
Vasopressin Pituitary Works with CRH to
modulate release of
ACTH during
pregnancy.
Ma et al. (2005),
Mastorakos and Ilias
(2003)
Prolactin Pituitary/placenta Promotes lactation
and mammary
growth. Suppression
of the immune and
stress response.
Suppresses ovulation
and maintains
pregnancy. Increases
maternal
neurogenesis.
Freeman et al. (2000),
Hu and Cross (2010),
Nephew and
Murgatroyd (2013),
Shingo (2003), Torner
(2016)
Placental Lactogens Placenta Main lactogenic
hormone at
mid-gestation.
Lactation and milk
production. Involved
in maternal
behaviour.
Bridges (1994),
Bridges and Grattan
(2003), Lee and Voogt
(1999), Lucas et al.
(1998)
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or exploited to ensure the survival of her offspring. Nests, even if already built, must
be re-constructed in a more elaborate and functional way for the young, to provide
protection and warmth (Lisk et al., 1969). Critically, the new dam must engage in
discrete acts of maternal care. These include retrieving, grouping, crouching over
and licking/grooming each individual pup (Franks et al., 2011). These mother-pup
interactions are thought to be vital in the development of the offspring. The pressure
of having offspring will force the female body into a more time efficient routine for
eating and sleeping. Maximising the care and fitness for both herself and her young.
Thus maternal behavioural testing is often used in animal models to determine
whether the dam has undergone the appropriate transition into motherhood. These
assays check that the dam has developed behaviours that allow her to effectively
care for her offspring. The lack of specific maternal behaviours point towards certain
maternal behavioural deficits that may suggest that either the dam is compromised
or that the offspring are.
1.5.1 Maternal Care and Offspring Outcome
Maternal care experience by offspring during postnatal development predicts their
long-term neurobiology and behavioural outcomes (Franks et al., 2015). This study
by Franks et al. (2015) indicated that lower postnatal care can be associated with less
frequent maternal behaviour during the pre-weaning period. Additionally, naturally
occurring variations in maternal care have been shown to alter the expression of genes
that regulate behavioural and endocrine responses to stress, as well as hippocampal
synaptic development (Meaney, 2001). Meaney (2001) revealed that parental care
can act as a key mediator for the effects of environmental adversity on neural and
behavioural development. It is widely understood that postnatal maternal separation
can produce lasting abnormalities in emotion-related behaviour and neuroendocrine
responses to stress in rodents (Lehmann et al., 1999, Millstein and Holmes, 2007).
There is increasing evidence that maternal care can play a role in the developing
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epigenome (Monk et al., 2012). Despite this the mechanisms behind what causes
these behavioural outcomes in the offspring are not well understood but it is most
likely a combination of factors stemming from both the in utero and early life
environments.
1.6 Modelling IUGR and LBW
LBW and IUGR have both been successfully been modelled in mice. These models
provide invaluable research tools for furthering the understanding of what causes
these conditions (Tunster et al., 2010). They also offer the unique opportunity to
study the co-occurrence of both LBW and maternal mood disorders (Janssen et al.,
2016).
The effects that both prenatal adversity and early life adversity has upon the postnatal
outcomes of the offspring has been well documented in both humans and mice. There
has been less research into whether there is a link between the in utero environment
and the subsequent maternal care in the early stages postpartum and what effect
this may have upon offspring behavioural development. This research presents a
novel mouse model that was used to assess both these facets in the development of
the offspring postnatally.
1.6.1 The in utero Environment and Offspring Out-
comes
In rodents the same patterns, that link the prenatal stressors found in human in
utero environments, also cause behavioural and neural abnormalities in these model
systems (Hausknecht et al., 2013). The in utero environment can often be a direct
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consequence of maternal lifestyle, but can also be due to the effects of dosage of
imprinted genes in the placenta. Changes in the expression of Insulin-like Growth
Factor 2 (Igf2) has been shown to have programming effects on later life adult
behaviour, where it has been shown to induce an anxiety phenotype in adult mice
(Mikaelsson et al., 2013). Similarly the changes in the expression of the paternally
expressed gene Peg3 has been associated with the co-adaptive behaviour in both
the dam and offspring. Including the suckling behaviour of the pups and nurturing
provision given by the dams during the pre-weaning postnatal period (Curley et al.,
2004).
The role the placenta plays in initiating the physiological changes that are necessary
for a successful pregnancy, as well as the placental origin of IUGR and LBW means
that gaining a better understanding of the placenta and its role during pregnancy is
essential.
1.7 The Placenta
The placenta is the first organ that begins to form early on in pregnancy, and is
the most important. The word “placenta”, which means “flat cake” in latin aptly
describes it underwhelming appearance, but fails to exemplify its extremely important
functional role during pregnancy (Cross, 2005, Watson and Cross, 2005). Placental
development begins at the point of implantation of the blastocyst into the maternal
uterine wall. This occurs at around day 6 or 7 post conception in humans, and on
E 3.5 in mice, just before implantation (Rossant and Cross, 2001). The placenta
plays an active role as a selective delivery interface for nutrients between mother and
offspring from its early days, but becomes most active as an endocrine organ between
weeks 12/13 and term in humans and between E10.5 and birth in mice (Watson and
Cross, 2005).
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The placenta features both a maternal and a fetal interface that allow it to perform a
variety of functions. In humans the maternally derived placenta is called the decidua
basalis and the fetally derived placenta is the chorion frondosum (Georgiades et al.,
2002). It is primarily comprised of extra-embryonic trophoblast cells and permeated
by blood vessels initiating from the umbilical cord and the maternal uterus. The
highly vascularised nature of the placenta is an essential component that allows it
to perform its vital role in the continued nourishment of the fetus. The placenta’s
role in the endocrine system during pregnancy is critical. It helps in the regulation
of hormones that bring about many of the physiological changes in the expectant
mother. The trophoblast cells that are critical for the development of the multitude
of roles for the placenta means that defects during their differentiation are associated
with a vast array of pregnancy complications, including: infertility, miscarriage,
pre-eclampsia and IUGR (Jauniaux et al., 2010).
The functional roles of the placenta have consequently been incorporated to define
the two broad functional categories:
1. Transport and Barrier: This functional spectrum begins from implantation
when the placenta prevents immune rejection of the semi-allogeneic fetus. The
exact mechanisms behind the protection that the placenta provides against the
maternal immune system are not fully understood (Georgiades et al., 2002).
Recent advancements in immunology however have begun to uncover how
the intricate process occurs. The increasing evidence suggests that decidual
macrophages plus regulatory T cells are key regulators of fetal tolerance by
the mother (Svensson-Arvelund et al., 2015). This work by Svensson-Arvelund
et al. (2015) has shown that these regulatory T cells are likely induced by the
human fetal placenta itself, mainly through the trophoblast cells. Subsequently,
the placenta is able to transport sufficient nutrients to the developing embryo
and remove toxic waste products whilst maintaining the protection of the fetus
from the maternal immune response.
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2. Invasive and Endocrine: Foundational to this is the vascularised nature
of the placenta. The fetally derived cells augment the modification of the
maternal arterial vasculature increasing the volume of maternal blood available
for undisturbed transfer (Georgiades et al., 2002, Watson and Cross, 2005).
This feto-maternal interface is a dynamic system that changes throughout
gestation in order to increase efficiency of the placenta (Moll, 1985). This
“vascular invasion” not only allows for transport and removal of the waste,
but also renders the placenta an important endocrine organ. The invasion
of the uterine wall results in the anchoring of the placenta and enables it to
regulate the release of hormones and cytokines into the maternal blood (Hu
and Cross, 2010). These hormones act to alter the mother’s metabolism and
re-programme the mother’s physiology in order to favour embryonic growth
through heightened blood flow to the placenta (Tunster et al., 2013, Watson
and Cross, 2005).
1.7.1 The Human Vs The Mouse Mature Placenta
To study placental function in humans presents a number of challenges. Genetic het-
erogeneity requires studies on large populations, examination of placental structure
and function during pregnancy although not impossible is limited in its applica-
tion and, for ethical reasons, intervention studies are a considerable undertaking.
Nonetheless, some progress has been made using randomised control trials such as
those done by Heazell et al. (2013) and Rai et al. (1997). These difficulties and the
need to understand the relationship between the structure and subsequent function
of the placenta means the use of a model system is still vital. Mice offer a genetically
tractable model system through which specific genes can be assessed via genetic
modifications and breeding programmes (Malassiné et al., 2003). Subsequently it is
critical to understand the differences between the two species placenta in order to be
able to relate the findings these mouse models to what we know in humans.
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The gross anatomy of mammalian placenta varies greatly between species (Leiser and
Dantzer, 1994, Perry, 1981). The same is true for the gross architecture of the human
and mouse placenta. However the core functional similarities between the cell types,
overall structure and the molecular mechanisms underlying placental development
are in fact quite similar between the two species (Cross et al., 2003). The key tissues
and their analogous cell types between the species are summarised in Table 1.3.
In mice, placental development begins in the blastocyst at E3.5 when the trophecto-
derm layer is set aside from the inner cell mass, slightly earlier than the equivalent
in humans. The overall shape of both human and mouse placenta are discoid. They
are both able to be split into three distinct structural layers (Georgiades et al., 2002).
These layers are known by different names between the species and are based on
their underlying structural function. The three categories are: the labyrinth in mice
and fetal placenta in humans, second is the junctional zone and the basal plate
respectively, thirdly is the murine decidua basalis or the placental bed in humans,
all of which are interspersed with Trophoblast Giant Cells (TGC).
Implantation occurs on E4.5 in mice, when the mural trophectoderm cells form. This
simple trophectoderm surrounding the blastocyst ultimately goes on to differentiate
into a variety of different trophoblast cell subtypes, with specific functions (Georgiades
et al., 2002, Watson and Cross, 2005). The trophectoderm cells that are not in direct
contact with the Inner Cell Mass (ICM), become TGC. The TGC are analogous
to the extravillous cytotrophoblast cells in the human placenta. In both species
these cells stop dividing, but still continue to replicate DNA in a process known as
“endoreduplication”, becoming polyploid.
In contrast, two diploid cell types emerge from the polar trophectoderm and are
in direct contact with the ICM. These are the extraembryonic ectoderm and the
ectoplacental cone. The extramembryonic ectoderm will ultimately become, the
chorion layer and, finally, the labyrinth in mice. The ectoplacental cone contains
the trophoblast specific protein alpha (Tpbpa)-positive progenitors that give rise to
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Figure 1.2: The Human Placenta Vs Mouse Mature Placenta. A simplified schematic
demonstrating the differences and similarities of the human and mouse placenta. The labyrinth
(L) region of the mouse placenta is the equivalent of the fetal placenta or inter villous space (IVS)
found in humans. Some of the fundamental differences between the structure of the mouse and
human placenta is found in the fetal vasculature. Humans have a villous (V) structure with a series
of branching and sub-branching. The same region in mice is interconnected and more similar to a
maze or labyrinth. The consequence of this difference is that the blood sinuses found in the mouse
placenta are considerably smaller than those in the human placenta. Above the labyrinth/fetal
placenta region there is a distinct group of cytotrophoblast cells. These cells are referred to as the
spongiotrophoblast (S) in mice and the basal plate or maternal decidua (MD) in humans. A final
layer of giant cells covers the cytotrophoblast cells is similar in both humans and mice. Adapted
from Kanellopoulos-Langevin et al. (2003)
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the SpT, the glycogen cells and four of the six TGC subtypes of the mature mouse
placenta (Rai and Cross, 2014, Simmons et al., 2008). It is the SpT that goes onto
functionally support the developing labyrinth.
The SpT itself is a compact layer of cells sandwiched between the labyrinth and
the outer giant cell layer. It corresponds to the column cytotrophoblast of the
human placenta. This layer is known collectively as the junctional zone in mice
and the basal plate in humans (Rossant and Cross, 2001, Watson and Cross, 2005).
This region is known to be a key endocrine region in both species. It secretes
hormones associated with pregnancy, including Prolactin-like Proteins (Prls) in
mice and the Chorionic Somatomammotropin Hormone 1 (CSH1) and Chorionic
Somatomammotropin Hormone 2 (CSH2) in humans, known collectively as Human
Placental Lactogens (hPL). As gestation continues the SpT begins to contain
glycogen trophoblast cells that have differentiated within this layer. It is the glycogen
cells that diffusely invade the uterine wall. There has been some speculation that they
could influence the secretory behaviour of the SpT due to there close association with
them and because they express calcyclin, an inducer of Prls secretion by trophoblast
(Farnsworth and Talamantes, 1998)
The vascular portion of the placenta is derived from extra-embryonic mesoderm at
E8.0 in mice. At this stage the allantois forms. This then extends from the posterior
end of the embryo and joins the chorion (the umbilical chord), in a process known as
chorioallantoic attachment. The chorion is the outer fetal membrane that together
with the amnion form the amniotic sac. Once the chorioallantoic attachment is
formed, the chorion begins to fold to form the villi (Rossant and Cross, 2001, Watson
and Cross, 2005). These villi help create space into which the fetal blood vessels grow
from the allantois. The chorionic trophoblast cells start their differentiation into three
labyrinth cell types. The first and second are the multi-nucleated syncytiotrophoblast
cell layers I and II, formed by the fusion of trophoblast cells (Georgiades et al.,
2002, Rossant and Cross, 2001). Mice display extensive branching of the villi in the
labyrinth. In humans this is comparable to the chorionic villi, both however become
21
Hugo Creeth The Placenta
larger and more extensive right up until birth (Adamson et al., 2002). Unlike mice
however, the human chorionic trophoblast form a single syncytiotrophoblast layer
making it monochorial, compared to the trichorial nature of the mouse chorionic
trophoblast (Georgiades et al., 2002). In both however the maternal and fetal blood
flows past each other in a countercurrent way through the labyrinth and fetal placenta
in order to maximise the functional exchange of nutrients and waste between the
mother and offspring.
So overall the similarities between the mouse and mature human placenta are
numerous. The main differences are found within the fetal vasculature. The human
placenta is villous, the chorionic villi maintain a tree-like pattern with innumerable
branches and sub-branches, all having villous like extremities. In contrast this region
in mice is interconnected and much more like a maze, this difference contributes to a
considerably larger intervillous space in humans, or smaller blood sinuses/lacunae in
mice. These differences are based on general appearance rather than function, as the
functionality and origins of the cell types are the same (Carter, 2007). Therefore,
the mouse offers a model that has a short gestation time, large litters and immature
offspring (altricial young). Mice are also phylogenetically similar to humans/primates
meaning they share many similarly conserved features of pregnancy and development.
The emerging importance of imprinted genes in placental development and structure
cement the mouse as an ideal model organism to use when studying placental
development due to its genetic tractability and readily available embryonic stem
cells, that are crucial for gene targeting and transgenic model development (Carter,
2007, Watson and Cross, 2005).
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Table 1.3: Human vs Mouse Placenta
Mouse Human
Labyrinth Fetal Placenta
Maternal Blood Space/Lacunae Intervillous
Junctional Zone -Spongiotrophoblast and
Glycogen Cells
Basal Plate - Cytotrophoblast and Glycogen
Cells
Giant Cells Giant Cells (invasive extravillous trophoblast)
Decidua Placental Bed
1.8 Prolactin and the Placental Hor-
mones
In mice the various endocrine cell types and their respective functions have been
recently reviewed by John (2013) and are summarised in Table 1.4 and Figure
1.3. The SpT, TGC and the glycogen cell lineage all express Prls as well as other
hormones (Simmons et al., 2008). This complex group of hormones exert both
local and systemic endocrine effects on the mother including, amongst others, the
suppression of the maternal immune system and preparing the mother’s body for
pregnancy (Bridges, 1994, Hu and Cross, 2010). The known functions are summarised
in Table 1.1, Table 1.2 and in Figure 1.1.
Prolactin and Growth Hormone (GH) genes arose from a common ancestral gene
(Forsyth and Wallis, 2002). They have since expanded into clusters via a species
dependent mechanism, with humans and primates focussing on the GH locus. In
rodents this expansion occurred for the prolactin gene locus, which has become highly
evolved. It is now known to contain 22 genes (Table 1.5) in mice. Most of the Prls,
are expressed in the placenta but some are expressed in the decidua (Hu and Cross,
2010, Simmons et al., 2008, Wiemers et al., 2003). In humans the prolactin that
is expressed in the decidua is indistinguishable from pituitary prolactin. The large
number of Prls in mice means that mouse prolactin is distinguishable from the Prls
(Freeman et al., 2000). Prolactin has important roles in the metabolic adaptations of
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Table 1.4: Mouse Placental Cell Types
Trophoblast Cell Type Location Propoese Function
Sinusoidal TGC (sTGC) Labyrinth, exposed directly to
maternal blood
Nutrient, gas and waste
exchange between mother and
fetus
Syncitiotrophoblast Layer I
(SynTI)
Labyrinth, between sTGC
and SynTII
Nutrient, gas and waste
exchange between mother and
fetus
Syncytiotrophoblast Layer II
(SynTII)
Labyrinth, closest to fetal
endothelial cells
Nutrient, gas and waste
exchange between mother and
fetus
Parietal trophoblast giant
cells
Bordering maternal decidua
layer
Hormone production
(together with the other
TGC)
Canal-associated TGC Decidua and junctional zone,
surrounding maternal blood
canals
Vasodilation, hormone
production
Channel TGCs Ch-TGC Line the small channels of the
labyrinth
Collect deoxygenated blood
Spiral artery-associated TGC Decidua Invasion, spiral artery
remodelling, vasodilation,
production of angiogenic and
anti-coagulative factors
Spongiotrophoblast cells Junctional zone Endocrine signalling to
sustain pregnancy and induce
maternal physiological
adaptations, together with
TGC.
Glycogen cells Junctional zone, maternal
decidua (by migration)
Function unknown âĂŞ
enhancing maternal blood
flow, sustaining late
embryonic growth
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Figure 1.3: Placental Cell Types. A diagram showing the names and locations of the different
cell types present in the murine placenta. Taken from John and Hemberger (2012)
the mother, contributing to the induction of leptin resistance in increased food intake
during pregnancy (Grattan et al., 2007). Prolactin is involved in the suppression of
the stress response (Torner, 2016, Torner and Neumann, 2002), as well as showing
inhibitory effect on the HPA axis (Torner et al., 2002), by inducing changes in activity
of OXT neurons (Kokay et al., 2006), and in suppressing ovulation (Freeman et al.,
2000). Prolactin is elevated throughout pregnancy, parturition and lactation. The
expression levels however do show distinct patterns, peaking initially in rodents before
dropping off during mid-gestation and then peaking once more before parturition.
This is in contrast to the Prls, which show a steady increase throughout pregnancy
(Soares, 2004).
A subset of the Prls act on the Prlr much like prolactin (Bu et al., 2016, Linzer and
Fisher, 1999, Tunster et al., 2016). It has also become evident that Prls act upon
a wide range of other tissues to induce changes required for a successful pregnancy
(Grattan, 2011, Grattan and Kokay, 2008). The original Prls discovered in rodents
were named Placental Lactogen I (PLI) and Placental Lactogen II (PLII). Since this
25
Hugo Creeth Prolactin and the Placental Hormones
PLI has been shown to contain three genes that encode distinct Prls in mice. The
three genes for PLI are the Prl3d ’s, whilst PLII encodes one Prl, Prl3b (Table 1.5).
These three Prls are most well understood with regards to their lutenizing effects on
dams whilst the remaining Prls functions are not so well understood and many of
their receptors are still not known. In humans these Prls are known as CSH1 (with
three isoforms: α, β and γ) and CSH2. These are homologous to the Prl3d and
Prl3b genes in mice (Power, 2012).
The Prl3d’s (PLI) and Prl3b (PLII) have a wide spectrum of activities and act upon
numerous target tissues, independently of the mammary gland. These hormones act
on the ovary of the mother, where they act alongside progesterone and oestrogen
to maintain the corpus luteum of pregnancy. Specifically certain Prls actually
stimulate luteal progesterone production to help maintain pregnancy. In early
pregnancy pituitary prolactin is depended upon for progesterone production and
luteal maintenance (Forsyth and Wallis, 2002). Once the Prl3d levels reach sufficient
amounts after implantation, pituitary prolactin is functionally replaced by the Prl3d’s
(Simmons et al., 2008, Talamantes and Ogren, 1988). At around mid gestation
the synthesis of Prl3d’s decrease, making way for an increase in Prl3b expression
(Rosenfeld, 2015, Talamantes and Ogren, 1988).
1.8.1 Hormones and Maternal Behaviour
There is considerable evidence in rodents that hormonal priming of maternal be-
haviour occurs not only throughout pregnancy but as it ends. Many postnatal
behaviours have been hypothesised to be from the sudden removal of the placenta
and the associated hormones that are released from it throughout pregnancy to
prepare the mother and protect the fetus (Grattan, 2011, Shingo, 2003, Woodside,
2016). These fluctuations in pregnancy related hormones may result in dysregulated
brain responses that cause dramatic changes in maternal behaviour after birth, and
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Table 1.5: Mouse Prl/PL Family
PRL Family Gene Name Official Symbol (Human Analogue)
Prolactin Prl (PRL)
Prolactin family 2, subfamily a, member 1 Prl2a1
Prolactin family 2, subfamily b, member 1 Prl2b1
Prolactin family 2, subfamily c, member 2 Prl2c2
Prolactin family 2, subfamily c, member 3 Prl2c3
Prolactin family 2, subfamily c, member 4 Prl2c4
Prolactin family 2, subfamily c, member 5 Prl2c5
Prolactin family 3, subfamily a, member 1 Prl3a1
Prolactin family 3, subfamily b, member 1 Prl3b1 (CSH2 )
Prolactin family 3, subfamily c, member 1 Prl3c1
Prolactin family 3, subfamily d, member 1 Prl3d1 (CSH1α)
Prolactin family 3, subfamily d, member 2 Prl3d2 (CSH1β)
Prolactin family 3, subfamily d, member 3 Prl3d3 (CSH1γ)
Prolactin family 4, subfamily a, member 1 Prl4a1
Prolactin family 5, subfamily a, member 1 Prl5a1
Prolactin family 6, subfamily a, member 1 Prl6a1
Prolactin family 7, subfamily a, member 1 Prl7a1
Prolactin family 7, subfamily a, member 2 Prl7a2
Prolactin family 7, subfamily b, member 1 Prl7b1
Prolactin family 7, subfamily c, member 1 Prl7c1
Prolactin family 7, subfamily d, member 1 Prl7d1
Prolactin family 8, subfamily a, member 1 Prl8a1
Prolactin family 8, subfamily a, member 2 Prl8a2
Prolactin family 8, subfamily a, member 6 Prl8a6
Prolactin family 8, subfamily a, member 8 Prl8a8
Prolactin family 8, subfamily a, member 9 Prl8a9
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any disruption to this neuro chemical cocktail may predispose new mothers to altered
behaviour that may ultimately lead to mood disorders (Tan and Tan, 2013) (Figure
1.4).
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Figure 1.4: Hormonal Interactions. Factors that may predispose mothers to postpartum
mood disorders. These hormonal interactions could account for pre-natal depression, which show a
co-occurrence with post-natal mood disorders. Thus it follows that any disturbance in this early
neuro chemical cocktail may result in altered prenatal and postpartum behavioural outcomes, thus
linking this array of conditions. Adapted from Brunton and Russell (2008).
At the point of parturition, progesterone withdrawal combined with increasing
oestradiol levels activates Medial Pre-Optic Area (mPoA) neurons, as does pup-
seeking behaviour or postpartum exposure to pups (Champagne et al., 2001, Numan
et al., 2005). The mPoA has been linked to improved parenting behaviour in mice
(Wu et al., 2014). Previously Modney et al. (1990) suggested that neuronal changes
are caused by stimulation provided by pups alone. Numan (2006) demonstrated that
this so called sensitisation was possible, renewing the debate that asks whether it
is possible for sensory stimulation from newborn pups alone is enough to influence
the learning and memory of a dam or non-pregnant female. Further evidence has
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since indicated an increase in dendritic spine concentrations (improving synaptic
signalling) in lactating females, whose circulating hormone profile is vastly different
from the late-pregnant one, suggesting an influence of the pups. This work has
subsequently been supported through the experimental work in rodents that showed
how central prolactin infusion alone could stimulate maternal behaviour in steroid
primed female rats (Bridges et al., 1990). Similarly, Svare and Gandelman (1976)
reported that suckling stimulation, and olfactory cues from pups, maintain maternal
aggressive behaviour (Garland and Svare, 1988, Svare and Gandelman, 1976). Taken
together this may indicate that there is a combined role of hormonal priming and
the reinforcement of neuronal restructuring and plasticity brought about through
the combined affect of hormonal release and exposure to pup provided stimuli.
It therefore follows that any disruption to either of these key points in pregnancy
and early life will have an impact upon the maternal postnatal phenotype. Numan
(2006) demonstrated that changes in the brain of pregnant rats allows the estab-
lishment of maternal behaviour; behaviour that will disappear unless reinforced
through maternal experience postpartum. In sheep olfactory memory is essential
for bonding (Kendrick, 2000). Research using non-human primates that focussed
on neural and endocrine regulation have all produced converging results (Keverne
and Kendrick, 1994, Saltzman and Maestripieri, 2011). This ensures confidence
when applying discoveries about maternal behaviour onto the human condition, and
mammals in general (Numan, 1994, 2006, Pryce, 1992). This is because although
outwardly different the behavioural adaptations that occur in human pregnancies are
fundamentally very similar in non human species and are likely mediated by similar
systems, such as the maternal hormones originating from the both the placenta and
the brain (Kristal, 2009).
29
Hugo Creeth Prolactin and the Placental Hormones
1.8.2 Prolactin and Neurogenesis
Prolactin and the Prls not only help indicate the reproductive state, they have been
shown to indirectly coordinate a range of neuronal and neuroendocrine adaptations to
pregnancy including neurogenesis (Bridges and Grattan, 2003, Larsen and Grattan,
2010). Interestingly, as the levels of oestrogens get higher during gestation, it
facilitates the entry of prolactin into the brain of the mothers by increasing the
production of the Prlr in the choroid plexus (Pi et al., 2003), suggesting the importance
of prolactin and the Prls signalling in the brain. An idea that is substantiated by the
indirect evidence that prolactin is essential for normal maternal behaviour (Bridges,
1994, Larsen and Grattan, 2010), aiding in the transition to motherhood. Shingo
(2003) were first to show the exciting work that indicates that prolactin stimulates
neurogenesis in adult female mice. New neurons stimulated initially by the act of
mating, continue to be produced in the forebrain during pregnancy and lactation and
migrate to the olfactory bulb where they likely participate in processing olfactory
cues received by the new dam as she adapts to the challenges of raising young
(Alvarez-Buylla and Garcia-Verdugo, 2002, Alvarez-Buylla and Lim, 2004, Shapiro
et al., 2009). Brunton and Russell (2008) in their review highlighted the different
dimensions of gestation that are known to contribute to maternal behaviour. Research
by Lucas et al. (1998) further implicated a role of prolactin, their paper showed that
heterozygous Prlr KO mice have severe maternal-behaviour deficits, demonstrating
the essential role of prolactin and/or Prls in initiating maternal behaviour.
As the placenta is a source of hormones, in particular the Prls (John, 2013, Tunster
et al., 2015), it is hypothesised that the placenta may be involved in the initiation of
maternal neurogenesis. The hormones generated by the placenta during pregnancy
have previously been described in section 1.8, and are manufactured by TGC and SpT
lineages in mice. Prolactin is a closely related hormone that has been implemented
in the generation of specific maternal behaviours. The fact that Prls far outweigh
prolactin levels at midgestation (Lee and Voogt, 1999, Soares, 2004), and their action
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on the Prlr makes them key candidates for playing a key role in the development of
maternal behaviour. Prolactin is periodically released by the pituitary in response
to pregnancy (Freeman et al., 2000, Soares, 2004). It is known for its involvement in
inducing multiple maternal behaviours and lactation, its involvement in stimulating
adult neurogenesis in the SVZ of the forebrain lateral ventricles and SGZ of the
Dentate Gyrus (DG) within the hippocampus is relatively new (Shingo, 2003). The
hippocampus has been shown in rodent models to be vital for memory and learning
(O’Keefe and Nadel, 1978). The SVZ being a presiding contributor to the olfactory
system of the brain and thus olfactory reception. This therefore shows the need for
a functional SVZ in normal postnatal maternal behaviour including grooming and
cleaning in mice (Larsen and Grattan, 2010, Shingo, 2003).
Studies have focussed primarily on the impact of prolactin and have been promising.
The results, caused by changing levels of these hormones, caused reduced pup retrieval
scores. When loss of function of the Prlr models were used for both homo- and
hetero- zygous nulliparous female rats, they went on to develop a defect in the
olfactory dependent foster pup induced maternal behaviour (Lucas et al., 1998). A
model where the experimentally reduced prolactin levels had the effect of increasing
postnatal anxiety and decreased pup retrieval (Lucas et al., 1998). This is consistant
with Shingo (2003)’s findings that a heterozygous loss in the Prlr gene in pregnant
mothers causes a 50% reduction in forebrain SVZ neurogenesis on GD7. The way that
prolactin appears to work is through increasing hippocampal precursors/interneurons,
seen through neurosphere assays (Walker et al., 2012, 2013).
There are no reports that look at adult neurogenesis status in the SVZ and SGZ
of the maternal brain during late gestation when the placenta is signalling most
intensely. The female rodents blood stream during pregnancy contains many times
more Prls compared to pituitary prolactin in the later stages of gestation (Newbern
and Freemark, 2011, Soares, 2004, Soares et al., 2007). This may imply that there is
a shared contribution between Prls and prolactin in maternal neurogenesis, leading to
the hypothesis that altering levels of either of these hormones will result in changes in
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maternal behaviour. The transient decrease in neurogenesis seen in the hippocampus
on E11.5 and E12.5, indicated through BrdU/DCX positive cells by Rolls et al.
(2007) coincide with a decrease in signalling before a further spike in Prls that have
previously been widely ignored.
Maternal behavioural adaptations are sparsely studied in detail in humans outside of
psychology (Saltzman and Maestripieri, 2011). Meaning the processes surrounding
the induction of these behaviours are not well understood, and are subject to ongoing
debate and research. In rodents it is known that certain aspects of maternal behaviour
once established do persist, whilst others can revert back to the pre-pregnancy state.
Those that do persist, do so independently from hormonal regulation and are thus
considered permanent. This suggests structural alterations in the neurons in the
maternal brain (Bridges et al., 1990). The indirect support from rodent studies
that links lactogenic hormones, in particular prolactin and the Prls, to maternal
behavioural alterations suggests that these hormones are critical signals to the
maternal brain(Grattan and Kokay, 2008). Taken together it is likely that the initial
neurogenesis and early behavioural phenotype may be dictated by hormones but
maintained through mother-pup interaction.
1.9 Imprinting
Imprinted genes, which are expressed from one parental chromosome as a consequence
of epigenetic events initiated in the germline (Surani et al., 1993) have been proposed
to play a role in regulating placental hormones (Haig, 1993). This monoallelic parent
of origin dependent expression is what is known as “genomic imprinting” (Surani et al.,
1984). Genomically imprinted genes are genes that are subject to complex epigenetic
processes and have been linked to key roles in the regulation of fetal growth and
placental development (Crossey et al., 2002, Fowden et al., 2006, Georgiades et al.,
2002, Tunster et al., 2012). Imprinted genes only make up approximately 0.4% of
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the mammalian genome, but have a disproportionately important influence on early
mammalian development (Tycko and Morison, 2002). In diploid organisms there are
two copies of each autosomal chromosome. These chromosomes are homologous and
are a result of the inheritance of a complete haploid set of chromosomes from each
parent at the point of conception. Autosomal genes are represented by two alleles
that are usually capable of being transcribed (Watanabe and Barlow, 1996). This
biallelic expression is hypothesised to be vital in protecting the genome from harmful
genetic mutations such as random insertions and deletions (Otto and Goldstein,
1992). In spite of the proposed advantages of biallelic expression at least 100 protein
coding mammalian genes are imprinted genes that are monoallelically expressed
(Cross, 2005, Isles and Holland, 2005).
+
Biallelic Expression
Paternally Expressed
Imprinted Gene
Maternally Expressed
Imprinted Gene
Non-Imprinted 
Gene
Monoallelic Expression
Fertilisation
Figure 1.5: Biallelic and Monoallelic Expression of Genes. A basic schematic showing
the difference between biallelic expression of a gene and monoallelic expression for a paternally
expressed gene (green) and maternally expressed gene (blue).
The term genomic imprinting was initially used in the context of experiments
in mammals examining parthenogenetic and androgenetic development in mice
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(Mann and Lovell-Badge, 1984, Surani et al., 1984). Parthenogenesis is an asexual
process where an embryo develops without fertilisation by a male. It is common
in invertebrates but extremely rare in vertebrates occurring exclusively in fish,
reptiles and birds (Chapman et al., 2007, Rougier and Werb, 2001). Parthenogenetic
individuals usually contain duplicate copies of maternal DNA. Micromanipulation
of newly fertilised mouse embryos was used to generate individuals with either two
maternal genomes or two paternal genomes (Surani et al., 1984). Parthenogenetic
embryos were shown not to be viable, dying by E9.5. Androgenetic conceptuses (two
copies of paternal DNA) were found to die earlier with developmental delay leading
to the hypothesis that both parental genomes are vital for development in mammals.
Importantly, parthenogenetic and androgenetic trophoblasts were phenotypically
abnormal. The associated extraembryonic tissue of parthenogenetic embryos was
almost non-existent. This was seen to be a likely contributing factor to the observed
embryonic lethality (Thomson and Solter, 1988).
These reciprocal phenotypes, associated with gynogenetic/parthenogenetic and an-
drogenetic conceptuses therefore not only suggested complementary roles for the two
parental genomes in the development of the embryo, but also in the development
of the placenta. Although imprinted genes were not yet discovered the observation
that large amounts of extraembryonic tissue was present in androgenetic embryos,
pointed to idea that the expression of paternal genes were required for placental de-
velopment. Whilst those controlling stages of embryonic development were expressed
from the maternal genome (Barton et al., 1984). It wasn’t until further experiments
using chimeric mice, generated from a mixture of parthenogenetic/gynogenetic and
androgenetic cells, that the striking pattern of segregation of the two cell types
was revealed. Trophoblast tissue was shown to tend to consist of androgenetic
cells and the embryo being formed largely from parthenogenetic/gynogenetic cells
(Surani et al., 1987, Thomson and Solter, 1988). These chimeras also failed to
survive to term. This indicated that there was still an incomplete complement of
gene expression. Therefore it was proposed that some placental-specific genes are
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also maternally expressed and similarly there are some embryo specific genes that
are paternally expressed. A theory that has been shown to be the case. Despite
this, these experiments importantly identified a critical role for imprinted genes in
placental development.
Monotremes
Marsupials
Eutheria
No Placentation
No Imprinting
Non-Invasive Placentation
Limited Imprinting
Invasive Placenta
Extensive Imprinting
Evolution of Placentation
~ 170 M.y.a
~ 150 M.y.a
Co-Evolution of Imprinting and Placentation
Figure 1.6: Co-Evolution of Imprinting and Placentation. Placentation evolved 170 million
years ago. Marsupials and Eutherians diverged around 150 M.y.a. It was at this point that the
imprinting of specific genes enabled the evolution of the more invasive eutherian placenta after
diverging from marsupials around 150 M.y.a.
Imprinted genes allelic expression can be absolute, partial, temporal or tissue-
specific with some genes such as Growth Factor Receptor Bound Protein 10 (Grb10)
displaying both maternal and paternal-exclusive expression depending on tissue type
(Blagitko et al., 2000, Dent and Isles, 2014). Thus recently the definition of an
imprinted gene has more accurately been described as one that shows differential
expression of parental alleles in one or several tissue types (Moore, 2001). The
predicted danger of monoallelic expression of genes is that the protection offered
from single point mutations in biallelic expression is forfeited (Wilkins and Haig,
2003). Similarly, due to the dosage-related function of most imprinted genes, loss of
silencing can also result in phenotypic changes (John and Hemberger, 2012). This
is the case Silver Russell Syndrome (SRS) (Yoshihashi et al., 2000), Prader-Willi
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Syndrome (PWS) (McNamara and Isles, 2013) and cancer (Rainier et al., 1993). In
BWS, SRS (human chromosomal region 11p15) and PWS (human chromosome 15)
both genetic and epigenetic abnormalities on these chromosomes have been linked to
distinct phenotypes associated with these diseases (Davies et al., 2015, Kent et al.,
2008). Specifically BWS and SRS are thought to be reciprocal growth disorders that
result as a consequence of loss and gain in expression of paternally and maternally
expressed genes, for example IGF2 and CDKN1C (Shmela and Gicquel, 2013). It
is now commonly accepted that dysregulation of imprinted gene expression either
through deletion, inappropriate silencing or loss of imprinting can lead to or be the
causal factor in sporadic, inherited and environmentally induced growth disorders
(Butler, 2009, Miozzo and Simoni, 2002).
1.9.1 Imprinting and Behaviour
The importance of imprinted genes to physiological systems has been widely accepted
and demonstrated through the use of gene knockout studies and those parthenogenetic
and androgenetic studies previously described (Falls et al., 1999, Isles and Wilkinson,
2011a,b, Jelinic and Shaw, 2007). Several of the imprinted genes that have been
described in the literature have been shown to be involved with several neurological
and psychological traits found in humans (Arima et al., 2005, Buettner et al., 2005,
Diaz-Meyer, 2003).
These disorders are most commonly investigated through mouse models, as these
offer the most tractable genetic analogs. Perhaps one of the most relevant studies
into this area is the study by Li et al. (1999) that investigated the phenotypic effect
that knocking out the paternally expressed Paternally Expressed Gene 3 (Peg3) gene
had in female mice. Loss of function of Peg3 resulted in LBW and the Peg3+/-
mothers exhibited aberrant maternal behaviour (Li et al., 1999). These findings
were later corroborated through a study that demonstrated a marked reduction in
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oxytocin-producing neurons and impaired maternal behaviour (Curley et al., 2004).
These mice have been shown to have a marked delay in reaching puberty (Broad
et al., 2009). Peg1/Mest a closely related gene has also been studied by Li et al.
(2002), where they found an association between embryonic growth and maternal
behaviour. Vitally these genes are analogous to Paternally Expressed Gene 1 (PEG1)
and PEG3 in humans on chromosome 7q32. The link between imprinted genes and
maternal behaviour through the direct alteration of specific neurons in the maternal
brain, highlights the potential for further analysis of this area to help understand
the co-occurrence between LBW and maternal mood disorders.
1.10 The Evolution of Imprinting
Genomic imprinting is also found to occur in plants, more specifically imprinted
genes are expressed during the development of the endosperm (Kinoshita et al., 1999,
Vinkenoog et al., 2003). The evolution of imprinting in animals and plants evolved
independently, despite there being similar mechanisms used for gene regulation
between the two (Feil and Berger, 2007).
The fact that genomic imprinting represents the monoallelic expression of genes
over the biallelic expression of certain genes is fiercely questioned as the protection
offered from single point mutations in biallelic expression is forfeited (Wilkins and
Haig, 2003). Specifically, the reason why imprinting evolved in mammals at all is
hotly debated (Patten et al., 2014). There are a few potential theories that offer
explanations why imprinting may have evolved in mammals.
The first, known as the “Adaptation of Host Defence” theory cites the idea that the
human genome is made up of a considerable amount of “junk” DNA, potentially
over 40% (Smit, 1999). The fundamental theory that at least some of this “junk” is
actually transposable elements that have been inserted over time, with the majority
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of them no longer active, holds true (Palazzo and Gregory, 2014). These transposable
elements could pose a threat to the host organism if incorporated into endogenous
genes and ultimately the effect this has upon the gene product. The mammalian
genome inactivates these elements via methylation and chromatin modifications
(Slotkin and Martienssen, 2007). These mechanisms are the same ones that control
the expression of imprinted genes (Li et al., 1993). Therefore it follows that some have
theorised that due to this common usage of control mechanisms, genomic imprinting
has evolved as a result of these host defence mechanisms (Ono et al., 2001, Tunster,
2009).
The second theory, which has widely been disbanded is the “Ovarian Time Bomb
Hypothesis”. The theory purports that imprinting arose as a way to prevent unfer-
tilised oocytes implanting and causing malignant trophoblast disease (Varmuza and
Mann, 1994). The theory by Varmuza and Mann (1994) proposes that these “tumors”
become less invasive as a direct result of imprinting silencing genes that promote
trophoblast invasion. The authors pointed to the phenotypic characterisation of com-
plete hydatidiform molar pregnancies (when there is the fertilisation of an enucleated
egg and duplication of the paternal genome), which can be highly invasive (Kajii and
Ohama, 1977). Critically this theory does not explain the imprinting of genes that
are not involved in trophoblast development or indeed the presence of imprinting in
the male genome. Meaning that it has been almost entirely rejected (Haig, 1994).
Thirdly and perhaps the most popular theory is “The Parental Conflict Hypothesis”
described by Moore and Haig (1991). This theory postulates that paternal genes
enhance, and maternal genes suppress, fetal growth. This is done through the
control of the distribution and availability of resources by these imprinted genes.
The paternal genome maximises the resources that can be extracted from the mother
during development, whilst the maternal genome acts to limit the nutrients available
to individual offspring and the offspring as a whole. The evidence that this theory
is based upon was the discovery of the reciprocally imprinted Igf2 and Insulin-like
Growth Factor 2 Receptor (Igf2r) genes, which are described in more detail in the
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next section.
1.10.1 Imprinting and the Placenta
Imprinting is more prevalent in eutherian mammals than marsupials (John and
Surani, 2000). This suggest the possibility that imprinting is driven by the extended
in utero development, as seen in Eutherians, adding additional selective pressure.
While both marsupials and eutherian mammals possess a placenta, and diverged from
monotremes 170 million years ago (Figure 1.6). The marsupials have less extensive
fetal development and less extensive imprinting and a less elaborate noninvasive
choriovitelline placenta supports this development. This is in contrast to the more
extensive imprinting that occurred in eutherian mammals alongside a more invasive
placenta and longer gestational times (John and Surani, 2000). This leads onto
the interesting fact that imprinted genes are only sparsely expressed in the adult
mammal, whilst they show comparatively high and prolific expression in the placenta
(Coan et al., 2005, Frost and Moore, 2010, John and Hemberger, 2012). In total
there are thought to be around 100 protein coding imprinted genes almost all of
which are expressed in the placenta and yolk sac (Bressan et al., 2009, Fowden
et al., 2011, Tunster et al., 2013). Importantly, a significant number of mouse
studies demonstrate that imprinted genes often act to regulate placental development
(Tunster et al., 2013). Imprinted genes are expressed in the brain and are essential
in brain development as originally suggested by Keverne (1997) when there was
non-random distribution of cells within the androgenetic and gynogenetic genomes
in chimeric brains. Androgenetic cells tended to contribute to the hypothalamus
and areas associated with primary motivated behaviour, while gynogenetic cells
accumulate in the neocortex and regions linked to more complex behaviours (Keverne,
1997).
The first two protein encoding imprinted genes to be discovered were Igf2 and its
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receptor Igf2r (Barlow et al., 1991, DeChiara et al., 1991). Both of which confer
reciprocal functions in placental and fetal growth (DeChiara et al., 1990). Igf2
encodes a growth hormone (Chao and D’Amore, 2008). Its loss of function resulted in
embryonic growth restriction phenotype following paternal transmission of a specific
deletion (Constância et al., 2002, DeChiara et al., 1990). This was initially put down
to haploinsuffiency, but was later ruled out after Igf2 expression levels were noted to
be lower than a 50% reduction. It followed that DeChiara et al. (1991) went on to
show that the locus of the gene was paternally imprinted. In contrast Igf2r has been
shown to be maternally expressed, and mediates the growth regulating properties
of Igf2 by attenuating the signalling of Igf2 by clearing Igf2 from the cell surface.
These phenotypes identified in mice were what ultimately gave rise to the parental
conflict hypothesis proposed by Moore and Haig (1991), and the seminal experiments
demonstrated that there were the tools necessary to answer the unanswered questions
about genomic imprinting (Barlow et al., 1991). A select few of these genes are
pivotal in the regulation of the endocrine lineage of the mouse placenta (John, 2013),
something that has led to a new focus suggesting a link between imprinted genes,
endocrine placental signalling and maternal behavioural adaptations.
1.11 Chromosome 7 and PHLDA2/Phlda2
1.11.1 Chromosome 7
Imprinted genes are commonly located within domains which can encompass sev-
eral megabases of DNA with both paternally and maternally expressed transcripts
(Bartolomei and Ferguson-Smith, 2011). One well studied domain is the human
chromosome 11p15/mouse distal chromosome 7 domain (Burton, 2011, Shmela and
Gicquel, 2013). In mice this domain is divided into two mechanistically distinct
domains, these being Imprinting Centre 1 (IC1) and Imprinting Centre 2 (IC2). IC2
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contains several genes that are imprinted and expressed in the placenta. This domain
has been shown to contain genes important for placental and fetal growth. Two
studies in particular, one by Fitzpatrick et al. (2002) and another by Mancini-Dinardo
et al. (2006) showed that through either the targeted deletion of the imprinting centre
or the removal of the long non-coding strand, Kcnq1ot1, respectively (Figure 1.7),
it is possible to restrict placental and fetal growth. Three key maternally expressed
genes from this region are Achaete-Scute Family bHLH Transcription Factor 2 (Ascl2)
(formerly Mash2 ), Cyclin Dependent Kinase Inhibitor 1C (Cdkn1c) and Pleckstrin
Homology Like Domain family A member 2 (Phlda2), have been targeted in mice
with additional over expression data for Phlda2 (Tunster et al., 2013). More recently
the consequence of over expressing Ascl2 have been reported (Tunster et al., 2016).
In humans, the domain is linked to a number of rare imprinting disorders including
BWS, SRS and IMAGe syndrome (Arboleda et al., 2012, Butler, 2009, Soejima
and Higashimoto, 2013). While ASCL2 is not imprinted in the human placenta
(Miyamoto et al., 2002), the gene sequences are well conserved which supports role
for these genes in the growth phenotypes reported in these syndromes (Shmela
and Gicquel, 2013). Imprinted genes found in domains are regulated by genomic
regions known as imprinting centres (ICs), but are also referred to as Imprint Control
Elements (ICEs) and Imprinting Control Regions (ICRs) (Bartolomei and Ferguson-
Smith, 2011). These ICs are differentially methylated in the germline, marks which
are maintained after fertilisation. Importantly, they have been functionally defined
through careful engineering of targeted deletions in mice (Chamberlain and Brannan,
2001, Williamson et al., 2006). If a deletion is inherited through one of the parental
germ lines, it releases every gene that is located in the domain from their imprinted
status causing a Loss of Imprinting (LOI).
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Figure 1.7: Imprinting. (a) An imprinting map of the mouse (Mus musculus) showing the
paternally expressed genes (blue) and maternally expressed genes (green) (b)The imprinting centre
2 (IC2) of the mouse (Mus musculus) showing the paternally expressed genes (blue) and maternally
expressed genes (green). Adapted from Tunster et al. (2013).
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1.11.2 PHLDA2/Phlda2
Phlda2 is the imprinted gene and the focus of this study. It is a maternally expressed
imprinted gene that has been known by several other names since its first discovery,
namely in humans BRW1C, HLDA2, IPL and TSSC3 (Salas et al., 2004). Studies
from the Tycko laboratory and our research group have defined a role for this gene
in the development of the placenta (Frank et al., 2002, Salas et al., 2004, Tunster
et al., 2015, 2010). Importantly, loss of expression and increased Phlda2 dosage has
a reciprocal effect on the junctional zone of the mouse placenta (Frank et al., 2002,
Tunster et al., 2015, 2010, 2014), described in more detail below.
Phlda2 encodes a small, cytoplasmic PH domain only protein whose function is
not yet known (Qian et al., 1997). Although the function of Phlda2 has not been
assessed, a closely related protein, Pleckstrin Homology Like Domain family A
member 3 (Phlda3) has been identified in having a role in the inhibition of Akt-
regulated processes (Kawase et al., 2009). Phlda2 is preferentially expressed in the
extraembryonic tissue, more explicitly the ectoplacental cone and extraembryonic
membranes (the visceral endoderm of the yolk sac). It then becomes restricted to
the labyrinth zone by E10.5 by which point the mature placenta has formed (Frank
et al., 1999). Past this point, E10.5, Phlda2 is solely expressed in the forming type
II trophoblast and at a lower level in type III trophoblast cells. It is after E14.5 that
Phlda2 expression declines.
Our most recent studies by Tunster et al. (2015) demonstrated that Phlda2 specifically
and exclusively regulates the size of the SpT lineage of the junctional zone. The
SpT is a key source of placental prolactins and Placental Specific Glycoproteins
(Psgs). Consequently Phlda2, indirectly, negatively regulates the production of
placental hormones. The RNA expression analysis (see Chapter 3) identified the
SpT transcriptome (Tunster et al., 2015).
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The SpT expresses a number of Prls and Psgs, displayed in Table 1.6 (Simmons
et al., 2008, Tunster et al., 2015). In the published model of Phlda2 -/+ (KO) placenta
express a number of prolactin family members at higher levels than wildtype (WT)
(Tunster et al., 2015). Conversely, Phlda2 +/+ BACx1 (TG) placenta (which carry an
extra copy of the Phlda2 gene on a Bacterial Artificial Chromosome (BAC), Chapter
2) express lower levels of these same hormones. This work led to the hypothesis
that the expression of imprinted genes in the placenta could influence maternal
adaptations to pregnancy (John, 2013). Importantly, these well characterised mouse
models provided a systems to test this hypothesis in a physiological relevant context.
Table 1.6: Placental Lactogens and Glycoproteins found in SpT
PRL Family Name Official Symbol
Prolactin Family 3, subfamily b, member 1 Prl3b1
Prolactin Family 8, subfamily a, member 8 Prl8a8
Prolactin Family 8, subfamily a, member 9 Prl8a9
Prolactin Family 7, subfamily a, member 2 Prl7a2
Prolactin Family 3, subfamily c, member 1 Prl3c1
Prolactin Family 3, subfamily a, member 1 Prl3a1
Prolactin Family 2, subfamily c Prl2c
Pregnancy Specific Glycoproteins Psgs
1.12 Project Overview
Prolactin and the Prls are known to play an indirect role in maternal behaviour. In
this project we used the imprinted gene Phlda2 to manipulate the levels of the size of
the SpT lineage of the mouse placenta, and thus the subsequent expression levels of
the Prls and Psgs (Figure 1.8). Embryos with zero, one and two-fold expression of
Phlda2 have 200%, 100% and 50% the levels of expression of SpT-specific hormones.
Using a process called RET, preimplantation embryos can be transferred into WT
recipient females to test the functional relevance of these different dosage of Phlda2
and subsequent placental hormone levels. This technique will allow the manipulation
of the Prls without having to delete the prolactin locus.
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Figure 1.8: Average fold changes for specific genes shown to have differential expres-
sion in the placenta of dams at E14.5. Phlda2 indirectly suppresses the expression of key
placental hormones. A. qPCR comparison of Prls at E14.5 between Phlda2 +/+ (WT, 1X), Phlda2
-/+ (maternal KO; 0X), Phlda2 +/+ BACx1 (2X) and Phlda2 -/+ BACx1 (rescue; 1X) 129 placentae.
B. qPCR comparison of Psgs at E14.5. C. In situ hybridisation of midline sections E14.5 placentae
using Psg17 to label the spongiotrophoblast (scale bar = 200 µm). For the qPCR analysis, n = 4
placenta per genotype (2 vs 2 from 2 independent litters). Error bars represent SEM. Statistical
significance: *p < 0.05, **p < 0.01 and ***p < 0.005. Data generated by Simon Tunster.
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The behavioural outcomes of these mothers carrying different placenta will be assessed,
and then a basic biomolecular characterisation performed. This will be done at an
earlier time point than when the behavioural tests were carried out, in order to
determine whether there are any molecular changes that predate the behavioural
phenotype and therefore offer an explanation on the mechanism that may cause any
behavioural changes that are observed.
Finally the offspring of the low placental signalling (Phlda2 TG) model dams will be
assessed in order to determine whether there is any lasting effect on the behavioural
and biomolecular phenotypes of the offspring. This model will also help determine
whether these effects are due to the in utero environment or post natal maternal
care.
1.13 Hypotheses
1. Imprinted genes influence maternal care behaviours via the placental endocrine
compartment.
2. Placental endocrine dysfunction can impact offspring outcomes either via fetal
growth restriction or poor maternal care.
1.14 Aims
The aims below are outlining the major focusses for each experimental chapter and
are by no means extensive.
1. To use microarray analysis to identify the SpT transcriptome in the placental
lineages of the different Phlda2 gene dosage mouse models.
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2. To assess maternal behaviour changes as a consequence to abnormally high or
low placental signalling. To do this three embryo types were transferred into
three cohorts of wild type female mice:
• Phlda2 -transgenic embryos (TG). These are a low signalling model and
contain an extra copy of Phlda2.
• Phlda2 -knockout embryos (KO). These are a high signalling model, one
copy of Phlda2 has been ablated causing high placental signalling.
• Wild type embryos (WT). These are the control with normal dosage of
Phlda2 and levels of signalling.
Several key maternal behaviours will be assessed including:
• Maternal anxiety in response to the three models using the elevated plus
maze test.
• Pup retrieval and Nest building in a specially designed home cage capable
of 24 hour monitoring.
• Specific nurturing behaviours scored manually using the 24 hour surveil-
lance of mothers during the nest building behavioural assay.
• Fetal weights and pup weights will also be recorded as indicators of
maternal nurturing behaviour effectiveness.
3. Perform a basic biomolecular characterisation of each of the three maternal
cohorts. Microarray on brain regions and analyse data to identify genes
and changes in gene expression in the maternal brain as a result of altered
placental signalling will be used to generate hypotheses about specific genes of
interest. These mothers will also have their neurogenesis levels evaluated using
immunohistochemistry.
4. Using the maternal care model for low placental signalling (Phlda2 TG) the
offspring outcomes will be characterised for both a behavioural phenotype and
a biomolecular phenotype.
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2.1 Mouse Model
The function of Phlda2 in pregnancy was studied using two mouse models, a Phlda2
knockout (KO) mouse model (Frank et al., 2002) and a Phlda2 over expression
(TG) mouse model (Tunster et al., 2010). The KO mice were originally generated
by targeted ablation of both coding exons of the Phlda2 gene as well as half the
upstream CpG island (Frank et al., 2002). Male Phlda2 heterozygotes (absence of
paternal allele, regarded as phenotypically wild type (WT)) were crossed to WT
129S2/SvHsd (129) females for > 12 generations and maintained by the John Lab.
To generate embryos without expression from the maternal allele (termed Phlda2
-/+ maternal KO; 0X), female Phlda2 homozygotes were mated with wild type 129
males (Figure 2.2).
Figure 2.1: BAC Transgene. Basic schematic illustrating the BAC transgene used in our mouse
model. The BAC spanned Phlda2 (yellow) and two other genes, Slc22a18 (red) and Cdkn1c (blue).
Cdkn1c expression from the transgene was replaced by a beta-galatosidase cassette (lacZ), and the
promotor ablated.
Hugo Creeth Mouse Model
In order to mimic the effect of the loss of imprinting, a BAC transgenic model (10-10)
was utilised. These mice possess a single copy of the BAC transgene (Figure 2.1)
resulting in expression at twice the endogenous level in the placenta (Tunster et al.,
2010). The transgene is 85kb in length and doesn’t undergo imprinting meaning
that Phlda2 is expressed on either the paternal or maternal allele; Phlda2 +/+ BACx1
(single copy Phlda2 transgene, TG; 2X). All the models were maintained on a pure
129 genetic background. The TG 10-10 line was maintained through mating 10-10
TG females with 10-10 TG males. Homozygous transmission of the TG results in
animals that are non-viable thus the line was kept as hemizygous.
WTTG WTTG WTWT KOKOWTWTWTWT
100% WT 25% Homozygous TG (Lethal) 
50% Hemizygous TG
25% Homozygous WT (NON-TG) 
100% Heterozygous Maternal KO
(1 X Phlda2 Dosage) (3 X Phlda2  Dosage)
(2 X Phlda2  Dosage)
(1 X Phlda2  Dosage)
(0 X Phlda2  Dosage)
or
or
or
Figure 2.2: Crosses/Matings performed. A schematic outlining the various crosses/matings
performed in order to generate the embryos utilised for the recipient embryo transfer procedure.
Phlda2 is maternally imprinted, therefore the maternal heterozygous KO results in no expression of
Phlda2. The transgene (TG) is not imprinted and can be transmitted on either the maternal or
paternal allele.
All animal studies and breeding was approved by the University of Cardiff ethical
committee and performed under a UK Home Office project license (RMJ, 30/3134).
Mice were housed on a 12 hour light/dark cycle with lights coming on at 07.00 hours
with a temperature range of 21°C ± 2 with free access to tap water and standard
chow unless otherwise stated. All procedures performed upon the mice were carried
out exclusively by Personal Licence Holders.
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2.2 Recipient Embryo Transfer (RET)
In order to isolate the affects of Phlda2 on the phenotype of the mothers in this study,
it was crucial to maintain the dams WT status. Therefore the RET procedure was
required. RET was carried out in the Cardiff Transgenic Production Facility (TPF) by
Bridget Allen. Through controlled matings pre-implantation embryos that were either
WT (Phlda2 +/+), TG (Phlda2 +/+ BACx1) or (Phlda2 -/+) KO (Figure 2.2) were
generated. Pseudopregnant WT females are then produced through the controlled
mating of virgin females with vasectomized males. Embryos that were harvested at
E1.5 were then implanted via bilateral oviduct transfer into pseudopregnant WT
females at E0.5 (Figure 2.3).
Ovary
Air
Embryos
Slit
Figure 2.3: Recipient Embryo Transfer Schematic. A schematic demonstrating the RET
procedure performed, in order to maintain the WT status of the dams.
On the fifth day of pregnancy these females were moved from a barrier unit at Cardiff
University to the Science Research Infrastructure Fund (SRIF) housing, where they
were monitored and weighed at predetermined intervals, so as to check general health
and for signs of pregnancy. The females that were viewed as being pregnant were
culled at E16.5 and dissected, or allowed to give birth and used for behavioural
testing (Figure 2.4).
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WT        + WT Embryo
WT(WT)
Phlda2 control (1X) 
(100% Spongiotrophoblast)
A. B. C.
WT        + TG Embryo
WT(TG)
Phlda2 x 2 (2X) 
(50% Spongiotrophoblast)
WT        + KO Embryo
WT(KO)
Phlda2 null (0X)
(200% Spongiotrophoblast)
Behavioural Testing
+
P7 Dissections
Behavioural Testing
+
P7 Dissections
E16.5 Maternal
Dissections
Behavioural Testing
+
P7 Dissections
E16.5 Maternal
Dissections
E16.5 Maternal
Dissections
Figure 2.4: The Three Cohorts for Behavioural and Biomolecular Analysis. Simplified
diagram explaining the basis of the mouse model generated through RET. Around 14-16 embryos
carrying varying doses of Phlda2 were implanted into 3 cohorts of 20 WT females. These WT
females then carried either A. WT or B. Phlda2 - TG or C. Phlda2 - KO fetuses. 12 dams were
allowed to give birth and then tested for behavioural changes before dissection. The other 8 dams
were dissected at E16.5 for bimolecular analysis.
2.3 Biomolecular Procedures
2.3.1 Genotyping
Polymerase Chain Reaction (PCR) was utilised to identify the genotype of the donor
females, stock animals and experimental animals born from recipient females. The
yolk sacs or ear biopsies from pups taken at weaning were digested in lysis buffer (50
mM Tris (pH 8.0), 100 mM EDTA (pH 8.0), 100 mM NaCl and 0.5% SDS in water)
containing 400 µl/ml Proteinase K (PK) at 55°C overnight.
Samples were shaken vigorously and allowed to cool at room temperature for 40
minutes. Lysates were diluted either 1:10 for ears or 1:20 for tails and yolk sacs in
10 mM Tris (pH 8) and taken up to 95°C for 30 minutes to inactivate PK. Dilutions
were vortexed to mix, allowed to cool for 30 minutes and 1 µl used as a template in
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a reaction volume of 15 µl as in Table 2.1.
Table 2.1: PCR constituents
Reagents Volume per reaction (µl)
H2O 10.3
10X Buffer 1.5
25 mM MgCl2 1.2
dNTPs 0.3
Primers 0.6
Taq 0.1
Template 1.0
Primers were designed using Primer3 (Table 2.4) and purchased directly from Sigma
Genosys. They were then diluted to 100 µM in 10 mM Tris (pH 8). Both the forward
and the reverse primers were combined at a 1:4 dilution in 10 mM Tris (pH 8) and
0.6 µl of appropriate primer mix used in each PCR reaction.
The thermocycler was set at 94°C for 15 minutes, followed by 35 cycles of 94°C for
30 seconds, 60°C. for 30 seconds, 72°C for 30 seconds and then 72°C for 3 minutes
for each PCR. The reactions were loaded in 1% 1X Tris-acetate EDTA (TAE) agrose
gel containing 0.5 µg/ml of SafeView (NBS Biologicals) and run against a 100 bp
PCR Ranger ladder (Gene Flow) and visualised using a transilluminator (BioRad).
2.3.2 Dissection of Pregnant Females at E16.5
and P7
The mice were weighed and then sacrificed according to schedule 1 (through cervical
dislocation and death confirmed) at either E16.5 or P7. The uterus was removed and
weighed and the location of the pups in the uterine horn was noted before the uterus
containing the individual pups and placentae were placed into ice cold PBS. E16.5
and P7 dams were decapitated and the maternal brain was removed from the skull as
described in section 2.3.9 and specific regions dissected. The areas dissected from the
brain were the olfactory bulbs, hippocampus, frontal cortex and the hypothalamus,
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which were placed in labelled 0.5 ml eppendorfs before being flash frozen on dry ice
and stored at -80°C.
2.3.3 Serum Collection
After cervical dislocation and before decapitation the thoracic cavity was exposed to
reveal the heart. A 19G needle connected to a 1 ml syringe was used to puncture
the left ventricle and then allowed to remain at negative pressure in order to collect
the blood from the animal. Any excess blood present in the thoracic cavity was also
collected. The blood was then injected into microtainer tubes (BD, Oxford, UK) and
left to coagulate before being centrifuged at max speed (13,000 rpm) for 5 minutes
whilst further dissections took place. After the 5 minutes serum was flash frozen on
dry ice and stored at -80°C.
2.3.4 Preparation of RNA
RNA Extraction - Method 1
Hippocampal tissue was homogenised in 1 ml of RNA-Bee (Ams Biotechnology) with
an RNA-Free pestle (VWR International) in a 1.5 ml microfuge tube. 200 µl of
chloroform was then added, homogenates mixed and incubated on ice for 5 minutes.
Homogenates were centrifuged at 13,000 rpm for 15 minutes at 4°C. The aqueous
phase was removed and added to 0.5 ml of isopropanol, mixed, incubate at room
temperature for 10 minutes and centrifuged at 13,000 rpm for 10 minutes. Pelleted
RNA was washed in 1 ml of 75% Ethanol (EtOH) centrifuged at 13,000 rpm for
10 minutes, left to air dry for 30-60 seconds and re-suspended in an appropriate
volume of 10 mM Tris (pH 8). RNA concentration and integrity was evaluated using
a NanoDrop Spectrophotometer, with RNA concentration adjusted to approximately
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1 µg/µl using 10 mM Tris (pH 8).
Genomic DNA DNase treatment was performed. Approximately 1-3 µg of RNA
was treated using RQ DNase1 (Promega) in a 1.5 ml microfuge tube at 37°C for 45
minutes. 1 µl of RQ DNase1 was used per µg of RNA. The volume of the solution
was made up to 500 µl by adding Tris (10 mM). Then 500 µl of phenol was added
and mixed well by inverting. This mixing was repeated every few minutes for 10
minutes. A new set of 1.5 ml eppendorfs was labelled and 500 µl of chloroform added
to each, 45 µl of 3 M NaOAc (pH 6) was added to a second set of eppendorfs. The
DNA/phenol mix was spun at 12 000 rpm for 10 minutes at room temperature. On
completion the upper aqueous layer was removed and added to chloroform and mixed.
A further spin at 12 000 rpm for 10 minutes was then performed before the top layer
was removed once more before being added to the NaOAc for precipitation. 1 ml
of 100% EtOH was mixed with this solution and then left to precipitate the RNA
overnight at -20°C. The next day this is spun at 4°C and the EtOH poured off. 1 ml
of 70% EtOH is then added for a final wash and spun at 12 000 rpm a final time for
10 minutes before removing the remaining EtOH and re-suspending the pellet in 20
µl of 10 mM Tris.
RNA extraction - Method 2
RNA was extracted from neural tissue using GenElute™ Mammalian Total RNA
Miniprep Kit (Sigma-Aldrich, UK). The samples were homogenised in 500 µl of
Lysis Buffer containing 5 µl 2-Mercaptoethanol using an RNA-Free pestle (VWR
International) in a 1.5 ml microfuge tube. Lysate was transferred into the GenElute
filtration column and then centrifuged at 12 000 rpm for 2 minutes. Then 500 µl
70% EtOH was added to the filtered lysate and mixed by pipetting. Once mixed
500 µl of the mixture was added to the GenElute binding column at a time before
being centrifuged for 15 seconds at maximum speed. The remaining 500 µl of the
lysate/ethanol mix was run through the GenElute binding column before the flow
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through was discarded. Wash solution 1 was run through the binding column at 250µl
for 15 seconds at maximum speed. At this point 10 µl of DNase 1 was combined with
70 µl of DNase Digest Buffer for each preparation and mixed gently by inversion in
order to prevent the denaturation of the enzyme. 80µl was then added directly onto
the binding column and left at room temperature for 15 minutes. After 15 minutes
another wash was performed using 250µl of wash solution 1 and a 15 second spin at
max speed. The column was then transferred to a clean collection tube where it was
washed with two washes of wash solution 2, 500µl each time, for 15 seconds then 2
minutes respectively. Once the flow through was disposed of an extra 1 minute spin
step was added so as to make sure the column was completely dry before placing the
column in a clearly labelled 1.5 ml RNase free eppendorf and adding 50µl of Elution
Solution to the column before centrifuging for 1 minute at maximum speed. The
RNA was then quantified using the Nanodrop and stored at -80°C until needed.
2.3.5 Preparation of cDNA - Reverse Transcrip-
tion
To generate cDNA, total RNA was reverse transcribed (RT). For each sample, two
reactions were set up: RT+ and RT-. Reactions were set up in strip tubes. Then for
each reaction components in Table 2.2 were included.
Table 2.2: Reverse Transcription Components
Reagents Volume per reaction (µl)
DNAse Treated RNA 5 (µg)
0.5 (µg/µl) random hexamers 1 (µl)
RNAse free H2O Upto 11 (µl)
Tubes were incubated at 70°C for 10 minutes whilst a master mix was made as per
Table 2.3. Tubes were removed from incubator and placed immediately on ice. 8
µl of master mix was added to each tube. After 2 minutes at 37°C 1 µl of MMULV
was added to the RT+ reactions only. The tubes were incubated for 2 hours at 37°C
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before a 15 minute heat shock at 70°C. 5 µl was taken from each reaction and diluted
in 100 µl of 10 mM Tris.
Table 2.3: Master Mix reagents for each RT reaction
Reagents Volume per reaction (µl)
5X first strand synthesis buffer 4 (µl)
10 mM dNTPs 1 (µl)
RNAse free H2O 3 (µl)
2.3.6 cDNA Quality Control
After preparation of cDNA, PCR reactions were performed to confirm that the
samples were free of genomic DNA contamination and that cDNA had been produced
correctly and in sufficient quantities. A PCR was performed on the RT+ and RT-
dilutions using primers Gapdh (149/150) and β-Actin (151/152) (Table 2.4) in a
volume of 20 µl as described in section 2.3.1. cDNA quality was demonstrated by
the presence of a band in the RT+ samples and the absence of a band on the RT-
samples.
2.3.7 Microarray
This microarray data analysis was performed using the Bioconductor platform that
was an open source software project based on the R programming language. A brief
outline of the major steps involved from annotation to normalisation, diagnostic
plots and pathway analysis is presented in the following sections. A more detailed
description of the techniques used can be found in the chapter written by Zhang
et al. (2009).
56
Hugo Creeth Biomolecular Procedures
RNA Extraction for Microarray
RNA was extracted from whole hypothalamic and hippocampal brain regions using
the methods described in section 2.3.4. The RNA was then sent to Central Biotech-
nology Services (CBS) for RNA quality testing and processing followed by microarray.
The system used was the Affymetrix GeneChip Mouse Gene 2.0 ST Array.
Software
The data set was analysed using the R Statistical Package and all additional pack-
ages required were downloaded from the Bioconductor website, installed and then
consequently loaded at the start of each new R session.
Sample Preparation
Sample information was manually into a .txt file containing the relevant comma-
seperated-value (.csv) information regarding the genotype, sample name and tissue
type (Figure 2.5).
Figure 2.5: Phenotype Data File. Phenotype data input file .csv
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Annotation and Normalisation
CEL files (.cel) were imported into R and normalised using the rma package. The
phenotype data was then added to the normalised data set and checked before
annotation. The probe set was annotated in R and a random selection of probes
listed to check annotations were successful (probes: 10060-10070). At this point
it was also possible to check the data graphically after it had been normalised, an
example of these can be seen in the boxplot and histogram below (Figure 2.6 and
Figure 2.7).
WT 1 WT 3 TG 1 TG 3 KO 1 KO 3
2
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8
10
12
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exprs
Figure 2.6: Boxplot of Normalised Data. Microarray data after normalisation.
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Figure 2.7: Normalised Histogram. Microarray data after normalisation.
Analysis using LIMMA
Once the data was annotated and normalised it was then possible to choose and
use the model for analysis. The complexity of this experiment and the number
of RNA targets meant that LIMMA was the perfect choice. LIMMA stands for a
“Linear Model for Microarray data Analysis”, it was designed to identify differentially
expressed genes between all pair-wise comparisons of the samples groups.
LIMMA is run in R using a Bioconductor package. In order to perform LIMMA
two matrices were constructed. These matrices consist of the design matrix, which
provides a representation of the different sample groups that have been analysed,
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and the contrast matrix. The contrast matrix allows the coefficients defined by
the design matrix to be joined into contrasts of interest. Therefore each contrast
corresponds to a pairwise comparison between specified sample groups. LIMMA
is an ideal choice for microarray analysis because microarray experiments usually
only utilise a small number of replicates for each experimental condition, making
gene expression level estimation difficult (Smyth, 2005). LIMMA employs a system
that leverages the large number of observations in a microarray experiment so as
to moderate the variation estimates based on data dependent information (Zhang
et al., 2009).
The results of this analysis were then plotted into a series of venn diagrams selecting
for varying significance levels and showing the numbers of differentially expressed
genes between the various pair wise comparisons and across all the samples.
These venn diagrams were then used to generate lists of significant gene changes
that were similar in expression between all three genotypes and between specific
genotypes compared to a single genotype. These gene names and labels could then
be used for further cluster and signalling pathway analysis.
Pathway Analysis
In order to see whether the gene expression changes detected from the microar-
ray analysis coincided with any particular signalling pathways and thus biological
processes, the gene ENSEMBL labels were extracted from each list and inputted
into the online platform DAVID (https://david.ncifcrf.gov/) as described by Huang
et al. (2009). DAVID performed analysis in silico that generated a list of potentially
affected signalling pathways.
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2.3.8 Gene Expression Analysis by qPCR
qPCR - Method 1
The genes of interest were assessed for expression in the maternal hippocampus
at E16.5 using quantitative PCR (qPCR). Primers were designed using Primer3
program before being purchased from Sigma Genosys (Table 2.4). Each primer was
designed to work optimally at an annealing temperature of 60°C, and spanning at
least 1 intron producing a product size of less than 200 bp. Before qPCR the newly
designed primers were rigorously checked using standard PCR on whole brain cDNA
in order to confirm the amplification of the expected band size and absence of primer
dimers using the original cDNA from the earlier 20 µl RT reaction.
The RT+ cDNA was diluted further for use in qPCR, up to a total volume of 400
µl by adding 380 µl 10 mM Tris to these dilutions. The primer mixes were made
for each of the four genes of interest and the two designated reference genes. This
was done by adding 25 µl of primer to 50 µl of 10 mM Tris. Then 5 µl of cDNA was
aliquoted into the appropriate wells on a 96 well plate and a master mix made for
the 96 reactions using the constituents seen in Table 2.5.
Eight 1.5 ml alpha tubes were labelled and 9.6 µl of each required primer mix was
pipetted into the designated tube. Then 179 µl of master mix was added to each
tube and mixed briefly by spinning. At this point 14.9 µl of each master mix is
aliquoted into the appropriate wells on the 96 well plates before being run on the
qPCR machine using program “60deg with 75deg anti dimer step”.
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Table 2.5: qPCR Reagents
Reagents Volume per reaction (µl)
H2O 1048
10X Buffer 192
25 mM MgCl2 154
dNTPs 39
Sybr Green 15.4
Taq 12.3
Template 4
qPCR - Method 2
Each primer designed and used for this method was made up to an initial concentration
of 100µM, to be used as stock. Then aliquots of 3 concentrations for each primer
were made up: 50, 300 and 700nM. These different concentrations of primers were
then used in 9 combinations and tested on pooled cDNA in order to work out the
optimum concentration graphically for the forward and reverse primers for a given
primer set (Table 2.4).
Once primers were optimised a 96 well disk was set up using a Corbett Robotics
CAS-1200™ (Qiagen) machine to contain triplicates of each sample and NTC, along
with the master mix seen in Table 2.6. The ring contained genes of interest and two
housekeeping genes run for 40+ qPCR cycles in a Rotor-Gene 6000 (Qiagen).
Table 2.6: qPCR Reagents
Reagents Volume per reaction (µl)
H2O up to 20
2X SensiMix SYBR No-Rox (Bioline,UK) 10
Forward Primer 1.4
Reverse Primer 1.4
Template 5
2.3.9 BrdU Injection
The cohorts of WT(WT), WT(TG) and WT(KO) dams were weighed in the morning
of E16.5 and injected intra-peritoneally at 20 minute intervals with BrdU Cell
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Proliferation Reagent (GE Life Sciences), 1 µl/g. Each dam was carefully monitored
in their home cage for 5-10 minutes after being injected before being left for 3 hours
to allow for the BrdU to be incorporated.
Anaesthesia and Surgery
The animal was weighed and the appropriate dose of euthatol administered intraperi-
toneally. Once the mouse was unresponsive to these stimuli the mouse was placed
securely onto a grid above a collection dish for the excess fixative and buffer as well
as other bodily fluids. The procedure itself was performed inside a chemical fume
cupboard. An incision was made through the skin of the mouse and the entire ribcage
and thoracic region was exposed the diaphragm was separated from the chest wall
at the base of the ribcage. At this point two separate lateral cuts were performed
dorsally creating a ribcage flap. This flap was then opened up to expose the heart
and secured.
The right atrium was cut and then left ventricle was punctured carefully using a
blunted 24G needle (Figure 2.8). The animal was perfused, initially with PBS
(20-35 ml) followed by 10% formalin fixative (20-35 ml).
Brain Dissection
The mouse was then decapitated at the base of the skull. Using a series of cuts
the dorsal skull was removed from the surface of the brain. The head was then
inverted and the brain was gently teased out, after excess connective tissue was cut
(Figure 2.9). The brain was transferred into a vial of 10% PFA before being stored
at 4°C. After 24 hours the brain was washed twice in 1 x PBS before being sent for
sectioning.
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A B C
Figure 2.8: Perfusion Fixation Procedure. A basic schematic depicting how to perform
trans-cardiac perfusion fixation on a terminally anaesthetised mouse.
A B C
Figure 2.9: Brain Dissection. A basic schematic depicting the process of removing an intact
adult brain from a mouse skull.
2.3.10 Immunohistochemistry
Sections were produced by Cardiff University’s School of Biosciences Histology facility.
Sections were sliced 10 µm thick coronally. 100 sections were taken for each brain
around the regions of interest (Bregma to -2). 3 sections mounted per slide. All
slides were processed in the same way over a three day protocol.
Slides were de-waxed by carrying out 2 x 10 minute washes in 100% xylene. The
slides were then rehydrated by washing them in decreasing concentrations of ethanol
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Table 2.7.
Table 2.7: Ethanol Washes
Ethanol Concentration Number and time of each Wash
100% 2 x 5 mins
95% 1 x 5 mins
70% 1 x 5 mins
The slides were then washed in distilled water before antigen retrieval and unmasking.
Diluted 10 mM citrate buffer was preheated in a 90 - 95°C water bath. The slides
were then placed in the preheated solution for 20 minutes before being allowed to
cool for 30 minutes at room temperature in the solution. The slides were then cycled
through three washes of 1 x PBS/T for 5 minutes each.
To prevent endogenous staining slides were blocked for 20 minutes with Envision+
peroxidase block (200 µl per slide) and placed in a dish contain a damp tissue to
prevent the slides from drying out. Slides were then washed in 1 x PBS/T wash
cycle of 3 x 5 minutes before being blocked in 1% BSA diluted in 1 x PBS/T (200 µl
per slide) at room temperature.
At this stage excess solution is shaken off before the primary antibody is added. The
antibodies used were either a 1:150 dilution of mouse anti-BrdU (BD, cat no: 347580)
or a 1:1000 Nestin antibody (Abcam, cat no: ab6142) or a 1:1000 DCX antibody
(Abcam, cat no: ab18723) diluted in 1% BSA in PBS/T overnight at 4°C.
The following morning the slides were washed in PBS/T 3 times before the secondary
antibody is added (DAKO Envision+ anti-mouse-HRP-polymer secondary for BrdU
and DCX or DAKO Envision+ anti-rabbit-HRP-polymer secondary for Nestin) for 1
hour at RT and then washed with PBS/T 3 more times.
DAB is made up and applied to each of the slides. The DAB reagents were made
up by mixing one drop of chromagen per 1 ml of substrate buffer (200 µl per slide,
i.e. 1 ml will do 5 slides). Once applied to each slide, slides were monitored for the
development of colour (between 5-10 mins). The final PBS/T series of washes is
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then carried out before slides were transferred to distilled water.
After 5 minutes the water was poured off and the slides counterstained using Haema-
toxylin for 45 seconds and then washed under a running tap until the water runs
clear. The final stage of the protocol requires the dehydration of the slides in ethanol
by a series of washes listed in Table 2.8 followed by 2 x 2 minute washes in xylene.
Table 2.8: Ethanol Washes
Ethanol Concentration Number and time of each Wash
70% 1 x 30 secs
95% 1 x 30 secs
100% 2 x 30 secs
The slides were then mounted in DPX and left to dry overnight.
2.3.11 Slide Scanning and Cell Counting
Slides were scanned at high resolution and stored in a digital format using the Carl
Zeiss Axio Scan.Z1. Blind cell counts were performed on Zen Blue Software (Carl
Zeiss). The equipment was calibrated using manual focussing for the coarse focus
and fine focus settings before automating the process (Figure 2.10).
Figure 2.10: Axioscan Focus Settings. Screenshot indicating the basic focus settings used to
scan the slides through the Zeiss Axio Scan.Z1.
Images were converted from .czi files into .tiff files using either the Zen Blue Soft-
ware (Carl Zeiss) or CZItoTIFF Convertor open source software (http://hcbi.fas.
harvard.edu/resourcessoftware). Total cell counts were produced manually using
Fiji imaging software.
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2.3.12 High Performance Liquid Chromatogra-
phy (HPLC)
Tissue from the hypothalamus, hippocampus, olfactory bulb and frontal cortex was
rapidly frozen using dry ice after being dissected from the brains of the dams at E16.5.
This tissue was then homogenised in 200 µl of perchloric acid and an ultrasonic cell
distributor (Microson, UK) and then sent to the Psychology Analytical Laboratory
(Cambridge University, UK), for processing.
2.3.13 ELISA
Prolactin - abcam®, UK (ab100736)
All materials and reagents were equilibrated to RT. Then 100 µl of each standard
and sample was added into wells on the plate in duplicate. Wells were covered and
incubated for 2.5hrs at RT. The solution in the wells was discarded and washed 4
times with 300 µl of 1X Wash Solution. Care was taken to completely remove all of
the liquid before 100µl of Biotinylated Prolactin Selection Antibody was added to
each well and incubated for 1hr at RT with gentle shaking. Following this the solution
was once again discarded and wash with 300 µl of 1X Wash Solution again. Then
100 µl of the provided 1X HRP-Streptavidin solution was added to the individual
wells before being incubated for 45mins at RT with gentle shaking. After another
wash step, as previously described, 100 µl of TMB One-Step Substrate Reagent was
put into each well then after another incubation, this time for 30 minutes at RT in
the dark with gentle shaking; 50 µl of stop solution was added to each reaction. The
plate was then read immediately at 450nm and the results analysed.
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Placental Lactogens - NovateinBio
All reagents were prepared as per manufacturer’s instructions and then brought
to RT along with the other components and samples. Sample diluent was added
at 50 µl to the standard wells in duplicate in order to act as the zero standard
before the pre-prepared standards were gently shaken and added in order (S1-S6) to
corresponding wells. Then 50 µl of samples were added to the sample wells. The
conjugate was then added to each well at 100 µl and mixed thoroughly. The plate
was then covered and incubated at 37°C for 1 hr. Once the incubation period was
complete the plate was manually washed for a total of five washes, taking extreme
care to thoroughly dry the the plate after the washes. 50 µl of Chromagen Solution
A and 50 µl of Chromagen Solution B was pipetted into each well and then the plate
was covered and incubated for 15 minutes in the dark before 50 µl of stop solution
was added to each well and care taken to mix thoroughly. The plates optical density
(OD) was then immediately read at 450 nm on a microtiter plate reader.
Prolactin-8A8 - Wuhan
Constituent reagents provided were stored as per manufacturer’s instructions while
not is use. Materials not supplied but that were required were prepared whilst
reagents and samples were brought to RT. When at RT reagents that needed further
preparation were sorted. This included taking care to ensure that any crystals
formed in the wash buffer concentrate were fully dissolved before the 30 ml wash
buffer concentrate was diluted up to a 750 ml with distilled water. Standard was
reconstituted with 1 ml of sample diluent forming a concentration of 5000 pg/ml.
The standard sat for 15 minutes before serial dilutions were made using 500 µl each
time. Detection reagents A and B were diluted using Assay Diluent A and B at 1:100
respectively.
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Firstly 50 µl of standards, blanks and samples were added to the appropriate wells.
Then immediately 50 µl of detection A was added to each well before being sealed
and mixed. At this point the first incubation was performed at 37°C for 1 hour. After
the first incubation the wells were aspirated 3 times using 400 µl of the wash solution
leaving for two minutes then removing the liquid. The second stage involved adding
100 µl of detection reagent B before also being sealed and incubated for a further
45 minutes at 37°C. After 45 minutes the second wash was performed as previously
explained. In the third phase 90 µl of substrate solution was added to the wells
before sealing and mixing. Then the last incubation of between 15-30 minutes was
carried out in the dark at 37°C. Then 50 µl of solution was added to each well and
mixed thoroughly before being read straight away at 450 nm to obtain the optical
densities of each well.
2.3.14 Statistical Analysis
qPCR data was run in triplicate and the fold change of each gene was calculated
using the 2−∆∆CT method described by (Schmittgen and Livak, 2008). Each qPCR
assay had its mean CT calculated then the ∆CT also determined by subtracting the
mean CT for the reference genes from the mean CT of each gene of interest. Each
of the ∆CT values had a Shapiro-Wilk test for normality performed upon them.
Following this ∆∆CT for each cohort was calculated by subtracting the ∆CT of the
WTs from the transgenic lines. Finally the 2−∆∆CT was calculated as follows:
2−[CT x GOI − CT x β−Actin] − [CT WT GOI − CT WT β−Actin]
N.B β − Actin is replaced with each reference gene and 2−∆∆CT calculated as well.
∆∆CT and 2−∆∆CT was used to visualise the data the ∆CT was the actual data
after each GOI was normalised to the housekeeping genes.
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Where data was normally distributed the statistical analysis was performed using
the two tailed students t-test. In the cases where data was not normally distributed
the non-parametric Mann Whitney U-test was used in order to gauge statistical
significance. To correct for multiple comparisons a Bonferroni corrected α was used.
HPLC and IHC data was analysed using a repeated measures ANOVA for specific
brain regions, where MOLECULE or CELL COUNT was the within subject variable
and GENOTYPE was the between-subjects variable. Similarly to qPCR data
Bonferroni corrections were utilised and the adjusted F and values displayed.
Microarray statistical analysis was performed in R as described in section 2.3.7
using LIMMA and subsequent linear models fitted for every gene making it more
appropriate for microarray data compared to ordinary ANOVA. A more in depth
description of how LIMMA analysis works can be found (Smyth, 2005).
2.4 Behavioural Testing
2.4.1 Elevated Plus Maze (EPM)
The EPM is an anxiety assay that is commonly used to assess a rodent’s aversion
to open space and height (Komada et al., 2008). The EPM was constructed of
several cut perspex pieces each uniformly wrapped in white tape so that the tracking
software could effectively and precisely track the dark coloured mice. The EPM used
(Figure 2.11) has four arms, two were enclosed on either side with an open roof (190
x 80 x 150 mm, length x width x height), the other two arms are totally exposed on
every side (175 x 78 mm, length x width). This section was the elevated by 940 mm
above the floor before being evenly lit by a 60 w fluorescent bulb.
The subjects were each placed centrally on the EPM, on separate trials, facing
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Figure 2.11: The Elevated Plus Maze. The EPM used as a simple anxiety assay for this
study.
an exposed/open arm. The new dam was then left for five minutes while being
recorded and tracked using Ethovision tracking software. Additional behaviours
were recorded alongside the zone transitions and durations recorded by the software.
These additional behaviours were: number of “Stretch Attend Postures” (SAPs) and
“Head Dips” that occurred over the edge of the open arms. Zones were defined in the
Ethovision software as both arms combined, thus the two open arms were defined as
the “Open Zone” and the two enclosed arms are known as the “Closed Zone”. Each
dam was placed in the EPM on post gestational day 2 (P2) between 0900 hours
and 1700 hours and given an additional 20 minutes before testing began in order
to habituate to the lower light levels. Offspring were tested in a similar manner at
between 6 and 8 weeks of age.
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2.4.2 Open Field
Another anxiety related behavioural assay is the Open Field (OF) test (Bailey and
Crawley, 2009). OF apparatus consisted of a perspex box without a lid (750 x 750
mm). The perspex used for the walls was opaque and the arena it enclosed was
evenly illuminated using a 60w bulb. The arena itself was divided into two inner
and outer virtual zones. The zones marked the central area of the arena (450 x 450
mm) and the external edge/periphery (300 mm). Animal subjects were released into
the arena and left to explore for 20 minutes (1200 seconds) whilst there movements
were tracked remotely using Ethovision tracking software (Noldus, UK). Movements
were subsequently interpreted in relation to distance moved, number of entries made
into each zone and total time spent in each zone. The zones consisted of the outer,
middle and inner zones. The outer zone is the least anxiogenic whilst the inner is
the most anxiogenic. The usual behaviour for mice is to show thigmotaxis and stay
in the outer zone.
750 mm
750 mm
A. B.
750 mm
75
0
 m
m
Figure 2.12: The Open Field Arena. The Open Field (OF) assay is a proxy measure of anxiety
phenotypes that may be expressed by an animal (in this case mice). A. Is the OF arena where
the mouse is placed in the centre and left to explore the area for 20 minutes or 1200 seconds. B.
Basic zones used by the Ethovision tracking software to determine the location of the mouse and
the distance travelled. The outer, middle and inner zones.
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2.4.3 Phenotyper Boxes
To allow for the continuous monitoring of the dam and her pups each dam was
relocated on P2 from their home cages to a specific unit, the Phenotyper Cage
(Noldus). Each Phenotyper was stocked with clean fresh water and food, like any
normal home cage. However the major difference was the special top unit. The
specifically designed top unit contained a camera that allows for the continuous
recording of each dam and her behaviour with her pups over a set period. These videos
could then later be retrospectively analysed using the Ethovision XT tracking software
package to assess various parameters. There were four Phenotyper boxes in total,
each measuring 30 x 30 cm containing an exercise wheel and sawdust (Figure 2.13).
Once the dams had been moved in, their weights, the pup weights and also the food
and water weights were recorded. After an initial 24 hour habituation period to
their new homes, which had identical 12 hour light and dark cycles to their previous
homes (between 0800 and 2000 hours) with controlled temperature and humidity.
Ethovision XT®
30 cm
30 cm
Figure 2.13: Phenotyper Box. A diagram showing one of the phenotyper boxes that was used
in conjunction with ethovision tracking software to monitor the dams over a 3 day period up to 24
hours at a time.
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2.4.4 Pup Retrieval
After the 24 hour habituation period in the Phenotypers the first behavioural assay
was performed on P3. The pup retrieval test is a simple assay that measures the
latency it takes for a dam to collect her pups when they are removed from the nest
and scattered either in a set location or randomly around the cage/arena. In order
to carry out this test on the dams, they were each temporarily removed from the
Phenotypers and placed back into their original home cages. Then the pups were
evenly scattered along the opposite side of the cage to the nest in the Phenotyper.
The video recorder was then started and the dams re-introduced. The pups were
checked every half an hour and returned to the nest after one hour if not collected
by this time. At the end of the test period in the Phenotyper of 24 hours the
video recording was removed and analysed for each dam. The latency to sniff the
pups and the latency to collect the first pup and return it to the nest was recorded
(Figure 2.14).
2.4.5 Ethovision - 1 hr and 23 Hour Monitoring
Immediately following the nest building assay, the video recorder was set to record
for 23 hours continuously until the following morning before the nest building assay
was performed. The videos themselves were analysed post hoc in a methodical
manner using pre-determined and pre-tested parameters, however in order to check
the reliability of the software, a random selection of videos were manually analysed.
The programme was set up in the following way:
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Figure 2.14: Pup Retrieval Set Up. 1. Schematic illustrating how the pups are arranged
during the pup retrieval test 2, 3 and 4. The varying stages of retrieval, 2. show pups having
been retrieved, although the time is stopped after just one pup is placed inside the nest. In 3. it
can be seen that the pup has been taken to the edge of the nest but not into the centre of it yet,
this does not count as having been retrieved. Picture 4. gives an example of a failed retrieval by
the dam after the designated time period.
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Arena settings
These were defined to match the Phenotyper cage’s size and dimensions. Once this
was completed it was possible to “grab” different zones of specific shapes and also
define quadrant zones using various tools provided in the GUI environment. At this
point it was necessary to calibrate the scale by measuring the size of the arena or
zone areas. Once the arena settings are validated it is possible to move on to setting
up the trial control instructions.
Figure 2.15: Ethovision Arena Layout and Settings. A screen grab of the areas defined in
the Ethovision analysis software program for each arena (Phenotyper Cage). These areas were
calibrated using a scale, then used to help track the movements of the subjects throughout the
testing period.
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Trial control settings
These are typically useful for controlling external hardware. However on a more
fundamental level it is critical for defining when a trial starts and when a trial ends.
In this sense it was possible for conditions to be made that told the programme when
to start recording/tracking and when to stop.
Figure 2.16: Ethovision Trial Control Settings. This demonstrates the typical control flow
of a trial. It defines the start as when movement takes place for longer than 1 second and the end,
which is the duration of the trial.
Detection settings
The critical settings for analysis as defining the correct parameters in this section
are important in order refine the method by which the animal will be tracked. On
occasion this would need to be tweaked for each individual animal and/or trial in
order to ensure a good and reliable track. The standard parameters used can be seen
in Table 2.9.
Table 2.9: Detection Parameters
Parameter Name Definition
Method Differencing/Dynamic Subtraction
Sample Rate 12.5 per second
Subject Darker (than background)
Dark Contrast 40-255
Subject Size 200-12500
Contour Erosion Yes (1 pixel)
Contour Dilation Yes (1 pixel)
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Hidden Zones
In order to combat the issue of poor tracking in certain areas of the Phenotyper cage,
like underneath the exercise wheel or within the nest, hidden zones were created.
This is were an animal/subject enters a zone in which its detectable body point is no
longer detected. During tracking if the animal is no longer detected it is assumed to
have entered this hidden zone. When there is more than one hidden zone in an arena
then entry an exit zones can be created. These were used so as to reduce the risk of
an overestimation of entrances into and exits from hidden zones and the inevitable
issues such a result would have on the other readings.
2.4.6 Nest Building
The protocol used in this study to assess nest building behaviour was a simple
rudimental scale of: 0 (no nest built), 1 (nest built but pups not placed in the nest)
or 2 (nest built and pups placed inside the nest). On P4 after 23 hours into the
tracked Phenotyper activity, the recording was paused and the dams removed and
replaced into their respective home cages once more. The nest was then removed
from the Phenotyper cage and replaced with a cardboard tube filled with a 30 x 30
cm strip of tissue paper. The pups were placed next to this nesting material and the
dams were then put back into each cage and recording resumed for 1 hour. After the
hour the mice were returned permanently to their home cages and the weights of the
dams and pups recorded (Figure 2.17).
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Figure 2.17: Nest Building Set Up. 1. Apparatus used for the nest building test including a
cardboard tube and a piece of tissue paper. 2. Scenario 1: In this picture you can see that the dam
has built a nest and moved her pups inside the nest, this was scored as “2” 3. Scenario 2: Dam has
built a nest but pups not placed in the nest, scored as “1”. 4. Scenario 3: Dam doesn’t build a nest
within the given time frame, scored as “0”.
Alongside the nest building task itself and the Ethovision tracking of the dams
throughout this assay, manual scoring of a select number of key grooming and
nurturing behaviours were recorded (Table 2.10). These were recorded manually as
at the time the tracking software was not able to do this accurately. The number or
frequency of occurrences of each behaviour was recorded and the total duration of
time spent performing the behaviour in question was recorded.
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Table 2.10: Manually Scored Nest Building/Grooming Behaviours
Behaviour Behaviour Description
Crouched Nursing Dam is positioned over the pups to permit
sucking or thermoregulation with a low to
moderate arch in her back.
Arched Nursing Dam is positioned over the pups with a high
arch in her back to permit sucking and pup
movement.
Passive nursing Dam is lying on her side with her ventrum
exposed to the sucking pups.
Licking/grooming Pups Dam is licking pups (anogenital or body
region).
Nest-building Dam is picking up pieces of bedding and
retrieving these to the nest or moving bedding
in the nest with her snout.
Self-grooming Dam is licking herself (often occurs during
bouts of pup licking).
2.4.7 Locomotor Activity
Locomotor Activity (LMA) behaviour of the offspring was assessed using 12 perspex
chambers (210 x 360 x 200 mm), these chambers each contained two infra red beams
that crossed the cages 30 mm from each end and 10 mm from the floor of the chamber
boxes. The number of beam breaks was indicative of varying degrees of activity. The
number of breaks was recorded by customised software BBC Basic V6 programming
and the ARACHNID interface (Cambridge Cognition Ltd, UK). LMA was carried
out over a 2 hour period each day over the course of three days, the 2 hour period was
consequently reduced to 5 minute bins (Figure 2.18). The final measure of activity
was the total number of beam breaks over the whole test period and within each bin
and gave an indication of the animals ability to habituate to a novel environment.
2.4.8 Acoustic Startle and Pre-pulse Inhibition
Acoustic Startle Response (ASR) and Pre-Pulse Inhibition (PPI) were monitored
using equipment re-designed for mice by SR-Labs. Both tests occurred in the same
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A. B.
C. 210 mm
300 mm
200 mm
Figure 2.18: Locomotor Activity Boxes. Schematic diagram showing the experimental set
up for the locomotor activity boxes. A. Shows the mouse being placed into one of the perspex
locomotor activity boxes with the lights on. B. Shows the mouse demonstrating a “break”, this is
when the mouse only breaks one of the beams dissecting the box. C. Shows what is classified as a
“run” this is when the mouse breaks both beams one after the other quickly. The test runs for 120
mins or 2 hrs and is carried out in the dark.
sound attenuating chamber with a speaker fitted to the roof 120 mm above the
animal. A perspex tube with a diameter of 35 mm housed each animal at the start
of the test, mounted on a perspex plinth (Figure 2.19).
The ASR assay was performed after 5 minutes of habituation for each animal in their
new surroundings, then the test began. The test consisted of 3 blocks of differing
amplitude startles, each set to a background white noise of 70 db. The first block
had an amplitude of 120 db followed by 105 db in the second and finally 80 - 120 db
in the third.
The procedure for the PPI test was to carry out pulse alone trials and pre-pulse
trials on each of the animals. The pulse alone trials consisted of a 40 ms startle noise
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SR-LAB
Figure 2.19: Pre-pulse Inhibition and Acoustic Startle Response Apparatus. Schematic
diagram showing the ASR and PPI equipment set-up
of 120 db. In contrast the PPI tests started with a short 20 ms acoustic pulse of 4, 8
and 16 db above the baseline background noise (70 db) followed by a 70 ms break
and then the usual 40 ms startle stimulus of 120 db.
Each block consisted of 5 single pulse trials, followed by 1 no stimulus trial and the 6
pre-pulse trials, two for each of the various pre-determined pre-pulse startles (4,6 and
8 db more than the baseline). The stimuli themselves were presented pseudorandomly
throughout every block.
ASR was quantified using a piezoelectric transducer setup linked to a computer. It
was recorded from the pulse alone trials and the inhibition to responding to pre-pulse
noise in a 65 ms window after each startle stimuli. Similarly PPI was deduced by
calculating the percentage reduction in the startle response between the pre-pulse
and pulse alone trials.
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2.4.9 Lick Cluster Analysis
The Lick Cluster Analysis (LCA) experimental apparatus was custom made and set
up in an isolated room. The apparatus consisted of 16 automated drinking chambers
(Med Associated, St Albans, VT, USA) measuring (32 x 15 x 12 cm, L x W x H),
each with a steel mesh floor and white acrylic sides (Figure 2.20). Mice were food
restricted for 16 hours overnight before each test (17:00 to 09:00 hrs), care was taken
to weigh each mouse before and after food restriction weight loss greater than 15%
meant the mouse was excluded from the test. After the food restriction subjects
were placed into the test cages and left for 20 minutes to drink the available sucrose
solution through stainless steel drinking spouts connected to 50 ml falcon tubes.
MED-PC
Figure 2.20: Lick Cluster Analysis Equipment. Schematic diagram showing the Lick Cluster
Analysis equipment set-up
The number of licks and the time of each lick was recorded using a contact sen-
sitive lick-o-meter attached to a microcomputer running MED-PC software (Med
Associates) that registered the time of each lick to the nearest 0.01 second. Lick
clusters were defined as a group of licks with lick intervals didn’t exceed 500 ms.
Thus licks that occurred after a 500 ms period were recorded as a new cluster. Mice
were trained over two solutions (8% and 12% sucrose) before being tested. This
was to ensure a sufficient baseline level of licks were being performed and to check
the equipment was working correctly. The two differing concentrations of sucrose
solution used for the test period were 4% and 16% made up with deionised water.
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A second task was performed for one week following the sucrose test, in which
saccharin was used to create a 0.1% solution. This test was carried out for one week
only in order to discern whether there was any possibility of calorie seeking behaviour
in the mice undergoing the testing.
2.4.10 Statistical Analysis
The experimental data for the all the behavioural tests were analysed using SPSS
Version 23 (SPSS, USA) unless otherwise stated. All behavioural data was presented
as mean values with the standard error of the mean (± SEM) also displayed. Each
behavioural test was analysed separately according to genotype, followed by any
appropriate comparisons between genotypes or across genotypes. This was done
using separate ANOVAs for various between-subject factor of genotype and within
subject-factors.
Maternal and Offspring Behavioural Tests
All data analysed using repeated measures ANOVA’s was tested using Mauchly’s
test of sphericity in order to check that the variances of the differences between all
combinations of related groups are equal. In any case where sphericity was violated,
indicating significant differences between variances within related groups, the degrees
of freedom was adjusted appropriately using the Greenhouse-Geisser adjustment
procedure.
EPM and OF assays where analysed with one-way ANOVAs in order to determine
the effect of genotype on various behaviours or factors during the test. The factors
were: Time spent in open/closed/middle zones of the EPM and Time spent in
outer/middle/inner/central zones of the OF arena. Several more ANOVAs were also
performed to analyse differences between factors including distance moved in each
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zone and overall for the EPM and OF tasks. Furthermore preference for the specific
zone (closed and outer) in both the EPM and OF tasks, respectively, that are known
to be the least anxiogenic were determined through the use of a paired sample t-test.
Specific Offspring Behavioural Tests
LMA habituation trial data was assessed using a number of repeated measures
ANOVAs for each session. DAY or BIN was the within-subjects factor and Genotype
was the between session factor.
Similarly ASR and PPI data was analysed using repeated measures ANOVAs with
either TRIAL or INTENSITY as the within-subject factor and Genotype as the
between subjects factor.
LCA analysis was normalised then analysed through a series of General Linear
Models (GLMs) for within-subjects factors: Total Consumption, Total Licks, Licks
per Bout, Average Inter-Lick Interval and Volume. These factors were then further
screened using a number of ANOVAs to look at between-subject effects of Genotype
upon the previously listed within-subject factors.
Significant tests were presented at an alpha level of 0.05. The results that were
found to be significant through the main ANOVA were then further analysed using
post-hoc tests and pair wise comparisons and these findings reported. Bonferroni
corrections were used for multiple comparisons when needed and Greenhouse-Geisser
degrees of freedom corrections also applied to repeated measure factors.
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3Placental EndocrineLineage Analysis
3.1 Overview
Loss of function of several maternally expressed imprinted genes results in an
expansion of the SpT lineage (John, 2013). This pattern suggests that the paternal
genome has selectively silenced genes that limit SpT specific functions. There are a
number of mouse mutants in which alterations in the SpT lineage have been reported,
however, these defects often occur in parallel to alterations in other placental lineages.
In particular, the glycogen cell lineage and four of the six distinct TGC lineages, all
of which share a common progenitor with the SpT (John, 2013) confounding their
functional assessment (Chapter 1).
As previously discussed, the loss-of-function of Phlda2 results in an enlarged placenta,
an expanded junctional zone and more placental glycogen but without affecting
fetal growth (Frank et al., 2002). When the expression is elevated to two-fold the
endogenous level, the effect is placental stunting, with the loss of the SpT lineage
and significantly reduced placental glycogen accumulation. The latter occurs without
any changes in the representation of the glycogen cell lineage or the parietal TGCs
which line the maternal decidua (Salas et al., 2004, Tunster et al., 2010). The main
observation regarding elevated Phlda2, was that it drives a late, asymmetric fetal
growth restriction (Tunster et al., 2014). When compiled the data suggested that
Phlda2 acts indirectly to restrict fetal growth through the limitation of the SpT
lineage’s expansion, which is essential in order to stimulate glycogen accumulation.
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The effects of increasing Phlda2 gene dosage on all the TGC lineages has not been
reported. Moreover, a characterisation of the placental lineages in the context of
loss-of-function has not been performed.
This chapter sought to investigate the role of Phlda2 in regulating the placental
endocrine lineages. The data entitled “The imprinted gene Phlda2 gene modulates
a major endocrine compartment of the placenta to regulate placental demands for
maternal resources” was published in Developmental Biology by Tunster, Creeth
and John (2015). In the paper we also looked at the role Phlda2 has in glycogen
accumulation and fetal growth.
The experiment focussed on performing an in depth examination of the placental
lineages in the different Phlda2 gene dosage mouse models. qPCR and DNA Mi-
croarray was used to assess the expression levels of the key genes that code for the
endocrine proteins/hormones that are known to be expressed in the various lineages
of the placenta.
3.1.1 Placental qPCR
The initial qPCR was performed by Simon Tunster on E14.5 placenta, it indicated
that there were several Prolactin-like Proteins (Prls) that were elevated in the KO
placenta and reduced in the TG placenta (Figure 1.8). The SpT is also known to
be a source of Placental specific glycoproteins (Psgs). PSGS in humans function as
immunomodulators by inducing secretion of IL-10, IL-6 and TGF-β 1 by monocytes
(Snyder et al., 2001). They have similarly been linked by several studies in having
immunoregulatory, pro-angiogenic, and anti-platelet functions (Moore and Dveksler,
2014, Wu et al., 2008a).
The most abundant Psgs expressed during gestation are: Psg17, Psg18, Psg19
and Psg21 all of which were tested using qPCR and showed distinct increases in
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expression levels for the KO placenta and reduced expression levels in the TG placenta
(Figure 1.8). This combined with in situ hybridisation data of Psg17 (Figure 1.8)
revealed a reciprocal relationship between Phlda2 and the Psgs. The work done
by Simon Tunster also looked at the double transgenic placenta that carried both
the BAC transgene and also the maternal Phlda2 allele (Phlda2 -/+ BACx1 (rescue;
1X)), meant that these changes could be solely attributed to Phlda2. This data was
then substantiated through the use of microarray to look at the changes in gene
expression profiles at E16.5.
Finally due to the different sizes of the SpT, a key endocrine lineage, across the three
cohorts and the published data regarding qPCR gene expression levels of the Prls. It
was hypothesised that the levels of the Prls and prolactin in the blood of the dams
will show differing concentration levels. To test this ELISAs were performed upon
the maternal blood serum of a newly generated cohort of dams in order to determine
levels of specific Prls and prolactin in their system.
3.2 Methods
RNA was extracted from whole placenta at E14.5 for qPCR and E16.5 for microarray
using the extraction method described in Chapter 2 and section 2.3.4. The RNA for
microarray were all sent to Cardiff Biotechnology Service (CBS) for quality control
before finally undergoing microarray. RNA was only used if it had a RNA Integrity
Number (RIN) value equal to or higher than 7 (Table 3.1).
3.2.1 Microarray
RNA was hybridised to Affymetrix Mouse Gene 2.0 ST chips. The data was anal-
ysed essentially as described in chapter 2 and section 2.3.7 and also outlined by
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Zhang et al. (2009). Additionally the use of Partek® Genomics Suite™ Version 6.6
(Partek Incorporated, Missouri, USA) was employed in order to generate a principle
components analysis graph and validate the gene lists generated.
Finally, genes found to be either significantly up in Phlda2 -/+ (maternal KO; 0X)
and/or significantly down in Phlda2 +/+ BACx1 (single copy Phlda2 transgene, TG;
2X) E16.5 whole placenta were tested for enrichment of gene ontology molecular
function and biological process using the Database for Annotation, Visualisation and
Integrated Discovery (DAVID).
3.3 Results
Females were culled on E16.5 and whole placenta was taken. The yolk sacs for the
fetuses were genotyped before RNA was extracted and sent for microarray. The total
N = 11 with each cohort containing an n = 4. The samples were only used if they
had a RIN value equal to or higher than 7 (Table 3.1).
Table 3.1: RNA Values for E16.5 Microarray of Placenta
Sample ID Tissue RNA ng/µl RIN Value
WT_PL1 Placenta 433.0 8.4
WT_PL2 Placenta 419.0 8.3
WT_PL3 Placenta 566.0 8.8
WT_PL4 Placenta 390.0 8.3
KO_PL1 Placenta 361.0 8.3
KO_PL2 Placenta 336.0 9.3
KO_PL3 Placenta 347.0 7.5
KO_PL4 Placenta 310.0 8.3
TG_PL1 Placenta 704.0 8.7
TG_PL2 Placenta 118.0 8.0
TG_PL3 Placenta 213.0 7.0
TG_PL4 Placenta 465.0 n/a
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3.3.1 Microarray
Microarray analysis was performed on E16.5 placenta to give a more objective analysis
of the gene expression at this time point. A heat map was produced to indicate
visually any differences in gene expression levels between the three groups using
Partek™across the gene chips (Figure 3.1). A separate 3D principle components
analysis plot clustering placental gene expression across the three cohorts for the
differing placenta was also generated in a similar manner to get a better idea about
the arrangement of these differences and help identify if there were any outliers
(Figure 3.2).
The bulk of the analysis was performed at the genome wide level from the .CEL
files generated from the microarray using the Bioconductor package LIMMA and
custom scripts (see Chapter 5) to generate comprehensive gene lists highlighting the
differentially expressed genes between all pair-wise comparisons of the groups. A
venn diagram indicating the total number of differently altered genes, either up or
down, between the differing KO and TG placenta at the p-value > 0.05 confidence
level (Figure 3.3).
Pathway analysis was performed using the Database for Annotation, Visualisation and
Integrated Discovery (DAVID). DAVID allows the user to generate molecular function
and biological processes pathway data on the entire dataset highlighted significant
KEGG pathway changes in genes involved in cell cycle, cytokine-cytokine interactions
and sphingolipid metabolism (Table 3.2). The Venn diagram identifies the genes
that are both significantly up in the KO and significantly down in the TG whole
placenta, it is likely that these represent the SpT transcriptome. When this dataset
was similarly analysed by DAVID the output highlighted 10 distinct gene clusters
including: cytoskeleton pathways, cell division pathways and importantly the protein
superfamily prolactin/lactogen/growth hormone cluster (Cluster 3 Enrichment Score:
4.25, Table 3.3).
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Figure 3.1: Heat map indicating expression levels of genes in the Placenta. A three
way heat map showing the differing gene expression levels from the microarray across the three
cohorts in the placenta. Green indicates genes that were down regulated and red represents genes
that were up regulated relative to baseline.
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Figure 3.2: Principal Component Analysis of the Placenta. Three-dimensional principle
components analysis plot clustering placental gene expression across the three cohorts for the
differing placenta.
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Figure 3.3: Venn Diagram for Genes that were Significantly Up or Down Regulated in
the Placenta.The venn diagrams from the LIMMA analysis showing the genes that are significantly
up or down between the KO and TG placenta.
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Table 3.2: Placenta Signalling Pathways
Term Count % P-Value Genes List Gene Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR
Cell cycle 12 3.59 ≤ 0.001
ENSMUSG00000030867 Plk1
97 128 5738 5.545747422680413 8.26786740754426E-4 8.26786740754426E-4 0.008755491664069748
ENSMUSG00000032218 Ccnb2
ENSMUSG00000027379 Bub1
ENSMUSG00000005410 Mcm5
ENSMUSG00000026355 Mcm6
ENSMUSG00000019942 Cdk1
ENSMUSG00000020415 Pttg1
ENSMUSG00000059552 Trp53
ENSMUSG00000041859 Mcm3
ENSMUSG00000027715 Ccna2
ENSMUSG00000040084 Bub1b
ENSMUSG00000022285 Ywhaz
Oocyte meiosis 9 2.70 ≤ 0.001
ENSMUSG00000030867 Plk1
97 115 5738 4.6294935006723446 0.06392347569087509 0.03248952237759983 0.6968424671623286
ENSMUSG00000032218 Ccnb1
ENSMUSG00000040385 Ppp1ca
ENSMUSG00000019773 Fbxo5
ENSMUSG00000027379 Bub1
ENSMUSG00000019942 Cdk1
ENSMUSG00000020415 Pttg1
ENSMUSG00000057897 Camk2b
ENSMUSG00000022285 Ywhaz
DNA replication 5 1.50 0.003
ENSMUSG00000020471 Pold2
97 35 5738 8.450662739322533 0.24029136931372375 0.08753610974242165 2.867301122002619
ENSMUSG00000005410 Mcm5
ENSMUSG00000026355 Mcm6
ENSMUSG00000041859 Mcm3
ENSMUSG00000025395 Prim1
p53 signaling pathway 5 1.50 0.03
ENSMUSG00000022385 Gtse1
97 69 5738 4.286568056178096 0.9497057653873082 0.5264350506466848 27.130726789922477
ENSMUSG00000032218 Ccnb1
ENSMUSG00000040152 Thbs1
ENSMUSG00000019942 Cdk1
ENSMUSG00000059552 Trp53
Cytokine-cytokine receptor in-
teraction
9 2.70 0.05
ENSMUSG00000025929 Il17a
97 244 5738 2.1819334122021297 0.9959681825435983 0.668028980517003 44.21447884480347
ENSMUSG00000018914 Il3
ENSMUSG00000022971 Ifnar2
ENSMUSG00000073889 Il11ra1
ENSMUSG00000055170 Ifng
ENSMUSG00000027720 Il2
ENSMUSG00000020122 Egfr
ENSMUSG00000029371 Cxcl5
ENSMUSG00000044052 Ccr10
Progesterone-mediated oocyte
maturation
5 1.50 0.05
ENSMUSG00000030867 Plk1
97 85 5738 3.4796846573681015 0.9970074965434431 0.6203887188783928 45.9474267108672
ENSMUSG00000032218 Ccnb2
ENSMUSG00000027379 Bub1
ENSMUSG00000019942 Cdk1
ENSMUSG00000027715 Ccna2
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Table 3.3: Cluster Analysis of E16.5 Placenta: Cluster 3
Gene Name KO Fold
change
KO p-value TG Fold
change
TG p-value
prolactin family
2, subfamily c,
member 1
↑ 1.36 7.1x10-4 ↓ 1.91 9.2x10-7
prolactin family
2, subfamily a,
member 1
↑ 1.13 1.9x10-2 ↓ 1.16 1.9x10-2
prolactin family
3, subfamily c,
member 1
↑ 1.20 1.3x10-2 ↓ 1.96 9.1x10-3
prolactin family
5, subfamily a,
member 1
↑ 1.56 1.5x10-2 ↓ 2.82 9.7x10-5
prolactin family
7, subfamily b,
member 1
↑ 1.32 2.0x10-3 ↓ 1.53 2.3x10-3
prolactin family
8, subfamily a,
member 6
↑ 1.10 2.9x10-2 ↓ 1.69 2.6x10-3
inhibin beta-B ↑ 1.17 3.9x10-2 ↓ 1.48 2.4x10-4
interleukin 3 ↑ 1.16 7.4x10-3 ↓ 1.26 2.2x10-3
oncostatin M ↑ 1.10 4.8x10-2 ↓ 1.10 4.8x10-2
secretin ↑ 1.17 2.4x10-2 ↓ 1.35 4.3x10-4
Cluster 3 represented a large proportion of placental prolactins \lactogens known
to be expressed within the SpT (Simmons et al., 2008) and secretin, also highly
expressed within the SpT (Knox et al., 2011). When these data is combined with
the qPCR data it was confirmed that Phlda2 acts as a major rheostat for placental
hormone gene expression.
3.3.2 ELISA
qPCR and microarray demonstrated changes in the expression of key placental
hormone genes at both E14.5 and E16.5. In order to determine whether this
translated to altered serum levels of these hormones in the blood of the dams, ELISA
was used. No study had reported the use of an ELISA kit to measure specific mouse
Prls but there were commercially available kits for Prl8a8 (Wuhan, China), Prl3b1
(NovateinBio, USA) and prolactin (abcam®, UK).
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Placental Lactogen - (Prl8a8)
The maternal serum from three newly generated independent cohorts of WT dams
carrying different fetuses with the different placentas (described in Chapter 2 section
2.2, Figure 2.4) was collected and then analysed in duplicate to determine serum
levels of Prl8a8 using a specific Prl8a8 ELISA (Wuhan, China) (Chapter 2). There
were n = 15 WT(WT), n = 8 WT(TG) and n = 9 WT(KO) serum samples. While
there was an increase of around 2 ng/ml of Prl8a8 in the WT(KO) maternal serum
compared to WT(WT) dams levels (Table 3.4 and Figure 3.4), the observation
was not found to be statistically significant. WT(TG) maternal serum compared
to WT(WT) maternal serum was not greatly different indicating that Prl8a8 levels
were similar between these groups. Importantly, there was a large variation in both
WT(WT) and WT(KO) samples and the absolute levels were 100 times lower than
anticipated. This could be explained either due to a lack of specificity or serum
quality or potentially because Prl8a8, despite being very highly expressed in the
placenta, is not being released into the maternal circulation at E16.5.
Table 3.4: Prl8a8 ELISA
Genotype Concentration (ng/ml) SEM
WT(WT) 6.55 ± 1.79
WT(TG) 7.61 ± 0.63
WT(KO) 8.19 ± 1.58
Placental Lactogen - (Prl3b1)
The serum was run on a kit specific for Prl3b1 (NovateinBio, USA). This kit failed
to work and generated no useful data.
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Figure 3.4: Prl8a8 Levels in Blood Serum. Average levels of Prl8a8 in the blood serum of
WT(WT), WT(TG) and WT(KO) dams. Error bars represent SEM.
Prolactin
To establish whether there was an issue with serum quality, prolactin levels were
analysed in the maternal serum of the original three cohorts that were generated
for the biomolecular characterisation (Chapter 5) using a validated prolactin ELISA
(abcam, UK). For these groups there was n = 8 WT(WT), n = 8 WT(TG) and n =
12 WT(KO) serum samples. The results can be seen in Figure 3.5.
Normally the pregnancy-induced spike in prolactin levels resolves by mid-pregancy
(Soares, 2004) so the prediction would be similar levels across the three cohorts.
WT(KO) dams had on average a higher concentration of prolactin in their blood
serum at E16.5 compared to both WT(WT) and WT(TG) dams. In Table 3.5 it
can be seen that WT(KO) dams had an average of 2715.39 pg/ml of prolactin in
their serum, this was nearly 3 times the levels seen in the WT(WT) dams which only
had 939.90 pg/ml. There was a large amount of variation however between samples
in WT(KO) dams which meant these findings did not reach statistical significance
when comparing across the three cohorts using a one-way ANOVA (p-value > 0.05).
The fact that the ELISA kit worked with the serum samples suggested that the
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Figure 3.5: Prolactin and Prolactin-Like Protein Levels in Blood Serum. Average levels
of Prolactin and Prolactin-Like hormones in the blood serum of WT(WT), WT(TG) and WT(KO)
dams. Error bars represent SEM.
Prl8a8 experiment results were due either the absence of Prl8a8 in circulation or a
failure of the ELISA reactivity.
Table 3.5: Generic Prolactin/Prolactin-like ELISA
Genotype Concentration (pg/ml) SEM
WT(WT) 939.90 ± 156.59
WT(TG) 1088.37 ± 291.95
WT(KO) 2715.39 ± 1218.60
3.4 Discussion
This work showed that the imprinted gene Phlda2 acts exclusively to constrain
the expansion of the SpT compartment of the mature mouse placenta, without
significantly altering the cellular composition of other trophoblast lineages which
share a common progenitor. In this way Phlda2 becomes the first gene that has
been described that has this specific function. Taking what is already known about
Phlda2, the data suggests that it acts in placental development after the lineage
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decisions are made, but before Phlda2 expression subsides (Figure 3.6). This means
that it is now possible to assess in vivo the specific function of the SpT lineage.
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Figure 3.6: Phlda2 Functions. Schematic summarising the cell autonomous and non-cell
autonomous functions of Phlda2. Taken from Rai and Cross (2014).
Our other major discovery that is presented in this chapter, alongside the specific
action Phlda2 has upon the SpT lineage, is that through the use of loss-of-function
and gain-in-expression models, we now know that Phlda2 negatively regulates the
expression of key placental hormones. This could indicate a novel signalling function
of the SpT during placental and fetal development. The work by Tunster et al. (2015)
published in Developmental Biology also highlighted that there was a link between
having an expanded SpT and excessive storage of placental glycogen in both the TG
and NON-TG placenta that shared the same uterine environment. The implications
of this finding is that the SpT is likely to produce a signal that acts both locally,
resulting in a direct effect, and at a distance causing an indirect effect upon glycogen
accumulation. The knowledge that the SpT produces a vast array of Prls means
that these are prime candidates for causing this nutrient accumulation. Placental
hormones have a documented role in ensuring a successful pregnancy, through the
channelling of maternal resources to the fetus (Bhattacharyya et al., 2002, Samaan
et al., 1966, Wu et al., 2008b).
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Shingo (2003) showed that maternal neurogenesis is stimulated by prolactin during
pregnancy. The discovery that the SpT compartment is a key source of numerous
Prls, which are far more highly expressed during late gestation than prolactin (Soares
et al., 2007) and some of which bind to the Prlr (Freeman et al., 2000), has led us
to the hypothesis that these hormones are key regulators of the development of the
maternal instinct. The fact that Phlda2 negatively regulates the size of the SpT
provided a unique model to test this hypothesis in a mouse model. The ELISA
results although not statistically significant gives weight to the model. Specifically
in the WT(KO) dams which had up to 3 times the level of prolactin and a rise
in the Prl8a8 proteins. There is the distinct possibility that the prolactin ELISA
was detecting certain Prls that were shown to be more highly expressed through
the qPCR and microarray in this chapter. Either way the fact that the lactogenic
hormone profiles are disrupted make this a novel and exciting way to directly assess
the effects of having different placentas has upon the behavioural outcomes of the
dams and the offspring.
NOTE: Further to the identification of Phlda2 ’s role in regulating the expansion of
the SpT lineage, we published a paper entitled “Increased dosage of the imprinted
Ascl2 gene restrains two key endocrine lineages of the mouse Placenta.”, that was
also published in Developmental Biology by Tunster, MacNamara, Creeth and John
(2016), further supporting the original hypothesis that imprinted genes play a key roe
in regulating placental hormones (John, 2013). Ascl2 plays a vital role in placental
and intestinal development. Its loss-of-function results in the expansion of the parietal
TGC lineage and an almost complete loss of Tpbpa positive cells in the ectoplacental
cone alongside embryonic failure at E10.5. In this paper Tunster et al. (2016) showed
by using a genetic cross that Ascl2 requires the activity of Phlda2 in order to limit
the increased size of the SpT. Confirming that genomic imprinting is a critical element
to placental development, and that it can be hypothesised that imprinting plays a
vital role in placental signalling. Placental signalling that ultimately helps adapt the
mother and fetus to pregnancy and the outside world.
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Caveats
It must be noted that the use of the specific BAC transgene in this experiment
means that two other genes are added into the mice, Cdkn1c and Slc22a18. Cdkn1c
has been implicated in many disorders over the years, however its presence here
is unlikely to affect the phenotype of the mice as the promotor is absent on the
BAC transgene, thus Cdkn1c is not expressed. Slc22a18 is a solute carrier that
has a role in the kidney (Imai et al., 2014) and in cancer (Chu et al., 2011), it has
not been linked to placenta growth or function. The story of Phlda2 began when
Frank et al. (2002) discovered placental overgrowth in mice lacking Ipl (Phlda2 ).
Then Salas et al. (2004) showed that LOI of Phlda2 (and Slc22a18 using a BAC
transgene model lacking the promotor to Cdkn1c) resulted in placental retardation.
Then to isolate the role of Phlda2 a series of crosses between Phlda2+/- females and
Kvdmr1 +/- males the role of Phlda2 was isolated. This has since been genetically
verified by (Tunster et al., 2010) by use of a BAC transgene to create a double
transgenic (Phlda2 -/+ xBAC1, 1X âĂŞ like wildtype) that rescued the placental and
IUGR phenotype seen in the Phlda2 +/+xBAC1 transgenic (2X). This conclusively
excluded the role of Slc22a18 in placental growth restriction/IUGR. Despite this
evidence indicating that Slc22a18 is not directly involved in the placental phenotype,
it is plausible that it is having wider affects on the phenotypes of the mice that may
confound further findings.
Summary of Findings
• Phlda2 acts exclusively to constrain the expansion of the SpT compartment of
the mature mouse placenta.
• Phlda2 negatively regulates the expression of a number of key placental hor-
mones, including the Prls.
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• ELISA analysis of Prl8a8 levels and prolactin levels showed an increase in
blood serum concentration of prolactin in the WT(KO) dams serum but no
difference in Prl8a8.
• Thes role of Phlda2 on the expression of key endocrine genes from the major
endocrine compartment of the placenta provides the ability to test the hypothe-
sis that changes in expression levels of Prls from the SpT are vital in initiating
the maternal instinct.
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4Maternal BehaviouralCharacterisation
4.1 Overview
A number of indirect experiments suggest that placental endocrine function could
contribute to the programming of maternal care behaviours in rodents but this has
not been tested directly. This chapter describes the use of unique animal models
in which placental endocrine function was genetically manipulated to explore the
consequences for maternal behaviour.
In this study, the WT genetic status of all the dams was maintained using RET
(Chapter 2, section 2.2). This was to isolate the direct impact of the placental
phenotype on maternal behaviour without the confounder of the dams genotype.
The mouse models used were chosen after previous work in our lab demonstrated
that altering levels of the imprinted gene Phlda2 causes a significant change to a
key endocrine lineage situated within the junctional zone of the placenta called the
SpT (Tunster et al., 2015) (Chapter 3). This lineage expresses a number of prolactin
like proteins (Prls) (Simmons et al., 2008) and placental specific glycoproteins
(Psgs) (Coan et al., 2006). Loss-of-function of Phlda2 results in an enlargement of
the SpT compartment by approximately 200% (Tunster et al., 2015). Conversely,
two-fold expression of Phlda2 from a trangene results in a reduction of the SpT
compartment to 50% normal (Tunster et al., 2010). By combining RET with these
two genetic models, the consequences of manipulating the SpT compartment on
maternal behaviour could be studied.
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4.1.1 Behavioural Assays
A number of behavioural assays were used to investigate the maternal phenotypes
of three cohorts of primiparous dams exposed to different placenta. Assessing
maternal behaviour in laboratory rodents involves a number of classic assays primarily
examining behaviour towards pups (Franks et al., 2011). The tests that were chosen
were pup retrieval, nest building and 23 hour monitoring. All the tests occurred
between Postnatal Day (P)2-4 as it is widely reported that this is when maternal
behaviours are most prevalent in rodents. After P 6 these behaviours show a decline
(Champagne et al., 2007, 2003).
The Elevated Plus Maze (EPM) is an established test for testing anxiety in rodents
(Komada et al., 2008). it exploits the natural aversion of rodents to open and elevated
spaces, plus their ability to spontaneously explore novel environments. It has been
used numerous times on male and female mice to determine anxiety phenotypes.
It is not commonly used on primiparous lactating female mice, although has been
recently used in a mouse model of pre-natal trauma (Golub et al., 2016).
Pup retrieval is a maternal behavioural test as it measures the dams responsiveness.
Responsiveness to pups is a critical behaviour in mice in order to keep pups safe.
There are natural variations across mouse strains in this behaviour (Champagne
et al., 2007), but nonetheless, the behaviour persists making it a viable test for
maternal responsiveness to offspring.
Rodents build nests to keep warm (26°C), protect themselves and to protect and
nurture their young. The nest acts as a shelter and is important in reproductive
behaviour (Bond et al., 2002). There is research suggesting that hormones are needed
for the elicitation of nest building (Lisk et al., 1969). There are several methods in
the literature on how to measure nest building, the most common method is to score
the nest on an arbitrary scale, in this chapter an adapted version of this technique is
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used that also takes into account the dams responsiveness to her pups by scoring
whether nest building also elicits the maternal instinct to cover and nurture the pups
inside the nest once/if built within the time scale (Bond et al., 2002, Lisk et al.,
1969).
Pup retrieval and nest building took place in specially designed home cages known as
the Phenotypers (Noldus, UK). The Phenotypers allowed for the continuous tracking
of the animals throughout the tests. This meant that a complete behavioural 23
hour profile could be created using the software to perform retrospective computer
and manual scoring of a subset of maternal and standard behaviours. This type
of analysis can uncover patterns of behaviour during the “light” and “dark” phases
of a day that looked beyond just nest building activity as previously described by
Shoji and Kato (2006). Behaviours scored manually in the Phenotyper were specific
to those behaviours outlined in chapter 13 Mood and Anxiety-related Phenotypes
in Mice: Characterisation Using Behavioural Tests by Pietropaolo (2010). Key
techniques in measuring variations in maternal behaviour are described including
specific home cage behaviours (Table 2.10) that are known to have key behavioural
outcomes for offspring (Coutellier et al., 2009a). These behaviours are therefore seen
to be a reliable assessment of maternal nurturing behaviour.
4.2 Results
The three experimental cohorts were generated as described (Chapter 2). Briefly,
female mice of the appropriate genotype were superovulated, mated with the appro-
priate male and then embryos were harvested from plugged females two days after
a visible plug was observed (E1.5). The next day, WT 129 virgin females between
8-10 weeks of age were set up with vasectomised males to generate pseudopregnant
females. After a short period of incubation in M2 media (SIGMA, cat no: M7167),
14-16 newly fertilised E1.5 embryos were transferred into E0.5 pseudopregnant WT
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recipients (Table 4.1).
For the behavioural assessment 14 WT(WT), 11 WT(TG) and 13 WT(KO) pregnant
females were generated. Females were monitored through out pregnancy at set
intervals by carrying out regular weight and health checks to determine pregnancy
and well being. The day of birth was recorded as day P 0.5, with a note made of
litter size at time of birth and length of gestation. Litter size was also recorded at P7
(Table 4.2). Females with litter sizes between 6 and 12 were used for the behavioural
assessments.
Table 4.1: Matings for RET
Matings Embryos Generated
Phlda2 KO ~ x WT 129 | 100% KO (no Phlda2 )
10-10 TG ~ x 10-10 TG | 25% Homozygous TG ** / 50% heterozygous
TG / 25% WT
WT 129 ~ x WT 129 | 100% WT
Note: ** No homozygous offspring as they are embryologically lethal.
4.2.1 Litter Size
The average litter size across the three cohorts of WT dams carrying different
genotype pups was not significantly different (Figure 4.1 and Table 4.2; F2, 36
= 0.83, p-value = 0.45). Pups generated from 10-10 TG and KO dams were all
genotyped in order to determine the number of pups in a litter that were either
Phlda2 +/- (wildtype, WT; 1X), Phlda2 -/+(maternal KO; 0X) and Phlda2 +/+ BACx1
(single copy Phlda2 transgene, TG; 2X) at least 50% of the litter needed to be of each
genotype to be included. The WT(WT) cohort was likewise genotyped to ensure
that the litter was fully WT. In the WT(TG) model, this was particularly important
as we were unable to breed the transgene to homozygosity. Embryos were generated
by crossing het males with het females which resulted in litters with >60% pups
carrying the transgene (Table 4.1).
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Figure 4.1: Average Litter Size across cohorts. Basic Bar-Chart illustrating that there is no
significant difference in litter size across the three cohorts (F2, 36 = 0.83, p-value = 0.45). Error
bars represent SEM.
Table 4.2: Litter Sizes
Pup Genotype Litter Size (SEM)
WT 7.14 (± 0.63)
TG 6.91 (± 0.25)
KO 7.08 (± 0.35)
4.2.2 Fetal and Pup Weights
The average weight of the fetal and pups (n = 256) from WT(WT), WT(TG) and
WT(KO) dams were recorded at E16.5 and P7 in order to determine whether there
was any difference between the offsprings weights. The results showed that there
was no significant difference in weights between the three cohorts of mice at P7
(Figure 4.3). There was fetal growth restriction at E16.5 in line with previous reports
linking IUGR to Phlda2 TG (Tunster et al., 2014) and data here demonstrated rapid
postnatal catch-up growth (Figure 4.2).
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Figure 4.2: Average Pup Weight at E16.5. Basic Bar-Chart illustrating that there is a
significant difference in fetal weight at E16.57 between the three cohorts litters (F2, 254 = 4.7,
p-value = 0.045). x-axis represents pup genotype, not mothers genotype (which were all WT).
Error bars represent SEM. Statistical significance: *p < 0.05.
4.2.3 Elevated Plus Maze (EPM)
The EPM was carried out on P2 on each of the primiparous dams across the three
cohorts n = 16 WT(WT), n = 10 WT(TG) and n = 12 WT(KO). Each new dam
was given 10-15 minutes to habituate to the test room before embarking on the 5
minute test away from her pups.
The duration of time spent across the zones did not differ between cohorts (F2, 36
= 1.44, p-value = 0.25). There was no significant change in time spent in the most
anxiogenic open zone ((F2, 36 = 0.16, p-value = 0.85, Figure 4.4). However, all three
cohorts did not behave as expected in the middle zone.
Although the velocity by which the mice moved around the zones of the EPM was not
different overall (F2, 36 = 2.87, p-value = 0.069), the mean velocity of the WT(KO)
dams in the open zone was over twice that of WT(WT) mice (p-value = 0.077;
Figure 4.4).
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Figure 4.3: Average Pup Weight at P7. Basic Bar-Chart illustrating that there is no significant
difference in pup weight at P7 between the three cohorts litters (F2, 254 = 0.76, p-value = 0.53).
x-axis represents pup genotype, not mothers genotype (which were all WT). Error bars represent
SEM.
The increased speed of WT(KO) dams was not matched in the distance travelled
by them when compared to the WT(WT) and WT(TG) mice (Figure 4.4,F2, 36 =
1.58, p-value = 0.22 ) or the frequency of entries into the different zones of the EPM
(Figure 4.4, F2, 36 = 1.7, p-value = 0.19).
Average stretch and dip frequency was recorded manually in order to help quantify
explorative and anxious behaviour in the different zones of the EPM. No signifi-
cant differences between genotypes across the cohorts were found for stretch and
dip frequency (F2, 36 = 1.0, p-value = 0.395 and F2, 36 = 2.4, p-value = 0.076,
respectively).
4.2.4 Pup Retrieval
The pup retrieval test demonstrated that there was no significant difference (p-value
> 0.05) across the three cohorts in the time taken for dams to sniff their pups, with
WT(WT) and WT(TG) mice taking 49-53 seconds and WT(KO) dams taking 67
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(c) The distance moved in each zone of the EPM.
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(d) The frequency of entries into each zone of the EPM.
Figure 4.4: The Elevated Plus Maze. (a) A barchart showing the percentage time spent in
each zone of the EPM. There was no significant difference in time spent in each zone across the
three cohorts (F2, 36 = 1.44, p-value = 0.25). (b) A barchart showing the speed/velocity in each
zone of the EPM. Statistical analysis indicated that there was no significant difference between
the speed of the genotypes across the different zones (F2, 36 = 2.87, p-value = 0.069) although
WT(KO) dams did show a trend of moving faster in the open zone compared to WT(WT) dams.
(c) A barchart showing the distance travelled in each zone of the EPM (F2, 36 = 1.58, p-value =
0.22). (d) A barchart showing the frequency of entries into each zone of the EPM (F2, 36 = 1.7,
p-value = 0.19). Error bars represent SEM.
seconds on average (Figure 4.5) (F2, 36 = 1.1, p-value = 0.33). This can be taken to
suggest that there were no issues regarding either the WT(TG) or WT(KO) dams
ability to recognise the pups.
There was a significant difference in the latency to retrieve the first pup in the pup
retrieval task (F2, 36 = 4.8, p-value = 0.015). This was driven by WT(KO) dams
taking longer to retrieve their first pup compared to WT(WT) dams (p-value = 0.01)
and compared to the WT(TG) dams (Figure 4.5). WT(WT) and WT(TG) dams
took between 109 - 139 seconds to collect their first pup. Wt(KO) dams took three
times as long to retrieve their first pups with an average time of 339 seconds.
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(a) Latency to Sniff Pups across cohorts.
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(b) Latency to Retrieve Pups across cohorts.
Figure 4.5: Pup Retrieval Task. (a) A barchart showing the differences in the time taken to
sniff pups and the time taken to retrieve pups across the 3 cohorts. The time taken to retrieve pups
was significantly different between WT(KO) and WT(WT) (F2, 36 = 1.1, p-value = 0.33). (b) A
barchart showing the differences in the time taken to sniff pups and the time taken to retrieve pups
across the 3 cohorts. The time taken to retrieve pups was significantly different between WT(KO)
and WT(WT) (F2, 36 = 4.8, p-value = 0.015). Error bars represent SEM. Statistical significance:
*p < 0.05.
Within the pup retrieval paradigm the time taken to retrieve the first pup is a
measure of maternal responsiveness to pups. The overarching finding that WT(KO)
dams took longer to retrieve their pups but not sniff them in comparison to both
WT(WT) and WT(TG) dams implies that these dams have an impaired maternal
response that is independent of the basic recognition of the pups new location outside
of the nest, in the home cage. This phenotype was not anticipated as these dams
were exposed to placenta with a larger endocrine compartment and were predicted
to have enhanced maternal behaviours. However, there are different interpretations
of these data, as will be discussed later.
4.2.5 Ethovision - Monitoring of Pup Retrieval
Using the Phenotyper set up allowed for the continuous monitoring of the dams’
behaviour over the duration of the pup retrieval assay. This analysis was done
retrospectively so as to be able to ensure accurate tracking and control for any
software issues that if performed during the task may have been problematic.
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The Ethovision software was calibrated to track the dams movement during the
duration of the task. All the dams had collected the first of their pups within 20
minutes of the assay and the analysis continued for a further 40 minutes in order
to monitor behaviours associated with the collection of the remaining pups. An
example of the tracking can be seen in Figure 4.6 where the yellow signifies the dam
and the red the central axis of the tracker.
Figure 4.6: Ethovision Tracking. A screenshot of the tracking software and how it locates the
dams within the home cage (yellow) and then monitors their movement in the predefined home
cage and sub locations within the home cage.
.
Ethovision video tracking analysis from the 60 minute period of the pup retrieval
assay demonstrated a tendency for WT(KO) dams to visit the food zone significantly
over twice as quick WT(WT) dams (df = 1, p-value = 0.029), and twice as quick
as WT(TG) dams, although this was not significant (Figure 4.7). The WT(KO)
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dams were also significantly (df = 1, p-value = 0.046) quicker to visit the water zone
during this test period compared to WT(WT) dams (Figure 4.7).
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(b) Time taken to visit water zone during pup retrieval.
Figure 4.7: Ethovision Analysis of Pup Retrieval. (a) A barchart showing the time taken
for the dams across the 3 cohorts to first visit the food zone during the pup retrieval task. WT(KO)
dams visited significantly sooner than WT(WT) dams (df = 1, p-value = 0.029). (b) A barchart
showing the time taken for the dams across the 3 cohorts to first visit the water zone during the pup
retrieval task. WT(KO) dams visited the water zone significantly sooner compared to WT(WT)
dams (df = 1, p-value = 0.046). Error bars represent SEM. Statistical significance: *p < 0.05.
There are several interpretations of what these marked differences in behaviour
displayed by the WT(KO) dams mean in relation to maternal care and nurturing
behaviour. The use of other maternal behavioural assays like the nest building assay
aided the interpretation. Although some of the findings were challenging to interpret
in the absence of reliable data from the EPM test, as will be discussed later.
4.2.6 Nest Building
The results of the nest building, similarly to the pup retrieval task, indicated a
significant phenotype present in the WT(KO) dams behavioural response to the task.
The WT(KO) model dams exhibited poorer nest building behaviour in comparison
to both the WT(WT) and WT(TG) models (Figure 4.8). These WT(KO) dams
failed to build a nest 60% of the time, in contrast to WT(WT) and WT(TG) dams
whom built a nest 70-85% of the time. Intriguingly WT(TG) dams performed better
than the WT(WT) dams in this test, using the chosen method of scoring the nests.
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The WT(TG) dams were twice as successful at building nests and moving the pups
into the nest than WT(WT) control mice (p-value = 0.027).
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Figure 4.8: Nest Building: A series of pie charts highlighting the differences in nest building
behaviour across the 3 cohorts (F2, 36 = 4.3, p-value = 0.022). WT(KO) significantly differed from
WT(TG) (p-value = 0.019). WT(TG) dams differed significantly from WT(WT) dams (p-value =
0.027). Statistical significance: *p < 0.05.
4.2.7 Ethovision - Monitoring of Nest Building
Ethovision video tracking analysis from the 60 minute period of this test highlighted
significant differences in the distance travelled across the three cohorts (F2, 36 =
7.12, p-value = 0.001), with the WT(KO) dams travelling considerably further than
both WT(WT) (p-value < 0.001) and WT(TG) (p-value = 0.001), driving this
difference (Figure 4.10). This was mirrored in the frequency of visits to the food
zone across the cohorts (F2, 36 = 8.4, p-value = 0.001) where WT(KO) dams visited
more frequently than both WT(WT) (p-value = 0.001) and WT(TG) groups (p-value
= 0.01, Figure 4.10).
Using the video recordings for each of the 38 dams from the nest building task it
was possible to unobtrusively score other key behaviours. The behaviours that were
scored can be seen in table 2.10. Manual scoring these behaviours was performed
blind for duration and frequency by two separate investigators to exclude bias. The
results were compared across the genotypes and suggested that there was a significant
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Figure 4.9: Duration of time spent Nest Building. Graph indicating the duration of time
spent building a nest across the cohorts during the nest building task (F2, 36 = 6.967, p-value =
0.003). In particular WT(KO) spent significantly less time building nest compared to both WT(WT)
and WT(TG) mice, p-value = 0.029 and p-value = 0.002, respectively. Error bars represent SEM.
Statistical significance: *p < 0.05, **p < 0.01, and ***p < 0.005.
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(a) Distance travelled by mothers during nest building.
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(b) Number of visits to the food zone during nest building.
Figure 4.10: Ethovision Analysis of Nest Building. (a) A barchart showing the total
distance travelled by the dams across the 3 cohorts during the nest building test (F2, 36 = 8.7,
p-value = 0.001). (b) A barchart showing the number of visits to the food zone during the
nest building test across the 3 cohorts of dams. The WT(KO) signalling model visited the zone
significantly more than WT(WT) dams (F2, 36 = 8.4, p-value = 0.001). Error bars represent SEM.
Statistical significance: *p < 0.05, **p < 0.01, and ***p < 0.005.
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difference in the duration of time spent self grooming between the genotypes (F2, 36
= 6.61, p-value = 0.004, Figure 4.11). Specifically, the most significant difference
was between WT(KO) and WT(TG) (p-value = 0.009) which showed WT(KO) dams
spent five times longer self grooming than WT(TG) dams and two times longer
than WT(WT) dams. This was also found to be the case with the frequency that
dams undertook pup grooming during the nest building task (Figure 4.11, F2, 36 =
4.59, p-value = 0.017). In particular this difference was evident between WT(TG)
and WT(KO) dams (p-value = 0.012). These two cohorts also showed a significant
difference in the duration of time spent grooming their pups, despite taking into
account the large variation between individual dams (Figure 4.11, F2, 36 = 4.39,
p-value = 0.02). It was also evident that WT(KO) mice spent significantly less time
building nests compared to WT(WT) (p-value = 0.029) and WT(TG) (p-value =
0.002) mice (Figure 4.9), independently corroborating the results displayed in the
specific nest building test.
Crouched nursing frequency (F2, 36 = 6.54, p-value = 0.004) showed over a two fold
increase in the WT(KO) (p-value = 0.024) dams compared to WT(WT) and was
four times less in WT(TG) dams (p-value = 0.003) (Figure 4.11). The difference
crouched nursing duration was also significantly different across the groups (Figure
4.11, F2, 36 = 4.97, p-value = 0.012); with the behaviour most significantly altered
between WT(TG) and WT(KO) (p-value = 0.009). Arched nursing, however, was
not found to be significantly altered in either duration or frequency (p-values > 0.05)
and neither was passive nursing (p-value > 0.05).
The post-hoc tracking of each cohort of dams allowed for the generation of an array
of behavioural characteristics that are displayed by WT(TG) and WT(KO) dams
compared to the control WT(WT) cohort of dams. There initially appeared to be a
stronger phenotype present in the WT(KO) dams based on the nest building and pup
retrieval tasks. However, tracking plus manually scoring allowed the dissection of
behaviours that were disproportionately preferred between the groups with relation
to nurturing behaviour and protecting their offspring with both the WT(KO) dams
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Figure 4.11: Manually Scored Maternal Behaviours. (a) Graph indicating the duration of
time spent self grooming across the cohorts during the nest building test (F2, 36 = 6.61, p-value =
0.004). (b) Graph indicating the frequency of time spent grooming pups across the cohorts during
the nest building test (F2, 36 = 4.59, p-value = 0.017). (c) Graph indicating the duration of time
spent grooming pups across the cohorts during the nest building test (F2, 36 = 4.39, p-value =
0.02). (d) Graph indicating the duration of time spent by the three cohorts of dams performing
the crouched nursing behaviour on their pups during the nest building test (F2, 36 = 4.97, p-value
= 0.012). Error bars represent SEM. Statistical significance: *p < 0.05, **p < 0.01, and ***p <
0.005.
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and the WT(TG) behaving abnormally. These have been summarised in Table 4.3.
Table 4.3: Manually Scored Behaviours
Behaviour WT(WT) vsWT(TG) p-value
WT(WT) vs
WT(KO) p-value
WT(TG) vs
WT(KO) p-value
↑/↓ Regulated
(p-value)
↑/↓ Regulated
(p-value)
↑/↓ Regulated
(p-value)
Crouched Nursing
Frequency
0.59 ↑ 0.02 ↑ 0.003
Crouched Nursing
Duration
0.46 ↑ 0.05 ↑ 0.009
Arched Nursing
Frequency
0.84 0.14 0.058
Arched Nursing
Duration
0.74 0.22 0.070
Pup Grooming
Frequency
0.28 0.21 ↑ 0.012
Pup Grooming
Duration
0.82 0.057 ↑ 0.020
Self Grooming
Frequency
0.37 0.12 ↑ 0.009
Self Grooming
Duration
0.64 ↑ 0.02 ↑ 0.003
4.2.8 Ethovision - 23 Hour Monitoring - Day to
Night
When analysing the tracking of the 23 hour period of the mice, the adjustment of
behavioural patterns from the last two hours of “Day Time” and the first two hours of
“Night Time” were analysed. This is when mice are most active as they are nocturnal
animals and therefore activity around this period is heightened (Windhorst and
Johansson, 2012). Analysis showed that there was an overall effect of genotype on
the time spent in the nest zone during this AM-PM period (F2, 36 = 4.63, p-value =
0.016), driven by the main difference between WT(WT) and WT(TG) dams (p-value
= 0.014). WT(TG) dams spent longer in the nest zone compared to the WT(WT)
dams (Figure 4.12). The number of visits to the nest was also seen to be significantly
altered between genotypes (F2, 36 = 3.7, p-value = 0.035) and was similarly driven
by differences between the WT(WT) and WT(TG) cohorts (p-value = 0.031) where
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WT(TG) dams tended to visit the nest zone more often during this period compared
to the WT(WT) dams (Figure 4.12).
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(b) Number of visits to the nest zone during 10-14 hours of
monitoring.
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(c) Duration of time spent in the food zone during 10-
14 hours of monitoring.
Figure 4.12: Activity between Hour 10 to Hour 14 of Monitoring. (a) The graph shows
that during the most active phase of a 24 hour day it was evident that there was a significant
effect of genotype on the duration of time spent in the nest zone (F2, 36 = 4.63, p-value = 0.016).
This was driven by the difference between WT(TG) mice and WT(WT) mice (p-value = 0.014).
This difference indicated that WT(TG) dams spend longer in the nest zone compared to WT(WT)
dams. (b) The graph indicates that the number of visits to the nest zone during this period is
also significantly altered across the three cohorts (F2, 36 = 3.7, p-value = 0.035). WT(TG) dams
drove this difference by visiting the nest zone considerably more often that WT(WT) dams with a
significance of (p-value) = 0.031. (c) A barchart showing the duration of time spent in the food
zone during hours 10-14 of a 24 hour monitoring period. It can be seen that WT(TG) mice show a
decrease in the amount of time spent in the food zone during this period of heightened activity for
mice, however this did not reach significance. Error bars represent SEM. Statistical significance: *p
< 0.05 and **p < 0.01.
As well as the nest zone it was noted that the time spent feeding in the food zone
during this period was reduced in the WT(TG) dams and was nearing significance
(p-value = 0.051). The latency of the first visit to the food zone although not
significant (p-value = 0.056), indicated that WT(TG) not only spent less time in the
food zone, they also took longer to visit the food zone during this period of increased
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activity (Figure 4.12).
4.2.9 Hour by Hour - Circadian Rhythm
Following on from the previous analysis it was apparent that reviewing the three
groups of dams (n = 38) over the duration of the test monitoring on an hourly basis
might uncover further information. To analyse their 23 hour pattern of behaviour,
or their circadian rhythm, it was necessary to first define the 23 hour time period
in the two distinct phases, “light” and “dark” as previously described by Shoji and
Kato (2006). The light phase which is equivalent to day time is the period when the
mice should be least active (as they are nocturnal animals). The dark phase or night
time is when activity would be expected to be increased.
Using this method of analysis, there was a significant difference in the distance
travelled by WT(WT) dams during the light phase compared to distance travelled
in the dark phase (p-value < 0.001), demonstrating that WT(WT) dams displayed
increased activity in the dark phase of the day. This difference in activity between
the light and dark phases was not evident in the WT(TG) mice however with a
p-value = 0.13. Similarly the WT(KO) dams did not show a significant difference
in activity levels between day and night (p-value = 0.83). Consequently there was
significant differences between the WT(WT) dams and the WT(KO) dams (F1, 24 =
6.4, p-value = 0.038) but not between the WT(WT) and WT(TG) mice (F1, 25 =
1.93, p-value = 0.18) dams.
The nest zone phase analysis indicated that there was an overall effect of phase on
the time spent in the nest region for WT(WT) dams (p-value = 0.002), this was
a result of the dramatic decrease in the duration of time in the nest between light
and dark phases. WT(TG) dams spent a similar amount of time in the nest zone in
the light and dark phases (p-value = 0.68). This behaviour was also evident in the
WT(KO) dams (p-value = 0.96).
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Figure 4.13: Hour by Hour distance moved across the 23hr monitoring. The graph above
shows the hour by hour distances travelled by each cohort over a 23 hour period. The first 12 hours
are “day” time with 12-23 hours being “night” time. There was a significant difference in distance
travelled between day (light) and night (dark) phases for the WT(WT) mice (p-value < 0.001),
but no significant difference in the distance travelled for WT(TG) and WT(KO) mice between
day and night phases. There was however an effect evident between WT(WT) and WT(KO) mice,
where WT(KO) dams appeared to show significantly less of a time of day phase effect compared to
WT(WT) mice (F1, 24 = 6.4, p-value = 0.038). Error bars represent SEM.
When analysing the data by genotype with phase as the within-subject factor, there
was a significant difference between WT(WT) and WT(TG) dams (F1, 25 = 5.8,
p-value = 0.024). This was driven by the difference between time spent on the nest
in the dark phase of tracking between the two cohorts (p-value = 0.002). WT(TG)
cohort spent significantly longer on the nest during the dark phase in contrast to the
WT(WT) cohort of dams (Figure 4.14).
The average time spent on the nest by WT(WT) and WT(KO) dams across the two
distinct phases demonstrated a difference between WT(WT) dams and WT(KO)
dams similar to that seen between WT(WT) and WT(TG) mice. WT(WT) dams
spent less time on average in the nest during the dark phase of monitoring compared
to WT(KO) dams (Figure 4.14).
The time spent in the food zone in both the WT(WT) and the WT(TG) mice was
significantly different between the light and dark phases of the trial (p-value < 0.001),
indicating an effect of phase on time spent in the food zone. This was not the case for
the WT(KO) mice which showed no significant difference between the time spent in
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Figure 4.14: Hour by Hour time spent in the nest across the 23hr monitoring. There
was an overall effect of day and night or light and dark phases upon the time spent in the nest
for all the WT(WT) cohort p-value = 0.002), this was not seen in WT(TG) or WT(KO) dams,
whom tended to spend similar amounts of time on the nest irrespective whether it was light or
dark (WT(TG) p-value = 0.68, WT(KO) p-value = 0.96). This there was a significant difference
between time spent on the nest for both WT(TG) and WT(KO) dams when compared to WT(WT)
mice during the dark phase. The WT(TG) mice spent longer on the nest compared to WT(WT) in
the dark phase (F1, 25 = 5.8, p-value = 0.024). The difference between WT(KO) and WT(WT)
mice was similar with WT(KO) dams spending considerably more time in the nest zone compared
to WT(WT) dams (F1, 25 = 5.8, p-value = 0.018). Error bars represent SEM.
the food zone during the light hours and the dark hours of the day (p-value = 0.16).
The WT(WT) mice spent on average more time in the food zone during the dark
phase of tracking compared to WT(TG) mice however this was only approaching
significance (F1, 25 = 3.5, p-value = 0.071). In contrast when comparing WT(WT)
mice with WT(KO) mice there was no effect of genotype on the duration of time in
the food zone (F1, 24 = 2.5, p-value = 0.12).
4.2.10 Food and Water Consumption
Throughout the study food and water was regularly weighed for each dam. The total
amounts of both food and water consumed by the three cohorts were recorded (Figure
4.17). When analysed there was not a significant difference in total consumption
between the cohorts (p-value > 0.05, ). There was a visible decrease in the amount
of both food and water that WT(TG) dams consumed over the 48 hour period
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Figure 4.15: Hour by Hour time spent in the food zone across the 23hr monitoring.
The time spent in the food zone per hour is displayed in the graph above. There was asignificant
difference between the time spent feeding between the light and dark phases for both WT(WT)
and WT(TG) mice with a p-value < 0.001. This was not evident in WT(KO) mice however whom
showed no phase effects on feeding behaviour. There was also no significance when comparing
phases between the three cohorts. WT(WT) mice tended to spend more time feeding compared to
WT(TG) mice during the dark phase but this was only nearing significance (F1, 25 = 3.5, p-value
= 0.071). Error bars represent SEM.
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Figure 4.16: Hour by Hour time spent in the water zone across the 23hr monitoring.
This graph shows the time spent in the water zone across the 23 hours of monitoring. There was
no overall effect of phase on the time spent in the water zone for WT(WT), WT(TG) or WT(KO)
mice (p-value = 0.18). WT(TG) mice compared to WT(WT) mice display no difference between
time spent in the water zone within either the light or dark phases of the 23 hour monitoring (F1, 25
= 0.29, p-value = 0.59), as was the case for WT(KO) mice when compared to WT(WT) dams
for both the light and dark phases of the monitoring (F1, 25 = 0.26, p-value = 0.62). Error bars
represent SEM.
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compared to WT(WT) dams, eating around 5-10 g less, but this didn’t reach
significance. WT(KO) dams didn’t appear to consume any more than WT(WT)
dams despite spending a larger proportion of time feeding, and actually showed a
slight decrease in total consumption, however this was not significant.
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(a) The total food consumed every 12 hours across the co-
horts.
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(b) The total amount of food consumed over 48 hrs.
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(c) The total amount of water consumed over 48 hours.
Figure 4.17: Food and Water Consumption over 48 hrs. (a) This graph shows that whilst
there is no significant difference between the groups over the course of each 12 hour period; there
does seem to be a tendency for the WT(TG) dams to consume less food. (b) This graph summaries
the previous graph and shows the total consumption of food over 48 hours for the three cohorts.
There was no significant difference in total food intake between the groups of dams. (c) This graph
shows the total water consumed by each of the cohorts over the 48 hour period. There was no
significant difference between the groups, however WT(TG) mice did have a visibly lower total
consumption than both WT(WT) and WT(KO) dams.
4.3 Discussion
Overall, these series of assessments revealed phenotypic consequences related to the
behaviour of WT dams exposed to placenta with either an enlarged or a reduced SpT.
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By maintaining the WT status of the dams, these phenotypes can be attributed to
the genotype of the transferred embryos. The major change driven by altered dosage
of Phlda2 is in the size of the SpT, a lineage which expresses Prls. Considerable
data links these Prls to maternal care. WT(TG) dams performed better at the
pup retrieval task and the nest building task compared to WT(KO) dams, and out
performed the WT(WT) control group in relocating pups into the newly constructed
nest in the nest building assay. This was contrary to what was predicted based upon
the placental signalling hypothesis. The prediction was that, when the SpT was
reduced (TG placental model), the WT dams would be exposed to less placental
hormones including the Prls and would show an impaired maternal phenotype.
Conversely, it was anticipated that dams carrying the Phlda2 KO placenta with an
enlarged SpT would be exposed to higher levels of placental hormones enhancing
maternal behaviour. However, the WT(KO) cohort appeared to display differential
care of their pups.
Interpretation of Behavioural Tests
Pregnancy in both humans and rodents is associated with changes in anxiety-
related behaviours (Brunton and Russell, 2008, Grattan, 2011). Anxiety is generally
increased in the postpartum period of pregnancy and is an often neglected aspect
of psychopathology in new mothers (Farr et al., 2014, O’Hara and Wisner, 2014).
Although in recent times it is far more widely acknowledged (Matthey et al., 2003,
Miller et al., 2006). For this reason it was critical to assess the anxiety levels of
the dams. The initial behavioural testing focussed on the EPM, a well established
anxiety assay in rodents (Walf and Frye, 2007). Using this assay it was not clear
whether any of the cohorts exhibited an anxious phenotype. None of the models
showed statistically significant differences in anxiogenic or anxiolytic behaviour.
When looking at the duration of time spent in the three zones of the EPM it was
clear that all three cohorts spent significantly more time in the closed arm compared
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to the time spent in the open arm, which was indication that the assay fundamentally
worked.
It is hypothesised that any potential phenotype could have been masked through
the inclusion of the middle zone of the EPM. This is because the findings showed a
possible increase in anxiety in both the WT(TG) and WT(KO) dams, but due to the
presence of the middle zone the significance may have been masked by floor effects
(Figure 4.4). The EPM is based around the paradigm that mice that are more
anxious should spend more time in the closed arms of the maze and less anxious
mice should spend more time in the open arms. The middle is a confounding section,
however generally animals do spend time there. The dams demonstrated abnormal
behaviour by spending the majority of their time in the middle zone of the EPM and
very little time in the open zone. This behaviour was evident across all the cohorts.
By including the middle zone, a zone that is neither open nor closed, it results in us
being unable to determine the levels of anxiety an animal may be experiencing. This
is due to the middle zone being either anxiolytic or anxiogenic. Thus, the floor effect
of the animals spending very little time in the open zone and so much time in the
middle means it is difficult to tease apart any group differences. It is possible that
the reason the dams spent so much time in the middle is due to separation anxiety
from their new offspring, however this test fails to confirm this.
The EPM is one of the commonest tests used to measure anxiety but may not be the
most appropriate test to use in our model. As mentioned, the lack of clear results
may be due to the timing of the assay, so close to parturition. Whilst the EPM has
been used to study C57BL/6 BL6 mice, and at least one study on pregnant and
postpartum females (George et al., 2010, Golub et al., 2016), it has not been regularly
used previously with 129 mice and not at all with postpartum 129 females. The
experimental work required the use of 129 mice due the the phenotypic differences
between 129 and BL6 placenta focussing on the SpT compartment (Tunster et al.,
2012). Consequently, it is not possible to interpret the results of this test as a lack
of an affect on anxiety. A second potential confounder is the timing of the test
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procedure, on P2. Mice tested so soon after giving birth may have elevated stress
that disguised any effect from placental dysfunction. Similarly, 129 mice are generally
more anxious (Champagne et al., 2007), which could be a factor in interpreting
the results. Given the costs and complexities of generating the dams, it was not
possible to repeat the assessment on a second set of animals but future work could
involve a different time point, potentially both prenatally and post-natally. It may
be possible to repeat this experiment using the transgenic modification bred in BL6.
Alternatively, a modified version of EPM could be applied where there is no middle
zone such as the Elevated Zero Maze (EZM) (Braun et al., 2011, Kulkarni et al.,
2007). It would be worth trying altered levels of light in the test room as well to
determine the optimum testing conditions to encourage greater exploration and
activity. There are also other behavioural assays which measure anxiety such as
the light dark box test or open field. Taking these test results together would help
provide a more reliable anxiety profile of the dams.
It is usual that the pregnant state will generally have an anxiolytic effect on dams.
This is to help them prioritise defending their offspring against otherwise anxiety
inducing predators or danger, the aptly named “fight or flight” response. A typical
arousal of the “fight” response behaviour is known to be induced by prolactin and
oxytocin (Woodside, 2016). The EPM did not reveal alterations which could be used
as a indicator of anxiety since all the dams essentially exhibited anxious behaviours.
Despite the absence of a distinct anxiety phenotype, there were differences in the
speed at which WT(KO) dams moved in the anxiogenic open zone with a mean
velocity of 7 cm/s compared with both the WT(WT) and WT(TG) cohorts of dams
moving slower, at 3 cm/s. This was only evident in the open arm and velocity
was similar in the closed and middle zones for the WT(KO) dams. Although this
difference in speed did not reach significance in a rigorous test (p-value = 0.069),
the results warrant further investigation. While speed was potentially increased, the
distance moved in the open zone during the EPM for WT(KO) dams was unchanged.
Two specific mothering behavioural tests were performed to determine levels of
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maternal care in the dams. The pup retrieval task is perceived as a test for maternal
responsiveness. This task highlighted a potential difference in the latency of time
it took for WT(KO) mothers to locate then retrieve their pups. There was no
initial difference in the time taken between the three cohorts to sniff their offspring,
suggesting that there were no issues regarding any of the cohorts ability to recognise
their pups. Crucially, however it doesn’t distinguish how the dams initially recognise
and respond to their pups. This could be due to their smell or the levels of vocalisa-
tion/calls produced by the pups being different. The observation that WT(KO) took
significantly longer than both WT(WT) and WT(TG) dams to relocate the first pup
into the heart of the nest indicated an impaired ability of WT(KO) mice to respond
to their pups. This may be explained by the different genotypes of the pups born to
WT(KO) and WT(TG) dams. Phlda2 KO pups may be more or less recognisable by
smell or call more or less to the dam. Testing this using ultra-vocalisation recordings
and measuring pheromones given off by the offspring would help determine if this
was the case. Either way this is an unlikely explanation since Phlda2 is primarily
expressed and imprinted only in the placenta and yolk sac (Tunster et al., 2015).
Another way to address this rigorously would be in a cross-fostering assay, replacing
the dams pups with WT pups born naturally to WT dams, however, due to money
and time contraints, this was not possible. As described in the next chapter, work
was performed pre-parturition to explore this in more detail.
The second specific mothering behavioural task was nest building. This uncovered
a significant deficit in nest building behaviour. WT(KO) dams only built a nest
40% of the time compared to WT(WT) dams that built a nest 60% of the time.
In contrast, WT(TG) mice showed a much greater tendency to build a nest than
WT(WT) and WT(KO) dams. WT(TG) dams successfully built a nest 85% of
the time. All rodents build nests, but mothers are particularly likely to build a
nest, to provide a warm and secure environment for the newborn (Deacon, 2006).
Therefore nest building is commonly interpreted to represent an important feature
of the maternal instinct. One interpretation of the contrasting nest building between
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all three cohorts was to assign a hierarchy of “better” dams. Using this method it
would follow that based solely on this test WT(TG) dams were inherently better
nest builders and thus protected and cared for their pups better that WT(KO) mice
and even WT(WT) dams. This is a dangerous stance to take however, and the term
“better” even more so. When describing a behavioural phenotype, it is critical to be
aware that there are, very often, numerous other behavioural differences that are
affected in a knock-on response to another behavioural affect.
Nest building is a phenomenon that can be induced in virgin female mice through
the presentation of young although their nest is smaller in size (Gandelman, 1973,
Gandelman et al., 1979). Gandelman and his colleagues also identified a distinct
correlation between litter size and nest size in new dams (Gandelman, 1975). The
latter may imply that any differences in nest quality could be attributed to litter
size. In this study, there was no significant difference in litter sizes between the
three groups so this can be excluded. It is important consider the interpretation of
both nest building and pup retrieval. These assays are used to measure maternal
care behaviour with slower retrieval/poor nest building used as an indicator of an
inexperienced or unmotivated female. However, this interpretation in isolation should
be made cautiously since potentially these behaviours could also reflect a reduced
motivation to protect pups against predators manifesting in reduced agression or
anxiety.
Ethovision - Monitoring of Behaviours
With the help of tracking software and manual scoring of the other key rodent
behaviours described earlier (Table 2.10), additional alterations in behaviour were
uncovered. These findings questioned the obvious conclusions that could have been
drawn from the lack of nest building by WT(KO) mice and their apparent disinterest
in their pups. In contrast to WT(TG) and WT(WT) dams, the WT(KO) dams spent
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a significantly longer duration of their time grooming their pups and themselves
during the nest building task, and on a more frequent basis. Licking and grooming
of pups is a key maternal behaviour. Importantly, Zhang et al. (2013) showed
that licking grooming in rats protects offspring from later life stress something that
is further explored in chapter 6. The theory of differentially prioritising certain
behaviours is further supported through the tracking of the three cohorts movement
throughout the pup retrieval task. It can be clearly seen that during this test the
WT(KO) dams took longer to retrieve their pups but they were quicker to visit
the water and food zones compared to WT(WT) mice. This is interesting as it
offers more support to the hypothesis that the placental endocrine compartment
can influence maternal behaviour. Thus there are several interpretations of these
marked differences in behaviour that WT(KO) dams display during Ethovision
tracking. WT(KO) spent a larger proportion of their time on activities related to
feeding and drinking, perhaps these dams are less receptive to the immediate needs of
their pups (warmth and protection) and instead prioritise self-nurturing behaviours.
Alternatively, there may be a secondary phenotype that requires dams to intake more
food and water than either of the other cohorts. The third possibility is that these
dams are less anxious and protective of their pups. Interpreting these findings is
challenging in the absence of reliable data from the EPM test. Tracking of movement
during the nest building task similarly indicated that WT(KO) mice travelled a
significantly greater distance and visited the food zone more frequently.
The final behavioural assessment involved examining 23 hours of behavioural tracking
analysis data from P3-4 for each dam. This was utilised to examine the behavioural
phenotype over a natural daily cycle of “light” and “dark” or “day” and “night”. Mice
are typically nocturnal animals so it was expected that activity would naturally
increase during the night time hours and decrease during the day. This was confirmed
for WT(WT) mice with regards to the distances travelled between these two phases
and similarly the duration of time spent in the nest. This was not the case for
the WT(TG) and WT(KO) dams neither of whom displayed phase effects between
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day and night. These observations moreover lent further support to the earlier
observation that WT(TG) mice tended to spend more time building a nest and
less time feeding themselves during the nest building task. It is important to note
however, that there was no difference in overall food intake between groups, there was
just a preoccupation by some groups to perform certain behaviours more regularly
and for longer than other groups.
The lack of a phase effect during the 23 hour monitoring supports the idea that
WT(TG) mice spend a larger proportion of their time nesting, suggesting perhaps
that this behaviour is a persistent trait not brought on through stress. This is evident
as during this period there was no tasks given to the dams and the behaviour was
done entirely without direction from external stimuli. Similarly when looking at the
time spent in the food zone across the two phases it is evident that unlike WT(WT)
and WT(TG) cohorts that exhibit obvious phase effects in relation to time spent in
the food zone, WT(KO) dams did not. In contrast, WT(KO) dams tended to spend
more of their time feeding consistently over both light and dark phases.
Caveats to Behavioural Characterisation
This work focused on the maternal behaviours exhibited by the mice. However,
it should be appreciated that other biological processes are involved that may be
dictating behaviours independently of the maternal instinct. The metabolism of
the dam may be altered during pregnancy with post natal consequences. Tunster
et al. (2010) showed that Phlda2 manipulates the placenta’s demands for maternal
resources by the fetus and that the SpT signals to stimulate the global accumulation
of glycogen in the placenta. The demand for these resources by the fetus may put
stress on the maternal metabolism resulting in the dams needing to obtain more
food more frequently postnatally. Prls stimulate development of the mammary gland
for lactation (Bridges, 1994, Flietstra and Voogt, 1996). Increased or decreased
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milk production could influence the time the dams spend feeding themselves and
their pups. Flietstra and Voogt (1996) showed that rat Prls initiate and maintain
lactation but inhibit suckling-induced prolactin release. If this is the case in our
WT(KO) dams, it could mean that the dams are getting less positive feedback from
suckling their pups meaning a less intense release of oxytocin, a known stimulator
of maternal behaviour (Ramos et al., 2008). These factors may contribute to the
altered behaviour displayed by these dams, including the more frequent trips to
the food and water zones. There is also the genotype of the pups to consider, as
discussed earlier. Some complex experiments will be required to further tease out
cause and effect relationships, which will be discuss in greater detail in chapter 6.
Conclusion
The data presented in this chapter lend support to the hypothesis that a structurally
altered placental endocrine compartment impacts the behavioural phenotype of
the dam. The research presented allows for a role of the maternal genotype to be
excluded, as all the dams were genetically WT and all cohorts were generated by
the same RET protocol. Litter size can be excluded as there was no significant
differences between the cohort. It is not possible to exclude a role for pup genotype
in the behavioural changes. In the next chapter we explore whether the behavioural
changes seen in this chapter are due to an alterations in the maternal brain or
other physiological factors related to pregnancy. Importantly, the major behavioural
changes seen do not necessarily confer an advantage or a disadvantage to any of the
three cohorts of dams. Despite WT(TG) being more effective at retrieving their
pups, building a nest and moving pups into their nest, this may not equivalent to
beneficial nurturing. These dams may be neglecting their pups in different ways
not explicitly tested for in the chosen behavioural assessments, although weight
data at P7 showing catch up growth does indicate that they are doing a good job.
Conversely the reduced retrieval and nest building behaviour of the WT(KO) dams
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may not be equivalent to maternal neglect. Evidence that this might be the case is
demonstrated by the increased levels of grooming and feeding behaviour displayed
by WT(KO) dams during nest building. It should also be noted that WT(KO) mice
tended to increase in activity when presented with a stressful or different task. At
this point the mechanisms by which these behavioural changes are initiated are not
well understood. Research beginning to address this deficit will be presented in the
next chapter.
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Summary of Findings
• The EPM did not uncover a group specific anxiety phenotype.
• WT(KO) dams took significantly longer to retrieve their offspring in the pup
retrieval task.
• During pup retrieval WT(KO) mice prioritised trips to the food and water
zones over retrieving their offspring.
• Throughout the Pup retrieval task WT(TG) dams performed much the same
way as WT(WT) mice.
• WT(TG) dams displayed a heightened tendency to construct a well developed
nest and move their pups inside the new nest compared to both WT(KO) and
WT(WT) dams.
• WT(KO) mice failed to build a nest the majority of the time during the nest
building assessment.
• During the hour long nest building task WT(KO) dams tended to spend a
larger proportion of their time grooming their pups and themselves as well as
travelling a greater distance and paying more frequent trips to the food and
water zones.
• There was a lack of phase effect for WT(TG) dams in relation to time spent in
the nest over a 23 hour cycle.
• There was also a lack of phase effect for WT(KO) mice with regards to the
time spent visiting the food zone during the chosen 23 hour period.
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5Maternal BiomolecularCharacterisation
5.1 Overview
The aim of this chapter was to perform an initial basic biomolecular characterisation
and begin to provide insight into the mechanisms driving the behavioural phenotype
from the previous chapter (Chapter 4). It is known that experimental infusion with
prolactin and placental lactogen stimulates maternal behaviour in non-pregnant
females (Bridges and Grattan, 2003, Larsen and Grattan, 2010). The evidence
previously described in chapter 1, supports the idea that prolactin and the Prls are
crucial in the induction of the maternal instinct but the exact mechanism is not well
understood. It is known that prolactin and/or the Prlr are involved with pregnancy
related adult neurogenesis in the SVZ of the hippocampus (Larsen and Grattan,
2012, Shingo, 2003, Walker et al., 2012). The SpT compartment expresses a number
of placental hormones and our findings in the previous chapter (Chapter 3) lend
support to the hypothesis that Prls are important in the development of maternal
instinct.
The majority of studies that look at prolactin during pregnancy have focussed on
the indirect effect that prolactin infusions have upon maternal behaviour (Bridges,
1994, Bridges and Freemark, 1995, Bridges et al., 1990). In this study, neurogenesis
was not examined, but has since been cited by Bridges and Grattan (2003) as an
exciting idea to investigate. Using the novel Phlda2 mouse model, in which solely the
SpT lineage of the placenta is altered (Tunster et al., 2015), we examined both gene
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expression and neurogenesis levels in the brain prenatally across the three cohorts of
mice i.e. preceding the time at which behavioural changes were discovered and prior
to exposure to the genetically altered pups. The identification of changes during
pregnancy, at a time when placental signalling is altered, would lend support to the
hypothesis that altering the size of the SpT drives the altered behaviour rather than
exposure to the genetically altered pups.
A series of biomolecular and genetic assays were performed to build up a basic
characterisation of the cohorts at E16.5, the time when the placenta is known to be
signalling most intensely and before any behavioural phenotypes were examined in
chapter 4. It allows a direct assessment of an in vivo alteration of these hormones
which makes it a useful way to assess the biomolecular outcome at E16.5 in the
brains of the dams. Importantly the persistency of any key gene changes that are
seen were tested again at P7 in the brain of the dams.
5.1.1 Maternal Neurogenesis and Pregnancy
In the adult mammalian brain two distinct regions retain neural stem cells that
can continually, and do, generate new neurons. Along the walls of the Lateral
Ventricles (LV) you find the largest of the two germinal zones, the SVZ (Alvarez-
Buylla and Garcia-Verdugo, 2002, Doetsch and Alvarez-Buylla, 1996). The second
region is the SGZ, found in the dentate gyrus part of the hippocampus. These
specialised micro environments or “niches” are spatially isolated but they have
common themes that have helped define what it takes to be an adult neurogenic
niche (Alvarez-Buylla and Lim, 2004). The differing locations of these niches and the
simplified cascades that lead astrocytes to turn from neural stem cells into progenitors
or neural precursors and then into new neurons are outlined in Figure 5.1.
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Figure 5.1: Neurogenesis. A schematic digram showing adult neurogenesis, “As” Cells (blue)
are the astrocytes in both coronal sections in (a) and (b). (a) Shows the lateral ventricle (LV,
light grey) which is filled with cerebrospinal fluid. The LV and SVZ is enlarged in the box. As
Cells act as the SVZ stem cell and also serve as niche cells. Ependymal cells (E, white) release
noggin that helps in the initiation of the As cells becoming the precursor cells (B, green). Precursor
cells are rapidly dividing, transit-amplifying cells derived from the As cells. Precursor cells give
rise to neuroblasts (C, red), these neuroblasts then migrate to the olfactory bulb via the Rostral
Migratory Stream (RMS), where they become local interneurons. (b) This coronal section through
the adult mouse brain at the level of the hippocampus (HP) indicates the dentate gyrus (DG). The
enlarged cross section shows the architecture of the SGZ. Astrocytes give rise to progenitors (D,
orange), which mature into new granule cells (G, pink). These newly born granule cells integrate
into the DG. Adapted from Alvarez-Buylla and Lim (2004).
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The SVZ
As one of only two areas of the adult brain that has been shown to experience
neurogenesis, the SVZ has the largest population of proliferating neuronal cells. The
new neurons born in the SVZ migrate along the Rostral Migratory Stream (RMS)
where they mature into local interneurons (Altman, 1969, Pencea et al., 2001).
SVZ neural stem cells have been shown to be able to be grown in culture medium
(Kempermann and Gage, 2000). This is important as it demonstrates that the SVZ
is an important source of these progenitors that not only add to the plasticity of
the adult brain but also may be a reservoir of cells that may ultimately be useful in
combating neurodegenerative disease.
The new neurons born in the SVZ that move into the RMS end up in the Olfactory
Bulb (OB). A phenomenon that has been well studied in rodents but similar pathways
have been shown in primates (Kornack and Rakic, 2001, Pencea et al., 2001), and
suggested may occur in infant human brains (Weickert et al., 2000). The migration
along the RMS occurs through the neurons moving along each other using microtubule
polymerization and depolymerization (Alvarez-Buylla and Garcia-Verdugo, 2002).
Doublecortin (DCX) is a microtubule protein that is found to be key in neural
migration in development. It is predominately expressed by chains of cells in the
RMS suggesting that it plays a role in the translocation of the new neurons to the OB
(Alvarez-Buylla and Garcia-Verdugo, 2002, Gleeson et al., 1999, Magavi et al., 2000).
The total number of neurons that migrate to the OB far outweighs the number that
survive and become functional. Less is known about what these neurons are invloved
in once they are fully functional, compared to the new neurons that are born in the
DG of the hippocampus. The general consensus is that through the replacement
of neurons in the OB, it is possible to maintain the plasticity necessary to adjust
the olfactory circuitry based on new environments and experiences (Alvarez-Buylla
and Garcia-Verdugo, 2002). It follows therefore that postnatally the mother has
generated new neurons in order to effectively adapt to the change in environment
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and novel experiences that are commonplace with newborn offspring. Once these
new connections are made and the circuitry remodelled there is a period of intense
cell death that adds to this theory’s weight (Cecchi et al., 2001).
The SGZ
The SGZ of the hippocampal DG has been shown to generate new neurons robustly
in both rodents and humans throughout life (Eriksson et al., 1998). The new neurons
leaving the SGZ migrate into the adjacent DG granule cell layer. Neurogenesis in
these regions is regulated by physiological factors including sex hormones, glucocorti-
coids, growth factors and stress (Cameron and McKay, 1999, Kirschenbaum et al.,
1999, Kuhn et al., 1997, Shingo, 2003, Tanapat et al., 1999). There is considerably
less neurogenesis in the SGZ compared to the SVZ, something that is not well
understood (Curtis et al., 2012). Despite this it is considered an extremely important
source of new neurons, perhaps due to the role that the hipocampus as a whole
plays in the functioning brain. The hippocampus is part of the limbic system, which
is involved in a host of higher order brain functions. These include emotionality,
behaviours, memory and learning (Curtis et al., 2012, O’Keefe and Nadel, 1978).
Importantly neurogenesis in the hippocampus and DG cell proliferation have been
demonstrated experimentally to impact upon learning and social behaviours (Hockly
et al., 2002, Malberg and Duman, 2003) also neurogenesis has been linked to en-
vironmental enrichment and depression (Lieberwirth et al., 2012, Lucassen et al.,
2010). Interestingly studies have shown that social environment can influence rate of
neurogenesis, reviewed by Lieberwirth et al. (2012). Positive social interaction such
as mating increases neurogenesis, whilst negative interactions such as social isolation
causes a reduced rate of adult neurogenesis in the limbic system, which highlights a
correlation between the phenomenon and mental health outcomes.
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5.1.2 Biomolecular Characterisation Assays
When considering behavioural phenotypes it is essential to assess changes in the
brain regions that might be associated with these behaviours. The two areas we
looked at were: the hypothalamus, which is associated with maternal behavioural
adaptations and the hippocampus, which is a known location for neurogenesis and is
strongly associated with psychotic illness. Therefore these are the two brain regions
that were focussed upon for the majority of the characterisation.
DNA microarray is a high throughput technology that allows the expression levels of a
vast number of genes to be measured simultaneously. It has been used for many years
and is a helpful method in developing hypotheses and also in helping answer proposed
hypotheses (Hoheisel, 2006). There can be problems with microarray analysis in the
post hoc stages of the analysis, however the development of programs and an active
online community means that statistical analysis using various statistical programs
is becoming more and more precise and reliable. One such platform that uses the R
statistical package is the Bioconductor platform. The LIMMA analysis method was
the preferred statistical package used to analyse the microarray data in this chapter.
This is because LIMMA offers an unbiased approach to microarray data generated
through an Affymetrix array of the mouse genome (mogene) (Zhang et al., 2009).
Microarray is useful in determining gene expression changes within a given system,
whilst RT-qPCR or qPCR is the staple method for confirming and quantifying
gene expression changes highlighted through other higher throughput means. This
is because by measuring the amount of cellular RNA it is possible to accurately
determine the extent of a given genes expression. In order to quantify this expression
the end point of the qPCR is needed, this is known as the threshold cycle (CT). The
CT is the point at which the fluorescence signal of the reporter dye (e.g. SYBR
Green) passes an arbitrary value in the exponential phase of PCR amplification. The
CT value is inversely related to the amount of amplicon in the reaction (Schmittgen
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and Livak, 2008). Therefore a subset of genes identified in the microarray needed to
be confirmed by qPCR in order to validate the results.
It was necessary to establish the effects, if any, these different placenta had upon
normal neurogenesis levels present in the maternal brain during pregnancy. There are
many methods that can be used to assess neurogenesis in the adult rodent brain, most
of which are outlined by Pan et al. (2013) in their paper. The most common method,
due to its ability to “birthdate” cells as they proliferate and/or differentiate into a
specific cell type, is Brdu (BrdU) labelling. BrdU labelling of cells is permanent and
marks cells in the S-phase of the cell cycle. This method is flexible and convenient
due to its ability to work hours or months after administration of BrdU into the
animal and helps identify Adult Neural Stem Cells (aNSCs) (Ming and Song, 2005,
Taupin, 2006). Therefore mice were injected with BrdU as described in chapter 2, and
tissues harvested 3 hours later. IHC staining performed on the relevant brain sections
to look at cells positive for BrdU. Importantly, this approach allowed assessment
for Neuroectodermal Stem Cell Marker (Nestin) (a label for neural precursor cells)
and DCX (a label for the cytoskeleton of new neurons) in order to further examine
neurogenesis. The behavioural changes exhibited by the dams meant that HPLC
analysis was undertaken on the full range of brain regions that were dissected. This
generated data regarding neurotransmitter levels and there metabolites, this would
enable us to determine whether behavioural changes could be attributed to changes
in neurotransmitter levels in the dams brains.
5.2 Results
Mice were generated following the same RET methodology previously outlined in
chapter 2 and 4. They were all carefully monitored throughout pregnancy in order to
check for health and determine pregnancy by regularly measuring their weight every
two days from P 8.5 and comparing it to pre-pregnancy weight. Mice were sacrificed
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on E16.5 of gestation, a time at which the SpT is maximally expanded and placental
signalling presumed to be at its maximum. The relevant biological samples were
collected. Fetuses were also collected and weighed. For the WT(TG) model, fetuses
were also genotyped as these litters were generated by crossing heterozyogus parents.
Only litters with > 60% TG fetuses were used for downstream analysis (Figure 5.2).
Dams were only used if there litter was between 6 and 12 embryos (Table 5.1).
Figure 5.2: Flow Diagram Showing Experimental Design. A flow diagram illustrating
the overall methodology and procedure used to generate the material and resulting data for the
maternal behavioural characterisation and the biomolecular characterisation of the dams at E16.5.
Table 5.1: E16.5 Litter Sizes
Embryo Genotype Litter Size (SEM)
WT 7.14 (± 0.63)
TG 6.91 (± 0.25)
KO 7.08 (± 0.35)
5.2.1 Microarray
For each cohort of dams RNA was extracted from the hippocampus and hypothalamus.
There was an n = 4 for each group. The samples were all sent to Cardiff Biotechnology
Service for quality control and microarray. RNA was only used if it had a RIN value
of higher than 7 (Table 5.3, Table 5.2 and Figure 5.3) (Schroeder et al., 2006).
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Table 5.2: RNA Values for E16.5 Microarray of Hippocampus
Sample ID Tissue RNA ng/µl RIN Value
WT(WT)1 Hippocampus 487.0 10
WT(WT)2 Hippocampus 427.4 10
WT(WT)3 Hippocampus 325.0 10
WT(WT)4 Hippocampus 340.7 10
WT(TG)1 Hippocampus 248.2 10
WT(TG)2 Hippocampus 282.6 9.9
WT(TG)3 Hippocampus 411.2 10
WT(TG)4 Hippocampus 445.2 10
WT(KO)1 Hippocampus 336.5 10
WT(KO)2 Hippocampus 251.8 10
WT(KO)3 Hippocampus 254.1 10
WT(KO)4 Hippocampus 693.0 10
Table 5.3: RNA Values for E16.5 Microarray of Hypothalamus
Sample ID Tissue RNA ng/µl RIN Value
WT(WT)1 Hypothalamus 309.9 10
WT(WT)2 Hypothalamus 217.9 10
WT(WT)3 Hypothalamus 145.9 10
WT(WT)4 Hypothalamus 188.7 10
WT(TG)1 Hypothalamus 171.1 10
WT(TG)2 Hypothalamus 151.0 9.7
WT(TG)3 Hypothalamus 218.3 10
WT(TG)4 Hypothalamus 142.5 10
WT(KO)1 Hypothalamus 192.3 10
WT(KO)2 Hypothalamus 297.1 10
WT(KO)3 Hypothalamus 280.6 10
WT(KO)4 Hypothalamus 154.7 10
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Figure 5.3: RIN Value Graph. An example of the RIN value graph used to determine RNA
quality.
Before analysis took place images of the Affy chips were generated from the .CEL
files, these were then assessed for any damage or visual inconsistencies that may
have affected the analysis and read outs from the chips. Two examples of the images
generated can be seen in Figure 5.4. There were no visual inconsistencies present
on the chips and no obvious signs of damage that would cause issues with the further
analysis of gene expression levels.
Heat Maps
Using the .CEL files it was then possible to write a custom script using both python
and R Statistical software language to extract the information on the chips about
gene expression levels at a genome wide level (Figure 5.5).
Initially, heat maps were generated using the Heatplus package on R statistical
software. This was to immediately identify visually whether there were any distinct
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Figure 5.4: Example of Affy Chips used for Microarray. An example of the Chips used for
both the Hippocampus and the Hypothalamus. Chips were assessed for any damage before being
included in the microarray analysis.
gene changes between the three groups. Heat maps were plotted for the genes
that showed changes in expression levels at a p-value < 0.05 in the hippocampus
and the hypothalamus. Specifically, the LIMMA analysis organised the subjects
independently of their genotype, based upon similar gene expression levels. This
resulted in the dendrogram placing the WT(WT), WT(TG) and WT(KO) gene
profiles together (Figure 5.6 and Figure 5.7). The only exception was WT(KO)-1
in the hippocampus that appeared more similar in gene expression profile to that of
the WT(WT) controls.
The heat maps provided a visualisation of the general pattern of fold changes for the
gene chips across the samples and between the cohorts.
Venn Diagrams and Gene Lists
Further analysis allowed the generation of a table of genes based on the heat maps
that showed the altered expression across the WT(WT), WT(TG) and WT(KO)
dams and between each of these cohorts (Table 5.4). This table was plotted into a
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Figure 5.5: Microarray R Script. A screenshot of the microarray R script used to analyse the
.CEL files
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Figure 5.6: Heat map indicating expression levels of genes in the Hippocampus. A
three way heat map showing the differing gene expression levels from the microarray across the
three cohorts in the hippocampus. Red indicates up regulated genes and green represents down
regulated genes.
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Figure 5.7: Heat map indicating expression levels of genes in the Hypothalamus. A
three way heat map showing the differing gene expression levels from the microarray across the
three cohorts in the hypothalamus. Red indicates up regulated genes and green represents down
regulated genes.
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series of Venn diagrams (Figure 5.8) according to the tissue type being analysed.
The number of genes that are listed were selected based on the standardised p =
0.05 significance level and show the pairwise comparisons across all the samples. The
number of significant genes that showed altered gene expression between all three
cohorts in the hypothalamus was 8 and the hippocampus was 54. The genes that
differed from WT(WT) mice in both the WT(TG) and WT(KO) cohorts totalled
288 and 1279, in the hypothalamus and hippocampus respectively. The number
of genes that were uniquely different in expression levels between the WT(TG)
dams hypothalamus and the WT(WT) dams hypothalamus was 640. This number
increased dramatically in the hippocampus where 3297 specific genes showed altered
expression between the WT(WT) and WT(TG) dams alone. In contrast the unique
differences between the WT(KO) dams and the WT(WT) dams remained fairly
similar in number between the hypothalamus and the hippocampus. There were 1138
genes specifically that showed differing expression between WT(WT) and WT(KO)
mice in the hypothalamus and 1472 genes that were uniquely different between the
two in the hippocampus.
Taking this table of uniquely altered gene expression levels meant that entire lists
of these genes could be produced based on the specific comparisons that were of
interest. These two tables showing a selection of the top gene changes between
WT(WT) dams and both WT(KO) and WT(TG) dams in both the hippocampus
and hypothalamus, that were then taken on into qPCR analysis to confirm theses
gene changes.
Pathway Anaylsis
In order to identify scientifically relevant biological pathways of importance an in
silico pathway analysis was performed online using DAVID. To use DAVID a gene
list is inputted into the online portal and various parameters selected based on the
type of gene list that is submitted. The software provides a comprehensive set of
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Table 5.4: Gene Expression Changes
Genotype Comparisons Brain Region Number of Genes
WT(WT) vs WT(TG) vs
WT(KO) - Top gene changes
shared between all groups
Hippocampus 54
WT(WT) vs WT(TG) vs
WT(KO) - Top gene changes
shared between all groups
Hypothalamus 8
WT(WT) vs
WT(TG):WT(KO) - Gene
changes that were different
between WT(TG) and
WT(KO) compared to
WT(WT)
Hippocampus 1279
WT(WT) vs
WT(TG):WT(KO) - Gene
changes that were different
between WT(TG) and
WT(KO) compared to
WT(WT)
Hypothalamus 288
WT(WT) vs WT(TG) - Gene
changes that were uniquely
different between WT(WT)
and WT(TG)
Hippocampus 3297
WT(WT) vs WT(TG) - Gene
changes that were uniquely
different between WT(WT)
and WT(TG)
Hypothalamus 640
WT(WT) vs WT(KO) - Gene
changes that were uniquely
different between WT(WT)
and WT(KO)
Hippocampus 1472
WT(WT) vs WT(KO) - Gene
changes that were uniquely
different between WT(WT)
and WT(KO)
Hypothalamus 1138
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Figure 5.8: Venn Diagrams for Number of Significantly Altered Genes in the Hip-
pocampus and Hypothalamus. The Venn diagrams from the Limma analysis showing the genes
that are significantly altered across the genotypes and between genotypes (p < 0.05). A is the
Hippocampus and B is the hypothalamus. The total number of probes for each array can be seen
in the bottom of the diagram.
Table 5.5: Top Genes of Interest in the Hippocampus Microarray
Gene name Symbol ↑ ↓ Regulated and p-value
Solute Carrier Family 6
Member 3
Dat ↓ 0.02
Urocortin 3 Ucn3 ↓ 0.02
Potassium Voltage-Gated
Channel Subfamily H Member
2
Kcnh2 ↓ 0.01
Tyrosine Hydroxylase Th ↓ 0.02
Tryptophan Hydroxylase 2 Tph2 ↓ 0.02
Endonuclease Domain
Containing 1
Endod1 ↓ 0.01
Tyrosine 3-
Monooxygenase/Tryptophan
5-Monooxygenase Activation
Protein Zeta
Ywhaz ↑ 0.03
5-Hydroxytryptamine
Receptor 2A
Htr2 (5-HT2 ) ↑ 0.03
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Table 5.6: Top Genes of Interest in the Hypothalamus Microarray
Gene name Symbol ↑ ↓ Regulated and p-value
Olfactory Receptor 45 Olfr45 ↑ 0.001
Olfactory Receptor 59 Olfr59 ↑ 0.003
Olfactory Receptor 347 Olfr347 ↑ 0.04
Olfactory Receptor 481 Olfr481 ↑ 0.05
Olfactory Receptor 615 Olfr615 ↑ 0.007
Olfactory Receptor 686 Olfr686 ↓ 0.002
Olfactory Receptor 945 Olfr945 ↑ 0.02
Olfactory Receptor 1239 Olfr1239 ↑ 0.02
Olfactory Receptor 1410 Olfr1410 ↑ 0.004
Olfactory Receptor 1491 Olfr1491 ↑ 0.002
Histocompatibility 2 M region
locus 2
H2-M2 ↓ 0.04
Histocompatibility 2 M region
locus 9
H2-M9 ↑ 0.006
Histocompatibility 2 Q region
locus 10
H2-Q10 ↓ 0.02
tools that allow for any number of the following:
• Identify enriched biological themes/pathways, particularly GO terms.
• Discover enriched functional-related gene groups.
• Cluster redundant annotation terms.
• Visualize genes on BioCarta and KEGG pathway maps.
• Display related many-genes-to-many-terms on 2-D view.
• Search for other functionally related genes not in the list.
• List interacting proteins.
• Link gene-disease associations.
Gene lists that identified gene expression level changes between WT(WT) and both
WT(TG) and WT(KO) dams were submitted generating lists of potentially affected
biological signalling pathways that appear to have been altered between the three
cohorts. The lists for both brain regions can be seen in Table 5.2.1 and Table 5.2.1.
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Table 5.7: Hippocampus Signalling Pathways
Term Count % p-value Genes List Gene Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR
Ribosome 5 1.26 0.09
ENSMUSG00000067038 Rps12-
ps3
113 89 5738 2.852739385502635 0.999955616995393 0.999955616995393 67.12471840125333
ENSMUSG00000039221 Rpl22l1
ENSMUSG00000029614 Rpl6
ENSMUSG00000061983 Rps12
ENSMUSG00000000740 Rpl13
ENSMUSG00000062997 Rpl35
ENSMUSG00000078193 Gm2000
Table 5.8: Hypothalamus Signalling Pathways
Term Count % p-value Genes List Gene Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR
Olfactory transduction 15 15.15 ≤ 0.001
ENSMUSG00000049334 Olfr902
32 960 5738 2.8017578125 0.007371621970343023 0.007371621970343023 0.17581019457602043
ENSMUSG00000061961 Olfr815
ENSMUSG00000057351 Olfr347
ENSMUSG00000054236 Olfr481
ENSMUSG00000045150 Olfr1161
ENSMUSG00000063380 Olfr945
ENSMUSG00000075088 Olfr1239
ENSMUSG00000059303 Olfr836
ENSMUSG00000073947 Olfr615
ENSMUSG00000070374 Olfr59
ENSMUSG00000066122 Olfr45
ENSMUSG00000063583 Olfr1410
ENSMUSG00000051172 Olfr672
ENSMUSG00000048425 Olfr686
ENSMUSG00000051156 Olfr1491
Allograft rejection 3 3.03 0.04
ENSMUSG00000067201 H2-M9
32 58 5738 9.274784482758621 0.776961542297281 0.5277305242737798 30.011214136503405ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
Graft-versus-host disease 3 3.03 0.04
ENSMUSG00000067201 H2-M9
32 58 5738 9.274784482758621 0.776961542297281 0.5277305242737798 30.011214136503405ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
Type I diabetes mellitus 3 3.03 0.05
ENSMUSG00000067201 H2-M9
32 63 5738 8.538690476190476 0.8260949051414685 0.44182450198195444 34.03291003241298ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
Autoimmune thyroid disease 3 3.03 0.06
ENSMUSG00000067201 H2-M9
32 72 5738 7.471354166666667 0.893150810348408 0.4282675948938529 41.24868587153916ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
Antigen processing 3 3.03 0.09
ENSMUSG00000067201 H2-M9
32 91 5738 5.911401098901099 0.9672102727309312 0.4951672037836681 55.63857938994323ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
Viral myocarditis 3 3.03 0.09
ENSMUSG00000067201 H2-M9
32 94 5738 5.722739361702128 0.9732663062596048 0.45318154760493823 57.741370591514716ENSMUSG00000067235 H2-Q10
ENSMUSG00000016283 H2-M2
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Collating the gene expression changes highlighted the signalling pathways that were
enriched in the hypothalamus. There were 13 genes that have linked been with
olfactory transduction, a critical element involved with maternal behaviour that
were highly significant (p-value < 0.001). Other pathways that showed significant
enrichment included: allograft rejection, graft-versus-host disease and type-1 diabetes
mellitus (p-value’s < 0.05). All of these pathways shared the same three genes H2-
M9, H2-Q10 and H2-M2. These signalling pathways are also functionally relevant
as pregnancy is an un-natural state in which the host (in this case the dam) is
carrying an immunologically different entity (in this case the offspring/fetus) this
may explain the relevance of these pathways showing enrichment. In contrast the
hippocampus showed no significant enrichment in any biological pathways, although
certain genes that grouped together, related to ribosome biology, were seen to be
commonly altered between the WT(KO) and WT(TG) cohorts. Ribosomal proteins
have been associated with neurogenesis (Ueno et al., 2002).
5.2.2 Confirmation of Results using RT-qPCR
Having performed microarray, a number of genes with significant alteration in
expression were identified. The gene expression levels for these subsets of genes were
then quantified using qPCR. In order to verify the robust nature of these gene changes
qPCR was performed on an entirely newly generated cohort of dams. There were 12
dams in total, with n = 4 for each group. RNA was obtained as described previously
and processed to cDNA as described in chapter 2. By performing qPCR on this
entirely new cohort of dams enabled any changes that concurred with the microarray
results from the previous cohort to be confirmed via independent verification.
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E16.5 Hippocampus qPCR
The genes assayed by qPCR, chosen to confirm the microarray calls, at E16.5 in the
hippocampus demonstrated that Ucn3, Kcnh2, Endod1, Th, Tph2 and Dat (Slc6a3)
all showed significant fold change differences (p-value < 0.05) in the newly generated
cohorts of WT(TG) and WT(KO) dams when compared to the WT(WT) dams
(Figure 5.9, Table 5.9 and Table 5.10). This equated to a 75% concordance rate
across the cohorts between the genes highlighted in microarray compared to the
qPCR results.
Th decreased in expression level in WT(KO) mice compared to WT(WT) dams, with
a p-value = 0.022 . This was also significantly changed (p-value = 0.036) in the
WT(TG) when compared to WT(WT) dams indicating a decrease in expression levels
from the control group. Dat showed a highly significant reduction in expression in
WT(TG) mice compared to the baseline WT(WT) dams (p-value = 0.004). WT(KO)
mice also showed a reduction in expression of Dat with a p-value = 0.043. Endod1
was similar to Dat with WT(TG) dams showing a highly significant decrease in
expression level, when compared to WT(WT) mice (p-value = 0.004). This gene was
also significantly reduced in WT(KO) mice (p-value = 0.02). The most prominent
reduction in expression levels for both groups was Ucn3 with very low expression in
the hippocampus of WT(TG) mice (p-value = 0.007) and WT(KO) mice (p-value
= 0.009). It should be noted that Tph2 showed significant reduction in expression
through qPCR for the WT(TG) dams, but not in the WT(KO) dams something that
was also observed in the microarray for this cohort, despite there being a dramatic
decrease in expression of Tph2 in the WT(KO) condition.
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Figure 5.9: Average fold changes for specific genes shown to have differential expres-
sion in the hippocampus of dams at E16.5. A bar graph showing the average fold change for
specifically chosen genes of interest in the hippocampus using qPCR that were initially shown to be
significantly altered in the microarray for either WT(TG) and WT(KO) dams. Error bars represent
SEM. Statistical significance: *p < 0.05 and **p < 0.01.
Table 5.9: Statistical Significance of the Fold Change in WT(TG) Hippocampus qPCR
Gene Fold Change (± SEM) WT(TG) p-value
Ucn3 ↓ 0.06 (±0.03) V 0.007
Kcnh2 ↓ 0.59 (±0.11) V 0.04
Endod1 ↓ 0.11 (±0.05) V 0.004
Th ↓ 0.21 (±0.12) V 0.02
Tph2 ↓0.12 (±0.06) V 0.04
Dat ↓ 0.43 (±0.15) V 0.004
Ywhaz 0.99 (±0.14) 0.96
Htr2 1.40 (±0.41) 0.70
Oxtr 1.21 (±0.27) 0.47
Note: V= Concordant to microarray fold change.
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Table 5.10: Statistical Significance of the Fold Change in WT(KO) Hippocampus qPCR
Gene Fold Change (± SEM) WT(KO) p-value
Ucn3 ↓ 0.12 (±0.06) V 0.009
Kcnh2 ↓ 0.52 (±0.12) V 0.026
Endod1 ↓ 0.40 (±0.10) V 0.02
Th ↓ 0.10 (±0.07) V 0.02
Tph2 0.17 (±0.08) V 0.10
Dat ↓ 0.60 (±0.20) V 0.04
Ywhaz 0.84 (±0.15) 0.34
Htr2 1.16 (±0.46) 0.35
Oxtr 0.78 (±0.38) 0.58
Note: V= Concordant to microarray fold change.
E16.5 Hypothalamus qPCR
Using the microarray of the hypothalamus from the dams sacrificed at E16.5 a
list of genes that showed differing levels of expression between the cohorts was
generated. A selection of these genes were also seen to be enriched in the pathway
analysis. The genes that were common to the top gene expression changes and also
appeared in pathway analysis were then further quantified using qPCR. The genes
that appeared to be most enriched were the olfactory receptor genes. These are
a type of G-Protein Coupled Receptor (GPCR) genes that have broad functional
roles (Zhang and Firestein, 2002). The rate of concordance between the qPCR and
microarray was 35% across all the cohorts in the hypothalamus.
Using the same newly generated cohort of mice, qPCR was used to examine gene
expression in the hypothalamus. qPCR confirmed altered expression levels of all the
genes tested at varying degrees of significance between the WT(TG) and WT(KO)
cohorts of dams and WT(WT) control mice. Olfr59, Olfr347, Olfr481, Olfr1239,
Olfr1410 and Olfr1491 all showed a significant increase (p-value < 0.05) in expression
levels in the hypothalamus of WT(TG) dams compared to the WT(WT) cohort
(Figure 5.10). Data from WT(KO) dams was not significantly different to that
of the WT(WT) dams but there was a high level of variation across individuals
within each cohort, which may have obscured these results. The statistical p-values
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Figure 5.10: Average fold changes for specific genes shown to have differential expres-
sion in the hypothalamus of dams at E16.5. A bar graph showing the average fold change
for specifically chosen genes of interest in the hypothalamus using qPCR that were initially shown
to be significantly altered in the microarray for either WT(TG) and WT(KO) dams. Error bars
represent SEM. Statistical significance: *p < 0.05, **p < 0.01, and ***p < 0.005.
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and relative fold changes for both WT(TG) and WT(KO) dams are summarised in
Table 5.11 and Table 5.12. The use of newly generated dams for the qPCR analysis
provided convincing evidence that the changed identified by microarray were genuine,
by adding independent verification.
Table 5.11: Statistical Significance of the Fold Change for WT(TG) Hypothalamus qPCR
Gene Fold Change (± SEM) WT(TG) p-value
Olfr45 1.20 (±0.18) 0.43
Olfr59 ↑ 2.44 (±0.19) V 0.001
Olfr347 ↑ 1.77 (±0.17) V 0.01
Olfr481 ↑ 1.69 (±0.23) V 0.03
Olfr615 1.13 (±0.19) 0.48
Olfr686 0.96 (±0.11) 0.68
Olfr945 1.33 (±0.37) 0.33
Olfr1239 ↑ 1.42 (±0.07) V 0.02
Olfr1410 ↑ 1.53 (±0.11) V 0.01
Olfr1491 ↑ 1.73 (±0.49) V 0.04
H2-M2 ↓ 0.32 (±0.14) V 0.02
H2-M9 1.10 (±0.17) 0.37
H2-Q10 1.01 (±0.03) 0.72
Note: V= Concordant to microarray fold change.
Table 5.12: Statistical Significance of the Fold Change in WT(KO) Hypothalamus qPCR
Gene Fold Change (± SEM) WT(KO) p-value
Olfr45 1.74 (±0.24) 0.10
Olfr59 1.58 (±0.50) 0.11
Olfr347 ↑ 1.74 (±0.48) V 0.05
Olfr481 1.38 (±0.56) 0.21
Olfr615 1.32 (±0.23) 0.30
Olfr686 0.86 (±0.15) 0.55
Olfr945 1.89 (±0.28) 0.09
Olfr1239 1.29 (±0.19) 0.11
Olfr1410 1.12 (±0.26) 0.24
Olfr1491 1.12 (±0.50) 0.27
H2-M2 ↓ 0.24 (±0.13) V 0.02
H2-M9 1.12 (±0.26) 0.32
H2-Q10 0.98 (±0.25) 0.87
Note: V= Concordant to microarray fold change.
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Hypothalamus and Hippocampus P7 qPCR
After behavioural assessments were performed on the original cohorts of mice, they
were culled at P7 to examine brain gene expression. The hippocampus and hypotha-
lamus for all the groups (n = 12) was assessed by qPCR to ask whether changes
identified at E16.5 persisted postpartum.
Table 5.13: Fold Changes and Statistical Significance in Hypothalamus Genes at P7
Gene WT(TG) Fold
Change
WT(KO) Fold
Change
p-value
Olfr45 1.10 (±0.28) 0.61 (±0.34) 0.28
Olfr59 1.13 (±0.32) 0.68 (±0.26) 0.32
Olfr347 1.08 (±0.41) 0.74 (±0.50) 0.51
Olfr481 1.10 (±0.40) 0.74 (±0.36) 0.50
Olfr615 1.09 (±0.48) 0.72 (±0.43) 0.56
Olfr945 1.04 (±0.46) 0.70 (±0.51) 0.56
Olfr1239 1.07 (±0.39) 0.70 (±0.38) 0.49
Olfr1410 1.12 (±0.24) 0.68 (±0.25) 0.23
Olfr1491 1.09 (±0.35) 0.68 (±0.22) 0.41
H2-M2 1.05 (±0.21) 0.57 (±0.31) 0.27
H2-M9 0.79 (±0.27) 0.65 (±0.21) 1.34
H2-Q10 1.24 (±0.31) 0.73 (±0.20) 1.28
Table 5.14: Fold Changes and Statistical Significance in Hippocampal Genes at P7
Gene WT(TG) Fold
Change (± SEM)
WT(KO) Fold
Change (± SEM)
p-value
Ucn3 2.31 (±0.78) 5.27 (±2.29) >0.05
Kcnh2 0.83 (±0.27) 0.90 (±0.32) >0.05
Endod1 0.21 (±0.11) 0.25 (±0.13) >0.05
Th 0.96 (±0.39) 1.97 (±0.90) >0.05
Tph2 0.34 (±0.12) 0.36 (±0.14) >0.05
Oxtr 1.32 (±0.33) 1.69 (±0.77) >0.05
As can be seen from the qPCR results in Table 5.13 and Table 5.14 there were no
persistent gene expression changes of the same genes that were altered at the E16.5
time point. There was a high level of SEM across these samples however, which is
one factor preventing some of these genes being significantly changed.
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5.2.3 Immunohistochemistry
To examine proliferation and neuronal markers, brains from WT(WT) (n = 6),
WT(TG) (n = 4) and WT(KO) (n = 4) dams, post BrdU injection (see Chapter 2),
were paraffin embedded and sectioned coronally, generating slices 10 µm thick. A
total of 18 sections per brain for each antibody were then stained using the previously
described protocol in chapter 2 for BrdU, Nestin and DCX. The resulting slides were
subsequently scanned using Carl Zeiss Axio Scan.Z1 slide scanner before positive
cells quantified using manual counting in Fiji (Schindelin et al., 2012) and Zen Blue
Software (Carl Zeiss).
Bromodeoxyuridine - BrdU
BrdU labels cell proliferation and new neurons, a one-way ANOVA on the total cell
counts indicated that there was a significant effect of genotype upon the number of
BrdU positive cells in the SVZ of the hippocampus at E16.5 across the three cohorts
(F2, 10 = 4.6, p-value = 0.046). Figure 5.11 shows that this effect was driven by a
significant decrease in the number of BrdU positively labelled neurons in WT(TG)
mice compared to WT(WT) controls (p-value = 0.01). This reduction was also seen
in the WT(KO) cohort (p-value = 0.05).
Examples of BrdU, Nestin and DCX positive cells are shown in Figure 5.16. The
average numbers of positive cells for BrdU, Nestin and DCX collated in Table 5.15.
BrdU is a marker for cell proliferation (Kee et al., 2002). A reduction in the number
of cells taking up this marker at E16.5 suggests a reduction in cell proliferation in
the SVZ in both the WT(TG) and WT(KO) cohorts E16.5 brain as a consequence
of the changes in the placenta. There appeared to be a simultaneous increase in the
number of BrdU labelled neurons as the SGZ showed in the WT(KO) dams had a
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Figure 5.11: Average number of BrdU Cells across the SVZ of the 3 cohorts. A graph
showing the average number of positive BrdU cells counted in the SVZ in each of the three cohorts.
There was a significant difference in BrdU positive cells across the cohorts (p-value = 0.046). With
both WT(TG) dams (p-value = 0.01) and WT(KO) dams (p-value = 0.05) exhibiting fewer BrdU
positive cells than WT(WT) dams. Error bars represent SEM. Statistical significance: *p < 0.05,
**p < 0.01, and ***p < 0.005.
larger number of positively labelled cells compared to WT(WT) dams (Figure 5.12
and Figure 5.13).
Nestin
Using Nestin, which is a label for neural stem cells (Johansson et al., 1999) it was
possible to quantify the number of stem cells that are in the SVZ. The results of
staining sections for this marker revealed that there was a significant change in the
number of positively labelled Nestin cells between the three groups of dams (F2, 10
= 6.3, p-value = 0.023). This effect was driven by the decrease in Nestin positive
cells in WT(KO) dams compared to WT(WT) dams (p-value = 0.035) (Figure 5.14
and in Table 5.15). There was no difference in the number of Nestin labelled neural
stem cells between WT(WT) and WT(TG) mice (p-value = 1.0).
Examples of sections stained for Nestin positive cells are given for WT(WT), WT(TG)
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Figure 5.12: Average number of BrdU Cells across the SGZ of the 3 cohorts. A graph
showing the average number of positive BrdU cells counted in the SGZ of the DG in each of the
three cohorts. There was a significant difference in BrdU positive cells across the cohorts (p-value
= 0.046). With WT(KO) dams (p-value = 0.01) exhibiting larger number of BrdU positive cells
than WT(WT) dams in the SGZ. Error bars represent SEM. Statistical significance: *p < 0.05 and
**p < 0.01.
and WT(KO) brains in Figure 5.16. The decrease in neural stem cells that is
indicated through the specific staining of Nestin suggests that there are few neural
stem cells present to the WT(KO) dams indicating that the reduced proliferation
could be due to a deficit in total number of cells. In contrast the WT(TG) dams
had no difference in neural stem cells in comparison to WT(WT) dams, thus the
reduction in total cell proliferation seen in the BrdU staining may be a consequence
of a delayed proliferation to generate new neurons.
Doublecortin - DCX
DCX is expressed in the cytoskeleton of new neurons, and is a microtubule associated
protein (Brown et al., 2003, Rao and Shetty, 2004). DCX has been linked to neural
plasticity, morphological changes and migration of new neurons (Klempin et al., 2011).
DCX marks the period of adult neurogenesis that comes between the progenitor cell
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Figure 5.13: Representative images of the BrdU labelled cells in the SGZ across the
3 cohorts. The positive cells labelled for BrdU can be seen as the brown staining for all three
cohorts in the SGZ.
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Figure 5.14: Average number of Nestin Cells across the SVZ of the 3 cohorts. A graph
showing the average number of positive Nestin cells counted in the SVZ in each of the three cohorts.
Error bars represent SEM. Statistical significance: *p < 0.05.
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stages and the early post-mitotic maturation stage. Specifically in the SVZ DCX
labeled migratory cells (Brown et al., 2003).
The DCX positive cells can be seen in Figure 5.16. The number of DCX labelled
cells appeared increased in the WT(TG) cohort of dams (Figure 5.15). This was
confirmed through a one-way ANOVA that suggested a significant effect of genotype
on DCX positive cell number (F2, 10 = 10.1, p-value = 0.009). This was confirmed
through post hoc tests indicating that this effect was driven by the larger number of
DCX labelled cells in the WT(TG) mice’s SVZ in comparison to WT(WT) dams
(Figure 5.15, p-value = 0.016). The reduction in DCX in the WT(KO) dams is
further indication of their reduced neural plasticity.
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Figure 5.15: Average number of DCX Cells across the SVZ of the 3 cohorts. A graph
showing the average number of positive DCX cells counted in the SVZ in each of the three cohorts.
Error bars represent SEM. Statistical significance: *p < 0.05.
Table 5.15: Cell Counts
Label Positive CellsWT(WT) WT(TG) WT(KO)
BrdU (SVZ) 626 (± 13.5) 472 (± 32.2) 474 (± 50.3)
BrdU (SGZ) 6 (± 1.5) 10.3 (± 2.4) 12.5 (± 1.0)
Nestin 117 (± 11.2) 117 (± 10.5) 71 (± 11.8)
DCX 485 (± 17.8) 538 (± 39.8) 316 (± 42.9)
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BrdU
Nestin
DCX
WT(WT) WT(TG) WT(KO)
SVZ
Figure 5.16: Representative images of the BrdU, Nestin and DCX labelled cells in
the SVZ across the 3 cohorts. The positive cells labelled for BrdU/Nestin/DCX can be seen
in the SVZ and are labelled brown in colour and non-BrdU labelled cells are purple in colour.
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5.2.4 High Performance Liquid Chromatography
- HPLC
The brains of each of the dams across the three cohorts were dissected into several
brain regions: frontal cortex, hypothalamus, hippocampus and olfactory bulbs. This
tissue was used for HPLC analysis and levels of nor-adrenaline (NA), dopamine (DA),
serotonin (5-HT), glutamate (GA) and aspartate and their constituent secondary
metabolites were assessed. The number of samples for each tissue are summarised in
Table 5.16. The HPLC was performed by the Psychology Analytical Laboratory
(Cambridge University, UK).
Table 5.16: Number of HPLC Samples
Region Number of Samples (n)WT(WT) WT(TG) WT(KO)
Frontal Cortex 5 5 5
Hippocampus 5 5 4
Hypothalamus 3 1 3
Olfactory Bulb 5 5 4
Note: Due to sample loss for WT(TG) dams the analyses for the hypothalamus from all cohorts
were discarded and not shown in this thesis.
Frontal Cortex Neurotransmitter and Metabolite Levels
Whole tissue neurochemistry analysis of the frontal cortex was performed on an n =
5 for each cohort. The frontal cortex was tested for specific neurotransmitter levels
and the subsequent metabolites. The data is displayed in Figure 5.17. The analysis
revealed no significant change in levels of NA, DA or 5-HT between the three cohorts
of dams.
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(b) Levels of Serotonin in the Frontal Cortex.
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Figure 5.17: Neurotransmitter Levels in the Frontal Cortex. (a) Average levels of nor-
adrenaline (NA) and dopamine (DA) in the frontal cortexes of WT(WT), WT(TG) and WT(KO)
dams. (b) Average levels of serotonin (5-HT) in the frontal cortexes of WT(WT), WT(TG) and
WT(KO) dams. (c) Average levels of glutamate (GA) and aspartate (ASP) in the frontal cortexes
of WT(WT), WT(TG) and WT(KO) dams. Error bars represent SEM.
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Hippocampus Neurotransmitter and Metabolite Levels
HPLC of the hippocampus for the same three neurotransmitters and their metabolites
did show a decrease in dopamine levels for both WT(TG) and WT(KO) dams
compared to the WT(WT) cohort, but this was not significantly different (Figure
5.18). The relatively high deviation in the WT(WT) samples suggested a natural
variation amongst the WT(WT) dams. Consequently greater numbers will be
required to determine the significance of these findings. No change in serotonin levels
within the hippocampus was apparent between the three groups (Figure 5.18).
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(b) Levels of Serotonin in the Hippocampus.
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Figure 5.18: Neurotransmitter Levels in the Hippocampus. (a) Average levels of nor-
adrenaline (NA) and dopamine (DA) in the hippocampi of WT(WT), WT(TG) and WT(KO) dams.
(b) Average levels of serotonin (5-HT) in the hippocampi of WT(WT), WT(TG) and WT(KO)
dams. (c) Average levels of glutamate (GA) and aspartate (ASP) in the hippocampi of WT(WT),
WT(TG) and WT(KO) dams. Error bars represent SEM.
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Olfactory Bulb Neurotransmitter Levels
There was a consistant but not significant decrease of nor-adrenaline for both WT(TG)
and WT(KO) mice in the Olfactory Bulb (OB). There was no difference between the
groups in levels of dopamine 5.19. The serotonin levels were likewise not changed
relative to WT(WT) 5.19.
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(b) Levels of Serotonin (5-HT) in the Olfactory Bulbs.
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Figure 5.19: Neurotransmitter Levels in the Olfactory Bulbs. (a) Average levels of nor-
adrenaline (NA) and dopamine (DA) in the olfactory bulbs of WT(WT), WT(TG) and WT(KO)
dams. (b) Average levels of serotonin (5-HT) in the olfactory bulbs of WT(WT), WT(TG) and
WT(KO) dams. (c) Average levels of glutamate (GA) and aspartate (ASP) in the olfactory bulbs
of WT(WT), WT(TG) and WT(KO) dams. Error bars represent SEM.
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Neurotransmitter to Metabolite Turnover
It is important to be aware of the ratio between the levels of neurotransmitter and
their subsequent metabolites. This gives a representative turnover rate between the
two. We only had the metabolite data for dopamine and serotonin (Table 5.17).
There was no obvious abnormalities in the rate of turnover across the cohorts for
any of the neurotransmitters to metabolites.
Table 5.17: Ratio of Neurotransmitter to Metabolites
Region DOPAC/DA 5HIAA/5HTWT(WT) WT(TG) WT(KO) WT(WT) WT(TG) WT(KO)
FC 0.71 0.54 1.16 0.67 0.7 0.62
HIPPO 0.26 0.34 0.3 0.34 0.3 0.34
OB 0.31 0.34 0.31 0.34 0.33 0.34
5.3 Discussion
The results presented in this chapter highlight distinct gene expression changes in
two key regions in the brain involved with maternal behaviour and also demonstrate
dramatic alterations in the level of neurogenesis occurring in the E16.5 maternal
brain between the three cohorts. The gene changes identified through microarray
highlighted clusters of genes associated with olfaction in the hypothalamus and
ribosomes/RNA binding in the hippocampus. More specifically, genes involved with
the dopaminergic and serotonergic systems were significantly altered in both the
microarray and then verified using qPCR. The results of the HPLC did not show
any significant differences in specific neurotransmitters in several brain regions.
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Gene Expression Levels in the Hippocampus and
Hypothalamus
The key gene changes that were identified and then confirmed via qPCR are some
that have been previously linked to mood and mental illness. In particular, there were
several genes involved in mediating the monoaminergic system that were significantly
down regulated in both the WT(TG) and WT(KO) dams hippocampus as well as
a gene involved in mediating the stress response and also calcium signalling gene
that has previously been linked to schizophrenia. These key genes and their known
functions in relation to this study are summarised in Table 5.18.
Specifically, the dopamine transporter (Dat) is known to be critical in controlling
both spatial and temporal dynamics of the neurotransmitter dopamine. It works
by driving the re-uptake of the extracellular dopamine back into the presynaptic
neurons (Vaughan and Foster, 2013). It is extensively reported that Dat is likely to
play a crucial role in many human conditions, including depression, bipolar disorder,
attention deficit hyperactivity disorder (ADHD) and Parkinson’s disease (Madras
et al., 2005, Nutt et al., 2004). This is because these diseases are all associated with
abnormal levels of dopamine and therefore Dat’s ability to modulate the levels of
dopamine are a vital component of these diseases aetiologies. Similarly, Tyrosine
hydroxylase (Th) is an enzyme that is responsible for catalysing tyrosine into L-
DOPA. L-DOPA is the precursor of the catecholamines which include dopamine,
noradrenaline and adrenaline. Th is the rate limiting enzyme in the production of
these key neurotrophic factors. Deficiencies in this enzyme therefore are linked to
the abnormal function of the dopaminergic system. The down regulation of Dat by
50% in the WT(TG) dams hippocampus and a similar reduction in the WT(KO)
dams hippocampus, combined with the Th being significantly reduced by 90% in
the WT(KO) dams point to a clear disruption of two key genes involved with the
dopaminergic system. Thus implying a potential role of these genes in the regulation
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and stability of the dams maternal behaviour.
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Table 5.18: Key Functions of Genes Investigated in the Hippocampus and Hypothalamus.
Gene Up ↑ or Down ↓ Regulated Function/s Reference/s
Ucn3 WT(TG)/WT(KO) ↓ Regulates food uptake during
stress and feeding behaviour. Itself
and other CRF family members
play a role in anxiety related
behaviours.
Reyes et al. (2001), Ushikai et al.
(2011), Venihaki et al. (2004),
Zheng et al. (2016)
Kcnh2 WT(TG)/WT(KO) ↓ Identified as a risk gene for
schizophrenia. Can cause
differences in microcircuit function
in the hippocampus and structure
and number of dendrites.
Carr et al. (2016), Hashimoto et al.
(2013), Heide et al. (2016),
Vereczkei and Mirnics (2011)
Endod1 WT(TG)/WT(KO) ↓ Implicated in psychiatric disorder
due to function in mylein
formation/neurogenesis.
Jahn et al. (2009), Morag et al.
(2011)
Th WT(TG)/WT(KO) ↓ Rate limiting enzyme in the
production of
dopamine/noradrenaline/adrenaline.
Lee and Voogt (1999), Voogt et al.
(2001)
Tph2 WT(TG)/WT(KO) ↓ Linked to increased expression
levels in the pancreas due to
elevated PL.
Kim et al. (2010), Mueller and
Bale (2008)
Dat WT(TG)/WT(KO) ↓ Linked to a role in ADHD,
Parkinson’s, depression and
bipolar disorder. Involved with
spatial and temporal dynamics of
dopamine.
Carlin et al. (2013), Peciña et al.
(2003), Vaughan and Foster (2013)
Olfactory Receptors Olfr ↑ and ↓ G-protein Coupled Receptors -
Implicated in a variety of
signalling pathways and are likely
to bind other functional ligands.
Zhang and Firestein (2002)
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What is known about Dat and the role of the gene plus the subsequent protein
may suggest that the WT(TG) dams greater down regulation is a natural response
to lower levels of dopamine in the system. Perhaps, in an attempt to stabilise
mood, cognitive ability and other key behaviours known to be partly controlled by
dopamine. This is perpetuated by the reduction in dopamine seen in the HPLC of
the hippocampus for both WT(TG) and WT(KO) dams. The less marked difference
in Dat down regulation in the WT(KO) dams could be attributed to the differences
in behaviour seen between the three cohorts. In contrast the large down regulation
of Th could suggest that in WT(KO) dams there is less dopamine being synthesised
and therefore there could be an active up-regulation of Dat. The fact that Dat is
still reduced in WT(KO) dams however indicates that there may well be something
else going on. Perhaps there could be a threshold response resulting from a bell
shaped curve in relation to the levels of placental signalling. Too much or too little
placental signalling may cause similar effects upon the maternal brain. This idea is
supported by the similar decrease in Th in the WT(TG) dams (80%). Too much or
too little of the key hormones from the SpT creates an imbalance driving maternal
brain gene expression patterns away from the optimum conditions for pregnancy.
It is known that Prls influence the expression of tryptophan hydroxylase (Tph2 ) in
the pancreas, the rate limiting enzyme in serotonin synthesis. Increased levels of Prls
induce the expression of Tph1 and Tph2 in the pancreas, specifically in islet cells
(Kim et al., 2010). Biomolecular qPCR analysis of the various brain regions taken
at E16.5 and P7 in this study was useful in helping identify whether changes were
present in the maternal brain. The results showed that there was a decrease in both
WT(TG) and WT(KO) hippocampi. Although only the down regulation of Tph2 in
WT(TG) dams was significant, there was a large decrease in expression of this gene
in WT(KO) dams. This may similarly point to a bell shaped action of an aberrant
placenta on maternal behaviour. There has not yet been a link between Tph2 and
postnatal depression. Although, serotonergic activity has been shown to play a role
more widely in depression as a whole, and implicated in postnatal depression through
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the effective treatment of the condition using selective serotonin re-uptake inhibitors.
The decrease in Tph2 in both these cohorts may indicate that SSRI’s could be an
effective treatment in this model and should be investigated.
Despite not being present on the microarray it was important to look at oxytocin
receptors in the hippocampus. This is because there is extensive research that has
demonstrated the link between oxytocin in the initiation of maternal behaviour, but
not in the maintenance of this maternal behaviour (Bick and Dozier, 2010, Schaller
et al., 2010). Consequently any changes in the level of the oxytocin receptor in the
brains of these dams may cause alterations in oxytocin levels and in neurodevelopment.
There was no significant change in the oxytocin receptor expression levels across the
groups. Despite this the Oxtr did show reciprocal expression between the WT(TG)
and WT(KO) dams indicating that although not significantly different to WT(WT)
dams there may be some biological relevance to the down regulation of the gene in
the WT(TG) and the up regulation in WT(KO) dams and the postpartum maternal
care provision. The surge in oxytocin at parturition is not all that occurs at the end
of pregnancy. There is also an abrupt decrease in the activity of serotonin neurons
in the brain of the dam. This is compounded by a substantially reduced availability
of tryptophan. It has been suggested that this may be a contributing factor to the
development of increased maternal aggression in rodents and linked to depressed
mood in humans after birth (Dennis et al., 2013). There was not the time to assess
maternal aggression in this study, however it would be an interesting behaviour
to address using the intruder task in mice and then follow it up with a directed
approach to potential pathways involved with aggression.
Urocortin 3 (Ucn3 ) is a member of the corticotropin releasing factor family (CRF ).
The CRF family of genes play a role in regulating food uptake in times of stress.
In the brain it may be responsible for the effects of stress on appetite. Ushikai
et al. (2011) and colleagues showed that centrally administered Ucn3 decreased food
intake in high-fat diet-fed obese mice and in lean mice, although not as strongly as
Ucn1. The results indicate that Ucn3 influences feeding behaviour and gut motility.
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The dams carrying different placentae and fetuses in this study showed differing
feeding habits compared to WT(WT) dams, further implicating this gene in feeding
behaviour. Interestingly the CRF family of peptides are recognised for there effects
on anxiety related behaviour, Ucn1 has an anxiogenic profile as it has a high affinity
for the CRF receptor 1, which mediates adrenocorticotropic hormone release. In
contrast Ucn2 and Ucn3 have preferential affinity for the CRF receptor 2 and this
mediates stress coping responses resulting in anxiolytic behaviour (Lewis et al., 2001,
Reyes et al., 2001). Important to note however is that these studies focussed on
the hypothalamus as the site of these genes, they haven’t been looked at in the
hippocampus which is where they have been identified as being significantly reduced
in both our WT(KO) and WT(TG) dams by around 90%. The role Ucn3 has in
coping with stress could help explain the heightened stress responses seen in these
mice during the EPM in chapter 4.
Potassium Voltage-Gated Channel Subfamily H Member 2 (Kcnh2 ) was identified
as being around 50% decreased in WT(KO) dams hippocampus and slightly less
decreased (40%) in WT(TG) dams. A KCNH2 variant was fairly recently highlighted
as a risk gene for schizophrenia in a study that looked at mRNA from the hippocampus
(Hashimoto et al., 2013). The study used a meta analysis of 5 ethnic groups and a
total n = 4329 individuals, the idea that having the KCNH2 variant can increase the
risk of developing neuropsychological deficits and schizophrenia later in life links with
the fact that mothers whom develop postpartum depression or puerperal psychosis
are more likely to go on and develop other mental health disorders later in life (Chu
et al., 2015, Jones, 2007). A mouse model investigating this variant has shown that
mice with the KCNH2 variant are normal and display usual sensory behaviours but
show differences in neuronal structure and microcircuit function in the hippocampus
and pre-frontal cortex, resulting in fewer mature dendrites (Carr et al., 2016). Could
this therefore be one aspect that is effecting the different levels of neurogenesis seen
in WT(KO) dams with significantly less expressed levels of Kcnh2? Accumulating
evidence has implicated KCNQ2 and KCNQ3, both potassium voltage gated channels
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similar to KCNH2 in bipolar disorder (Kaminsky et al., 2015). More evidence showing
the roles that these genes play in the effectiveness of drug responses to treating such
diseases add weight to their role in these disease phenotypes (Heide et al., 2016).
Despite these large genome wide searches for risk genes it is still debated whether
such research is useful for such diverse disorders such as schizophrenia (Vereczkei and
Mirnics, 2011). It is therefore critical that despite this research highlighting genes
that may play a role in the development of behavioural changes and eventually lead
to mood disorders in dams with aberrant placenta, that further research into their
exact effects be explored. Overall it is clear that key pathways have been disrupted
within the hippocampi of these dams that are known to be involved in mood and
mental illness.
The hypothalamus is a brain region that is implicated in eating, locomotor activity
sexual behaviour and exploratory behaviour. It is a key neuroendocrine signalling
organ that regulates a vast array of autonomic bodily functions in mammals, often
through its control of the anterior pituitary. There is a known cross talking link
between olfaction and the hypothalamus (Gascuel et al., 2012). The hypothalamus
shows sensitivity to olfactory stimuli from the environment, seen most clearly in
newly pregnant mice that are exposed to urine of a “strange” male mouse resulting
in complete pregnancy block, in a phenomenon known as the Bruce Effect (Bruce,
1959, Bruce and M, 1960). This effect is thought to occur as a result of hypothalamic
dopamine release causing termination of the pregnancy in mice (Rosser et al., 1989).
More subtly however the hypothalamus which is part of the limbic system is believed
to be involved with emotional responses to external and internal stimuli (Hess and
Akert, 1955). It was a surprise therefore to find that the most extensively up regulated
genes in the microarray of the hypothalamus was a number of olfactory receptor
genes. These were subsequently shown to be part of an enriched signalling pathway
for olfactory transduction.
Olfactory receptors make up about 60% of all GPCRs in the mouse and rat genome
and some 50% in the human genome (Hazell et al., 2012). Olfactory receptors are not
178
Hugo Creeth Discussion
known to be present in the hypothalamus. However, although they are called olfactory
receptors, the fact that they are expressed in such robust levels in the hypothalamus
suggests that they may simply be GPCRs that act in the hypothalamus and perhaps
bind various Prls (Zhang and Firestein, 2002). Despite the fact that a qualitative
analysis suggested that these olfactory receptors do not fall into particular olfactory
receptor types. This observation helps generate numerous questions surrounding the
functional significance of these receptors in pregnancy. We know that specific Prls
(but not all) bind to the Prlr, it is therefore possible that they also have specific
receptors themselves that are different from the Prlr. The current study was not
able to determine whether this is actually the case but further work on this would be
interesting. Another key question concerns the reasons behind the up-regulation of
the olfactory receptors. Are they up-regulated in WT(TG) dams to compensate for
the lower signalling from the placenta in these mice? And if so is it a self regulating
system? As a self regulating system it would make sense that when the system is
flooded with high levels of signalling hormones, in order to mediate the responses
that are initiated by these chemical signals then the appropriate receptors would
be down regulated. If this were the case it would be expected that WT(KO) dams
might show less enriched receptors and that this would potentially result in a less
severe maternal behavioural response. This is not the case however and supports the
idea that there is an optimum state for pregnancy.
Neurogenesis
There are two brain areas from which new neurons are made in adult brain, these are
both extremely plastic and are susceptible to be programmed through hormones and
experience (Kinsley et al., 2012, 2006). It is possible that differing levels of hormonal
release may impact the levels of neurogenesis in the maternal brain and subsequently
be a causal factor in specific maternal behaviours. The evidence presented in this
chapter demonstrated the difference in the levels of neurogenesis across the three
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cohorts of dams at E16.5. Both WT(TG) and WT(KO) dams have reduced BrdU
positive cell counts in the SVZ. Whilst WT(KO) dams have an increased number of
positively labelled cells in the SGZ. This is exciting as previously these findings have
not been reported in the maternal brain at this later time point during gestation,
with studies focussing on E6.5 (Bridges and Grattan, 2003, Larsen and Grattan,
2010).
The SVZ is known to give rise to new inter neurons that migrate along the RMS to
the olfactory bulbs. Where they are purported to function in an olfactory manner
and help in olfactory recognition of the new offspring. The reduction in new neurons
in the SVZ for both cohorts may imply that this aspect of maternal neurogenesis
has an optimum hormonal trigger. However the WT(TG) mice did seem to have
similar numbers of Nestin and DCX positive cells compared to the WT(WT) dams.
This contrasted to the WT(KO) dams, which maintained around a 20-40% decrease
across these cell markers.
The increase in new neurons in the SGZ of the WT(KO) dams could explain the
contrast in behaviour seen in the WT(KO) dams compared to the other two groups.
Whilst the reduced BrdU labelled cell number may be linked to the slower pup
retrieval seen in the WT(KO) dams. It would follow that the increased number of
BrdU labelled cells in the SGZ may link to previously reported findings that have
implicated an increase in grey matter volumes in brain regions that are involved with
maternal motivation. These findings first presented by Kim et al. (2010) suggested
that dams with increased neurogenesis in the SGZ show greater positive behaviour
towards their offspring. The SGZ is associated with learning and memory (Abrous and
Wojtowicz, 2008). Therefore testing more specific learning and memory behaviours
of these dams would be interesting. It must also be considered that any differences
in behaviour between these cohorts may not be due to the amount of neurogenesis
taking place, but be a result of neurogenesis taking place at a different time point. It
is plausible that WT(KO) dams may experience higher levels of neurogenesis at an
earlier stage of pregnancy, perhaps as a result of higher signalling from the placenta,
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meaning that the neurons are incorporated into the functional circuitry of the brain
sooner. In order to test this theory a longitudinal study should be undertaken and
assessment of neurogenesis at different time points during pregnancy between the
cohorts.
Although this research focussed upon neurogenesis in the well documented regions
of the adult maternal brain, it would be fascinating to assess levels of neuronal
development in less well documented areas, that are also involved with maternal
behaviour. In particular the hypothalamus. Several researchers have identified
neurogenesis in the hypothalamus and linked a potential role of hormones, specifically
oestrogen, on cell proliferation in hypothalamus and amygdala (Fowler et al., 2002,
2008, Okuda et al., 2009). If the Prls could be shown to impact upon the levels of
neurogenesis of this region it may help explain the increase in olfactory receptors in
the region. The amygdala has been implicated in a variety of social and reproductive-
associated behaviours, including olfactory and pheromonal processing (Dudley et al.,
1996, Meredith, 1991) as well as social learning and memory (Cahill et al., 1996). It
is important to note that despite several researchers documenting neurogenesis in
the cerebral neocortex there have been others that have not observed such changes,
which makes this an area of debate (Bhardwaj et al., 2006, Koketsu et al., 2003).
In conclusion, there are many factors that may affect the timing and rate of neuro-
genesis in the adult brain. These range from hormonal cycles (Rasika et al., 1994),
physical activity (van Praag et al., 2014) and living conditions (Kempermann and
Gage, 1999, Sandeman and Sandeman, 2000). Recently Goergen et al. (2002) have
demonstrated that in the crustacean brain there is an element of circadian control
of neurogenesis. Their data shows that there is a diurnal rhythm of neurogenesis
along olfactory projection neurons. Although this hasn’t been shown in mammals it
raises the question whether a similar mechanism of control could be apart of what
we have seen in our dams. Thus there is still large amounts of work that needs to be
done to clarify the significance in the variations in maternal neurogenesis that we
have demonstrated, and the underlying mechanisms behind the differences. However
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what we have shown is that there is a role of the placenta in our findings, which is
an exciting step forward in understanding the programming of the maternal brain.
Caveats to Biomolecular Characterisation
An overall limitation that may affect the validity of the region specific expression
changes seen through both microarray and qPCR of these genes, is that the dissection
method may be too crude and unspecific to confidently say the exact regions were
solely removed and analysed. This factor was controlled for through the use of a
second cohort of mice to perform qPCR validation upon and the same researcher
carrying out all the dissections. However perhaps the use of a more precise dissection
method such as laser capture micro dissection would aid in the specificity of the
dissections and allow for greater confidence (Espina et al., 2006).
It is important to note that differences seen in the microarray and qPCR may not
have been exactly alike (Chuaqui et al., 2002). This could be down to a number of
factors. RNA quality is extremely important for both qPCR and microarray. However
the stringent quality testing processes applied to RNA sent for microarray and the
preparation of the samples before the array itself can introduce certain discrepancies
between results of the two procedures (Freeman et al., 1999, Morey et al., 2006,
Wurmbach et al., 2003). Microarray analysis can incur non-specific and/or cross
hybridisations of labeled targets to array probes; an issue that isn’t the case in qPCR.
qPCR however has the issue of primer dimers, amplification biases and mis-priming
(Freeman et al., 1999, Wurmbach et al., 2003). These are controlled for through
normalisation of the data, but the global normalisation of microarray data can cause
differences (Yang et al., 2002). While there are undoubtably potential pitfalls in
microarray and qPCR procedures, most sources of error can be controlled through
robust experimental designs, good laboratory practices, and rigorous normalisation
of the data, as was the case for these data (Morey et al., 2006). If this experiment
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was performed again, RNAseq would be a great addition to the protocol, as would
the investigation of protein levels as the current study primarily focussed on only
mRNA levels. To look at protein levels Western blots would be useful and/or
immunohistochemistry assays. This would help create a greater focus on potential
mechanisms behind the behaviours.
Conclusion
The overarching finding of this chapter was that there are changes in the maternal
brain that preceded the changes in maternal behaviour observed in the dams in
chapter 4. The genes that have been significantly down or up-regulated in both
the WT(KO) and WT(TG) dams are linked to pathways associated with mood
and mental illness in humans. While these changes do not prove that the maternal
behavioural differences were due to placental factors, it does demonstrate alteration
in the maternal brain during pregnancy some of which have been linked to maternal
behaviour in previous studies (Bridges, 2016). These results do give support to the
hypothesis that the altered placenta is playing a key part programming the maternal
brain and the subsequent behavioural changes.
Alterations in neurogenesis taking place during gestation that may or may not confer
an advantageous effect on the maternal care postnatally. One key question is the
functional relevance of newborn neurons during pregnancy since those born at E16.5
would not be integrated into the nervous system in time for postnatal care. It will
be of interest to perform a longitudinal study to ask whether the dams have more
persistent alterations in behaviour. For example, are they better or worse mothers
in the second pregnancy.
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Summary of Findings
• Microarray analysis highlight distinct global differences in gene expression
levels between the three cohorts of dams in both the hippocampus and the
hypothalamus at E16.5.
• There were distinct pathways that were enriched in both the hippocampus and
hypothalamus between the three cohorts at E16.5.
• The hippocampus had enrichment of the ribosome and RNA binding pathways
although this didn’t reach significance at E16.5.
• The hypothalamus showed significant global enrichment of the olfactory trans-
duction pathway at E16.5.
• Genes that were significantly up or down regulated in both the WT(TG) and
WT(KO) dams hippocampi included key genes involved in the dopaminergic
and serotonergic systems. As well as Ucn3, Endod1 and Kcnh2. All of which
have roles in behaviour and neuronal development.
• The genes of interest were confirmed through qPCR. Validating the microarray
and enabling a more in depth look at specific gene changes.
• Olfactory receptor genes that showed distinct changes in expression levels
between the three cohorts and were enriched as a pathway were confirmed
through qPCR analysis at E16.5.
• The gene changes seen at E16.5 did not persist until P7 in the brains of the
dams.
• There was a decrease in BrdU labelled cells in the SVZ of both WT(TG) and
WT(KO) dams at E16.5.
• There was subsequently a significant decrease in Nestin and DCX positive cells
in WT(KO) dams SVZ at E16.5.
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• The SGZ showed increased BrdU positive cell numbers in WT(KO) dams only
at E16.5.
• HPLC analysis showed no significant differences in neurotransmitter levels or
in there metabolites across the three groups at E16.5.
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6Offspring Outcome
6.1 Overview
It has been consistently reported over the last century that the early life environment
is both a source of adult psychopathology and physiological disease (Bale et al.,
2010b, Champagne and Curley, 2009, Visentin et al., 2014). The early concepts
of “psychic conflict” and “toxic parenting” have been replaced with a view to genes
and the epigenome, due to a greater understanding of the complex relationship
between genes and the environment. This paradigm shift in knowledge has made
room for an exciting and rapidly growing field of research focussed on the early
life environment. The early life of an individual is a uniquely sensitive period of
development, during which adverse experiences can lead to enduring effects that
impact upon adult health. These range from physiological conditions such as obesity,
diabetes and cardiovascular disease (Elford et al., 1991, Reilly et al., 2005, Stein and
Charles, 1971) to psychological and neurodevelopmental conditions like schizophrenia,
bipolar disorder and ADHD (Bale et al., 2010a, McEwen, 2008, Mill and Petronis,
2008).
The previous two chapters (Chapter 4 and Chapter 5) identified a maternal care
and LBW phenotype based upon an altered placenta, potentially as a consequence
of changes that occur in the maternal brain during gestation. The knowledge that
maternal care is intrinsically linked to offspring outcome opened up the question
about what effect, if any, the maternal phenotype identified in chapter 4 may have
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upon the offsprings developmental trajectory.
This chapter aimed to dissect the specific effects that the in utero environment and
maternal care phenotype may have upon the offsprings behavioural and biomolecular
profiles. To do this an initial behavioural characterisation was performed and genes
associated with distinct behavioural outcomes assessed using qPCR for one of the
maternal phenotypes described previously.
6.1.1 Maternal Care and Development
The process of development post partum is dynamic. In the majority of mammals the
postnatal phase of development is characterised by a prolonged period of dependency
on mothers for warmth, nutrition, protection and stimulation (Franks et al., 2015,
Numan, 1994, Rheingold et al., 1963). These behaviours materialise in rodents
in the form of nest building, elevated eating levels to help balance the demands
placed on the body system through lactation (Chapter 1). The offspring of mammals
however show a periodic reduction in dependence (Curley et al., 2009, Rheingold and
Eckerman, 1970). In laboratory offspring this includes increased locomotor activity,
eye opening, play and other social interactions all of which can continue for up to 21
days post parturition, with some suggesting up to 28 days (Curley et al., 2009).
The bi-directional nature of the developmental process means that variations in the
interactions between mothers and their offspring can have significant effects on the
growth, neural development and behavioural outcomes in offspring (Champagne
et al., 2007, Duque et al., 2012). This has previously been shown to be the case in
situations of maternal separation or deprivation (George et al., 2010, Millstein and
Holmes, 2007). One study highlighted the increased stress reactivity in adulthood
of one group of young that suffered from maternal separation during development
(Champagne, 2011). These changes in behaviour are also evident in natural variations
of maternal care between mother and offspring in rats (Meaney, 2001, Meaney and
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Szyf, 2005).
The maternal phenotype and in utero environment that was studied in this chapter
was that of the WT(TG) dams. The reasoning behind this choice of phenotype is
based on on several reasons (a) the offspring from this in utero environment are
shown to be growth restricted and have LBW but then display rapid catch catch
up growth after birth (Tunster et al., 2014) (b) the mothers carrying a the TG
placenta have reduced maternal care and (c) utilising this model allowed assessment
of NON-TG litter mates to control for the direct effects of the transgene. There is
increasing evidence that IUGR plays a role in adult development and is a risk factor
for a spectrum of future health complications (Barker, 2006).
6.1.2 LBW and IUGR
One of the most problematic and prevalent conditions affecting up to 19% of all births
in developing countries worldwide and between 5-7% of births in developed countries
is, Low Birth Weight (LBW) (Valero De Bernabé et al., 2004). LBW is defined as a
birth weight that is less than 2500 grams in humans and is commonly used as an
overall measure of both fetal and maternal health (Alexander et al., 2014). This is
because offspring born too small at the time of birth are usually a result of either
poor growth in utero, a genetic abnormality or a consequence of a preterm birth
(Valero De Bernabé et al., 2004). Crucially several areas of research have highlighted
the idea that these newborns are more susceptible to birth complications leading
to an elevated mortality risk, and it is becoming more and more evident that LBW
is a risk factor for later life complications such as depression and ADHD but also
diabetes, obesity and other metabolic disorders (Grissom and Reyes, 2013, Loret de
Mola et al., 2014, Witt et al., 2012a,b). Research has focussed on understanding
the causes of LBW in human populations with many risk factors being discovered
including: maternal diet, smoking and ethnicity (Fulda et al., 2014), but also the
placenta has emerged as having a role in both maternal mood and programming
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childhood behavioural outcomes (Janssen et al., 2016).
6.1.3 The Placenta and Fetal Programming
The placenta’s role throughout pregnancy is well documented and has already been
described in detail in chapter 1. An optimally functioning placenta to protect the
fetus from many types of prenatal adversity. Recently however there is increasing
evidence that some forms of prenatal stress can lead to changes in placental function
(Blakeley et al., 2013, Jensen Peña et al., 2012, Mairesse et al., 2007, O’Donnell
et al., 2012), ultimately contributing to an altered in utero environment and poorer
outcomes for offspring (Janssen et al., 2016, O’Donnell et al., 2009).
The term “fetal programming” arose after David Barker and his team proposed the
“thrifty phenotype hypothesis” (Hales and Barker, 1992). This hypothesis primarily
focussed on the effect of poor fetal nutrition has upon metabolic organs such as the
pancreas. It has since been realised that the effects that occur early in pregnancy
and the post partum play a far wider reaching role upon offspring development, as
reviewed by Janssen et al. (2016).
Imprinted genes have been implicated in fetal growth, placental development, adult
behaviour and metabolism (Peters, 2014). It is this array of roles and the epigenetic
plasticity of these genes that led to Keverne (2010) suggesting their importance
in fetal programming. Moore et al. (2015) summarises the role of imprinted genes
on IUGR and LBW, whilst Green et al. (2015) and others (Marsit et al., 2012)
have suggested a link between imprinted gene expression in the placenta with infant
neuro-behavioural outcomes. This evidence provides a strong foundation to the
hypothesis that the offspring from mothers with a compromised placenta due to a
genetic alteration of the placenta will display the effects of fetal programming on
their behavioural outcome.
189
Hugo Creeth Results
The aim of this chapter was to characterise the behavioural outcome of both TG,
NON-TG and WT offspring that have been exposed to different placenta, in utero
environments and different maternal care. It sought to determine whether there
was any transgenerational effect that altered maternal care has upon the later life
outcomes of their offspring. The tests used will range from basic motoric and
anxiolytic assays to determine the natural states of the animals basic behaviour and
also use the LCA test to measure mood and hedonic response.
6.2 Results
6.2.1 Offspring Development
In order to determine whether there was a developmental deficit between the three
genotypes a comprehensive screening of the development was carried out on a day to
day basis using the JAX developmental chart that pinpoints milestones in a mouses
development from birth (Figure 6.1).
Figure 6.1: JAX Development Table. A schematic diagram illustrating the stages of develop-
ment for newborn mice over the first two week period.
Mice were scored blindly without knowledge of their genotype on whether they had
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reached the milestone or not by 1pm each day. The findings showed that there was
no developmental phenotype between the WT and NON-TG mice (which are geneti-
cally wildtype) but also importantly that there was no difference in developmental
trajectory for the TG mice that were identified after genotyping and before weaning.
6.2.2 Behavioural Characterisation
Genotyping of the TG, NON-TG and WT mice was performed before weaning so
that at time of weaning male mice could be separated according to their genotype
and sex. Female mice were used for a different study. A maximum n = 4 for each
genotype was housed in a single cage and initially no less than n = 2. The exact
numbers of each genotype used throughout the behavioural characterisation can be
seen in Table 6.1.
Table 6.1: Numbers of Mice in each Cohort of Offspring
Genotype Total Number (n)
WT 19
TG 12
NON-TG 17
Each cage was assigned a letter from the alphabet at random. A total of 16 cages
were initially used however this number did increase due to in fighting within cages
resulting in certain animals having to be separated and moved into another cage.
The letters were used to ensure that the genotypes of each cage were kept blind for
testing so that there was no investigator bias during manual scoring of behaviours.
Elevated Plus Maze - EPM
The elevated plus maze is an anxiety assay that can be used to decipher differences
between anxiolytic and anxiogenic behaviour in rodents. Mice from each cohort
were tested after a period of habituation to the testing room. There were n = 48
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mice in total. These were all run through the EPM blind by genotype. The findings
from the EPM showed that all the three genotypes had a preference for the least
anxiety inducing closed arm of the EPM (p-value < 0.05). This was indicated by the
amount of time spent on the closed arm compared to the middle zone and open arm
(Figure 6.2). There was no difference between the duration of time spent in each
zone between the three genotypes, closed arm (F2, 46 = 0.433, p-value = 0.43), middle
zone (F2, 46 = 0.295, p-value = 0.74) and the open arm (F2, 46 = 0.399, p-value =
0.67) of the EPM. Indicating that there was no impact of genotype on this aspect of
behaviour.
The distances that each of the three genotypes travelled in the open (F2, 46 = 0.82,
p-value = 0.45), closed (F2, 46 = 2.18, p-value = 0.13) and middle (F2, 46 = 2.08,
p-value = 0.14) zones was not seen to be significantly different by genotype (Figure
6.2). There was also no significant difference between the zones for WT mice (t1, 18
= 0.24, p-value = 0.21) TG mice (t1, 11 = 0.54, p-value = 0.61) and NON-TG mice
(t1, 16 = 0.12, p-value = 0.19).
There was no difference in the velocity/speed that the mice of each group moved
at within each of the three zones (Figure 6.2). The speed of movement was not
significantly reduced in the open arm between the genotypes (F2, 46 = 1.52, p-value
= 0.23), this was despite what appeared to be an obvious reduction in speed for the
NON-TG animals. This was also the case for the closed arm (F2, 46 = 6.64, p-value
= 0.63) and the middle zone (F2, 46 = 4.60, p-value = 0.63).
Manually scored behaviours were also recorded in each zone for the duration of the
test. These included rearing, stretching and head dipping (Figure 6.3 and Figure
6.3), there was no significant effect of genotype on any of these behaviours. There was
a significant effect of zone on the number of rears performed (F2, 46 = 3.84, p-value
= 0.025), this corresponded to the reduction in the number of rears in the open zone
compared to the number of rears performed in the less anxiogenic closed zone across
all the genotypes. This decrease was also evident in the number of stretches that were
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Figure 6.2: Offspring EPM. (a) A Bar-Chart illustrating the duration of time each cohort spent
in the three zones of the EPM. There was no significant difference between the groups in relation
to time spent in each zone p-value > 0.05. (b) A Bar-Chart showing the average distance travelled
by each cohort over the course of the EPM assay. There was no significant effect of genotype on
the distance travelled across all three cohorts. (c) A graph demonstrating the varying velocity by
each group within the three zones of the EPM. There was no significant difference within zones but
there was the expected difference between zones. Error bars represent SEM.
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performed by each cohort in the open zone (Figure 6.3) in contrast to the closed
and middle zones (F2, 46 = 13.77, p-value < 0.001). Similarly there was an effect of
zone on the number of head dips performed, with all three cohorts performing more
head dips in the middle zone compared to both the closed and open zones (F2, 46 =
23.76, p-value < 0.001). The number of fetal boli was recorded during the test but
was not statistically different across the groups.
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Figure 6.3: EPM - Manually Scored Behaviours. (a) A simple bar chart to display the
number of rears performed within each zone of the EPM for each cohort of mice. (b) A simple bar
chart to display the number of head dips performed within each zone of the EPM for each cohort
of mice. (c) A simple bar chart to display the number of stretches performed within each zone of
the EPM for each cohort of mice. Error bars represent SEM.
Open Field - OF
The OF test, like the EPM, is an anxiety assay that exploits the natural aversion
of rodents to spending time in an open space when they can otherwise stay closely
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around the edge of the arena (Chapter 2). The same numbers for each cohort used
for the EPM were used for the OF (Table 6.1).
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Figure 6.4: OF - Number of visits to each zone across cohorts. A barchart illustrating
the number of visits into each predefined zone of the OF across the groups. There was no significant
difference between the three cohorts. Error bars represent SEM.
All of the mice displayed standard behaviour, that remained consistent across the
three groups of mice. However TG mice showed a trend, where they visited each
zone less frequently on average compared to both WT and NON-TG mice. Despite
the trend it was not statistically significant (Figure 6.4).
The three cohorts conformed to the expected paradigm regarding the duration of time
they would spend in the various zones. All three displayed the expected thigmotaxis
behaviour (tracking around the edge of the OF box in the outer zone), by spending
6 times as long in the outer zone compared to each of the other zones (inner and
middle). Similarly all three cohorts travelled 3 times as far in the outer zone compared
to each of the other zones (Figure 6.6).
The OF further confirmed the findings of the EPM. There were no ascertainable
differences in anxiety related behaviour between the genotypes. There were the
expected natural variations across the groups and the standard responses to the
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Figure 6.5: OF - Duration of time spent in each zone across cohorts. A barchart showing
the duration of time each cohort spent within each zone of the OF. There was no significant
difference between any of the groups. Error bars represent SEM.
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Figure 6.6: OF - Total distance travelled in each zone across cohorts. A barchart showing
the total distance travelled by each cohort within each zone of the OF. There was no significant
difference between any of the groups. Error bars represent SEM.
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tests indicating that the tests themselves were appropriate. This suggests that any
behavioural differences that are seen are unlikely to be linked to an underlying
anxiety phenotype.
Locomotor Activity - LMA
The LMA task revealed that across the three cohorts all the animals exhibited the
expected habituation phenotype over the course of the three days of testing. This
was obvious due to the significant reduction in activity over time, represented by the
number of breaks (Figure 6.7, F1, 47 = 47.40, p-value < 0.001) and the number of
runs (Figure 6.8, F1, 47 = 24.92, p-value < 0.001).
When comparing between the genotypes, it was seen there was no difference between
the number of runs for WT (n = 19), TG (n = 12) and NON-TG (n = 17) mice
on day one (F2, 48 = 0.77, p-value = 0.47) and similarly on day three (F2, 48 = 1.00,
p-value = 0.37). This pattern continued for the number of breaks performed by all
three genotypes on day one (F2, 48 = 0.85, p-value = 0.43) and day three (F1, 47 =
0.26, p-value = 0.78). Summarised in Figure 6.7 and Figure 6.8.
Further analysis of the LMA sessions that looked at the entire 120 minute session
by breaking it down into 5 minute bins for the number of breaks (Figure 6.9) and
runs (Figure 6.10) over the duration of time that the test was running on each day.
This confirmed that both breaks and runs declined across time bin for day 1 and day
3. There was no significant difference (p-value > 0.05) between the three genotypes
in the number of breaks on day 1 and day 3. Furthermore there was likewise no
significant difference (p-value > 0.05) between WT, TG and NON-TG regarding the
number of runs on day 1 and on day 3. This indicates that neither TG or NON-TG
mice display altered locomotor reactivity to a novel environment, and that their
behaviour is analogous to WT subjects in the same situation.
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Figure 6.7: Number of Breaks Performed during LMA Task. Basic barchart illustrating
that there is no significant difference in the number of breaks performed between the three cohorts.
There was a significant difference across the days with the number of breaks reducing by over half
for all three genotypes between day 1 and day 3. Error bars represent SEM. Statistical significance:
***p < 0.005.
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Figure 6.8: Number of Runs Performed during the LMA Task. Basic barchart illustrating
that there is no significant difference across the three cohorts. There was a significant difference
between days with the number of runs halving for all three genotypes between day 1 and day 3.
Error bars represent SEM. Statistical significance: ***p < 0.005.
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(a) Locomotor Activity Breaks Day 1 - In 5 minute Bins.
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Figure 6.9: LMA Breaks between Day 1 and Day 3 in 5 minute Bins. (a) Graph
depicting the number of breaks over day 1 broken down into 5 minute bins. (b) Graph depicting the
number of breaks over day 3 broken down into 5 minute bins. There was no significant difference
between the cohorts. Error bars represent SEM.
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Acoustic Startle Response and Pre-pulse Inhibition - ASR
and PPI
The ASR and PPI assays assess a subject’s ability to filter out the unnecessary
information. Deficits in this ability have been linked to abnormalities in sensorimotor
gating and have been noted to occur in human patients suffering from schizophrenia
and Alzheimer’s disease (Braff et al., 2001, Ueki et al., 2006) and subsequently
modelled in rodents (Powell et al., 2009, van den Buuse, 2010).
To test these responses each mouse was securely placed in the tube so there was
no room for residual movement during the test. The findings showed there was an
overall effect of trial number on the Vmax startle response for all three genotypes
at 105 dB (F1, 11 = 3.18, p-value = 0.024). There was no interaction between trial
number and genotype, suggesting that genotype had no effect upon Vmax startle at
105 dB (Figure 6.11).
The same was the case for the trials at 120 dB (Figure 6.12), there was an effect of
trial number with ASR decreasing across the trials as habituation occurred (F1, 11 =
8.65, p-value < 0.001), there was also a significant interaction between genotype and
trial (F1, 11 = 1.85, p-value = 0.05). This was driven by the heightened response to
the 120 dB startle of the TG mice at the beginning of the test (p-value = 0.05).
When assessing PPI at both 105 dB and 120 dB there were a series of pre-pulses
at either 4 dB, 8 dB and 16 dB. The test indicated that there was no significant
blunting of the responses of either of the three cohorts based on any of the pre-pulses
(Figure 6.13 and Figure 6.14).
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Figure 6.10: LMA Runs between Day 1 and Day 3 in 5 minute Bins. (a) Graph depicting
the number of runs over day 1 broken down into 5 minute bins. (b) Graph depicting the number of
runs over day 3 broken down into 5 minute bins. There was no significant difference between the
cohorts. Error bars represent SEM.
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Figure 6.11: Acoustic Startle Response - 105 dB. Barchart illustrating that there is no
significant difference across the three cohorts. Error bars represent SEM.
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Figure 6.12: Acoustic Startle Response - 120 dB. Barchart illustrating the heightened
response to the 120 dB startle of the TG mice compared to WT mice (p-value = 0.05). Error bars
represent SEM.
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Figure 6.13: Prepulse Inhibition - 105 dB. Barchart illustrating that there is no significant
difference across the three cohorts in the PPI of the mice at 105 dB. Error bars represent SEM.
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Figure 6.14: Prepulse Inhibition - 120 dB. Barchart illustrating that there is no significant
difference across the three cohorts of the PPI of the mice at 120 dB. Error bars represent SEM.
203
Hugo Creeth Results
Lick Cluster Analysis - LCA
The LCA is used to assess the hedonic response of the mice. It was performed after
animals were trained to consume freely available 8% sucrose for 30 minutes after 12
hours of food deprivation. Only when individuals had shown stable consumption
for at least two days were they used for the testing phase. There was no dropout
from the mice during training. The exact numbers of mice used for the LCA for each
cohort can be seen in Table 6.1.
The lick cluster analysis had several measures that were able to be taken throughout
the test these are summarised in (Table 6.2) below:
Table 6.2: Lick Cluster Analysis Measures
LCA Measure Abbreviation
Consumption C
Total Licks TL
Total Bouts TB
Lick Cluster Size LCS
Total Bout Time TBT
1 Lick Bouts 1LB
Average Inter-Lick Interval ALI
Total Volume Consumed TVC
There was a significant effect of sucrose concentration on the consumption (F2, 37 =
4.49, p-value = 0.041) that was independent of genotype. There was no difference in
the TL between the two test solutions (F2, 37 = 1.89, p-value = 0.178) and similarly
no effect of genotype on TL (F2, 37 = 0.91, p-value = 0.41).
The measure that is most important when distinguishing between hedonic response
is the Lick Cluster Size (LCS). The overall pattern of consumption for both test
concentrations indicated increased palpability of the 16% solution compared to the
4% solution as can be seen in Figure 6.15.
This led to a significant increase in the LCS for all three cohorts (WT, TG and
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Figure 6.15: Consumption at 4% and 16% Sucrose. Line graph demonstrating distinct
differences between the volume consumed by the groups for the two different concentrations of
sucrose. Error bars represent SEM. Statistical significance: *p < 0.05.
NON-TG) with the main effect being solution (F2, 37 = 7.41, p-value < 0.05). There
was also a significant effect of genotype on the LCS (F2, 37 = 8.30, p-value = 0.007).
This was driven by the decreased LCS of the TG mice at the 4% sucrose solution
compared to WT mice (p-value = 0.001) as well as at the 16% solution (p-value
= 0.033). This difference was diminished in the wildtype NON-TG litter mates
when compared to the TG mice at 4% (p-value = 0.146) and 16% (p-value = 0.073)
solutions. There was a difference between WT and NON-TG mice at 4% sucrose
(p-value = 0.025) that wasn’t evident at 16% sucrose (Figure 6.16).
A second test was performed using 0.1% saccharin solution in order to determine
whether there was any form of calorie seeking behaviour evident amongst the three
cohorts of mice. This showed that there was also a difference between the cohorts
LCS for saccharin (F2, 37 = 10.35, p-value < 0.001). This was due to the dramatic
reduction in LCS for TG mice relative to WT mice (p-value < 0.001) and also the
difference between WT and NON-TG mice (p-value = 0.01), Figure 6.17. There
was a notable difference between the Average Inter-Lick Interval (ALI) of the TG
mice compared to WT and NON-TG mice (p-value = 0.045 and 0.036 respectively).
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Figure 6.16: LCS at 4% and 16% Sucrose. Line graph demonstrating distinct differences
between the LCS for the two different concentrations of sucrose. Error bars represent SEM.
Statistical significance: *p < 0.05, **p < 0.01, and ***p < 0.005.
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Figure 6.17: LCS for 0.1% Saccharin. Line graph demonstrating distinct differences between
the hedonistic response between the groups regarding number of licks per bout for 0.1% saccharin
solution. Error bars represent SEM. Statistical significance: *p < 0.05 and **p < 0.01.
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Suggesting that TG mice take significantly longer between each lick than both WT
and NON-TG mice.
6.2.3 Gene Expression Analysis of Ventral Stria-
tum and Hypothalamus
For each cohort of offspring the RNA was extracted and the ng/ml values for the
total RNA per µl checked. There was an n = 6 in each for each group. qPCR of the
Ventral Striatum (VS) and hypothalamus was performed; analysing the expression
levels of some opioid (Oprd1, Oprk1 and Oprm1 ) receptors associated with hedonistic
response in mice. Levels of some similarly associated dopamine receptors (Drd1,
Drd2 and Drd5 ) and the dopamine transporter (Dat or Slc6a3 ) were assessed in the
VS.
The VS showed that there was no significant fold changes in any of these genes for
either TG or their NON-TG littermates. Drd1 appeared to show a 50% decrease in
the TG mice and also a 25% decrease in the NON-TG mice, however this was not
significant (Figure 6.18).
Analysis of the hypothalamus for opioid receptor differences revealed no changes in
their levels of expression for either TG or NON-TG mice (Figure 6.19).
6.3 Discussion
The basic characterisation of behaviours for the three offspring cohorts in this chapter
indicated that there were no differences between the groups for the EPM, OF, LMA
assessment, PPI and ASR assays. The major discovery was that the LCA test
assessing hedonic response in the offspring highlighted a distinct phenotype in both
207
Hugo Creeth Discussion
0.0	
0.5	
1.0	
1.5	
2.0	
2.5	
Oprd1 Oprk1 Oprm1 Drd1 Drd2 Drd5 Dat 
Fo
ld
 C
h
a
n
g
e
 
TG 
NON-TG 
Figure 6.18: qPCR of Ventral Striatum. Bar chart showing the fold changes of opioid and
dopamine receptor genes for the TG and NON-TG mice compared to WT in the ventral striatum.
Error bars represent SEM.
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Figure 6.19: qPCR of Offspring Hypothalamus. Bar chart showing the fold changes of
opioid receptor genes for the TG and NON-TG mice compared to WT in the hypothalamus. Error
bars represent SEM.
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the TG and NON-TG mice. Both the TG and NON-TG mice had a smaller LCS in
comparison to WT mice, suggesting that both these groups had a reduced hedonic
response when directly compared to WT offspring. The qPCR analysis that looked
at the expression of key genes known to be associated with deficits in the behaviours
assessed, showed no significant changes in of the dopamine or opioid receptors tested.
Behavioural and Biomolecular Findings
The EPM and OF both confirmed that the groups of mice responded normally
throughout the tests. The lack of any significant findings regarding any abnormal
anxiolytic or anxiogenic behaviour within the cohorts meant that any differences
that were observed, for example how TG mice tended to move farther in the open
arm of the EPM, were down to the natural variation seen between the mice. The
LMA indicated that TG and NON-TG mice were not compromised in relation to
their basic motor function. This is interesting as in previous studies IUGR has been
known to lead to locomotor deficits (Bellinger et al., 2006, Curley et al., 2009). This
data implies that an aberrant placenta, which leads to IUGR and altered maternal
care postnatally doesn’t impact upon the locomotor development of the offspring.
Similarly the PPI assay, which assessed the mice’s ability to filter out irrelevant
information showed no deficits in any of the groups.
The PPI and ASR are sensitive to neuronal levels of dopamine. Rodents and
humans possess an involuntary motoric response to an unexpected acoustic noise
or startle. The response is blunted when the pulse is preceded by a pre-pulse that
does not evoke a response by itself (Groves et al., 1974). The reduced ability to show
inhibition to a startling acoustic noise that is preceded by a quieter pre-pulse, is one
characteristic of a hyper-dopaminergic state in humans (Hutchison and Swift, 1999)
and rodents (Ralph et al., 2001). As a result it has been shown that D1 and D2
receptor antagonists decrease the percentage inhibition of rodents (Swerdlow et al.,
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2005).
Anhedonia is the diminished ability to experience pleasure and is a common symptom
in both schizophrenia and depression (American Psychiatric Association et al., 2013).
It is also linked to the dopaminergic system which is intricately associated with
motivation and reward (Wise, 2008, Wise and Rompre, 1989). The development
of the LCA test has meant that it is possible to generate quantitative data that
relates to the animals hedonic response to a palatable solution that is independent of
consumption volume. Two-bottle choice tests have previously been used extensively
in the literature in order to help categorise and understand “pleasure” in rodent
models. The test predominately focusses on the animals preference for the two bottles
of different solutions. Typically however the assay works on the basis of consumption,
where total consumption of a solution is taken to relate to the palatability (Drew et al.,
2007, Hajnal et al., 2004, Vucetic et al., 2010). These approaches have been criticised
however due to the inverted-U shaped function of palatability confounding the results
(Dwyer, 2012). Another method that has been used, to avoid this confusion, is the
study of orofacial movements during consumption (Faure et al., 2010, Peciña et al.,
2003, Shin et al., 2011). The benefits of this method is that it can reliably inform
on the animals hedonic response, however it is more technically challenging in mice
than in rats where the test was first established and is open to subjective analysis.
The LCA test works by exploiting the known phenomenon that rodents will freely
consume palatable solutions, such as sucrose, in a predictable way over a course of
time (Dotson and Spector, 2005, Lin et al., 2013). When the animal is presented with
a solution, its pattern of licks is made in a group, burst or “cluster”. The size of these
clusters are indicative of the palatability of the solution. As concentration increases
so to does the number of licks per cluster, resulting in a linear increase so avoiding
the inverted-U problem described earlier and providing an accurate, quantifiable
and reliable way to determine the hedonic state of rodents Dwyer (2012), Dwyer
et al. (2009), Wright et al. (2013), Yoneda et al. (2009). In our cohorts there was an
obvious difference in palatability of the 16% sucrose solution compared to the less
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concentrated 4% sucrose solution with all three cohorts consuming more of the more
concentrated (16%) sucrose solution. This corresponded to an increase in LCS for all
three cohorts indicating a heightened hedonic response to the sweeter solution and
ultimately showing that all three cohorts prefer the 16% solution. Crucially there
was a significant effect of genotype on the LCS. TG mice had a smaller number of
licks per cluster for both 4% sucrose and 16% sucrose compared to WT mice, an
effect that was also evident at 4% sucrose for the NON-TG cohort of mice. The
latter observation indicates that the overall hedonic responses of both cohorts are
likely to be programmed through a combination of genetic and environmental factors.
The lack of motor dysfunction exhibited by the three cohorts in the LMA suggests
there is unlikely to be a difference in motor speed contributing to the reduced LCS
and consequently licking speed between the groups. This would need to be confirmed
however, in a test more explicitly looking at the motor ability of the orofacial muscle
ands movements.
The lack of increased preference between the two concentrations of sucrose in the
WT mice was unexpected and was problematic for the analysis. In developing
this test Dwyer (2012) highlighted that that the learned preference between the
test concentrations of the solutions should be a clear indicator that the test itself
worked. This work is focussed predominately on rats (Dwyer et al., 2009, Lydall
et al., 2010). Therefore it is likely that this issue was due to standardised ceiling
effects in the mouses ability to lick faster in the given time. The saccharin assessment
was ultimately used in this case to show the linear difference in preferences between
the three groups to a palatable solution. If this was to be performed again it would
be important to include more sucrose concentrations to confirm these suspicions.
The intimate link between the dopaminergic system and both hedonic response and
pre-pulse inhibition meant that genes involved with this system were investigated.
There are two main families of dopaminergic receptors. These are known as D1
and D2, and are based on their members structural similarities and intracellular
messengers. DRD1 and DRD5 make up the D1-like group and couple to Gα s intra-
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cellularly, increasing cAMP levels (Dearry et al., 1990, Zhou et al., 1990). Whilst
DRD2, DRD3 and DRD4 make up the D2-like group. D2 receptors couple to Gα
intra-cellularly, decreasing cAMP levels (Sokoloff et al., 1990). DRD1 and DRD2 are
the most abundantly expressed dopaminergic receptors in the human brain (Hurley
and Jenner, 2006). DRD1 and DRD2 receptors differ in their binding capacity for
dopamine. DRD2 has a greater affinity for dopamine compared to DRD1 (Baik,
2013). This introduces flexibility in the dopaminergic system. As different receptors
are activated depending on whether firing is phasic or tonic.
qPCR analysis didn’t highlight any significant changes in D1 or D2 receptors (specif-
ically Drd1, Drd5 and Drd2 ) and the Dat in the ventral striatum of the brains of the
TG or NON-TG offspring compared to the WT mice. It did raise some interesting
questions regarding the mechanisms controlling the altered behaviour displayed by
both TG and NON-TG mice in the LCA and lack of behavioural changes in the
other behavioural tests.
Dopamine has often been associated with reward processing, predominantly through
evidence from drug and genetic studies in humans and model organisms. Berridge
(2009) theorised that dopamine has a role in the incentive salience of a reinforcer, but
not necessarily the hedonistic response to it. In adult rats viral over expression of Drd1
in prefrontal dopaminergic neurons results in an increase in sucrose and saccharin
preference plus an improved motivation to work for cocaine in a progressive ratio
task (Sonntag et al., 2014). Whilst D2 receptors have been linked to food addiction
(Baik, 2013). It followed that these receptors could be critical in distinguishing
the behavioural responses of TG and NON-TG mice have to either sucrose and
saccharin. The lack in differences between these dopamine receptors supported
previous findings that Drd1 is not involved in the hedonistic response and explains
the lack of differences between the cohorts in the PPI and ASR tests. Therefore it is
possible to say that the behavioural phenotype observed in TG and NON-TG mice
is likely independent from the dopaminergic system and supports the findings of the
saccharin test that the phenotype is not based upon calorie seeking behaviour.
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Additionally we also looked at the potential role of the opioid system in the observed
behaviours. The opioid system is synonymous with addiction, pain and reward
(Dickenson, 1991, Wise, 1996). It has also been linked to emotionality and mood
disorders (Filliol et al., 2000), which in turn effect the success of bonding and social
attachment between the mother and infant (Curley, 2011, Higham et al., 2011). The
opioid system is mediated by the opioid receptors, specifically µ, δ and κ receptors.
KO models of these receptors have identified specific roles (Filliol et al., 2000, Matthes
et al., 1996, Simonin et al., 1998). Moles et al. (2004) identified that µ-opioid receptor
knockout mice pups had a possible attachment deficit as they emit fewer distress
vocalisations than WT mice when separated from their mothers. It follows that the
behavioural phenotype identified in this chapter, which is one measure of mood and
emotionality in mice may be a result of a deficit in these receptors. The results
of the qPCR analysis of these 3 opioid receptors in the hypothalamus showed no
significant changes in levels of expression of any of these receptors. This suggests that
the mechanism that underlies the behavioural phenotype needs further assessment.
Although this initial analysis didn’t indicate any changes in the opioid receptors they
can’t be ruled out as a potential mechanism for the behavioural phenotype, thus it
would be appropriate to look at them in other brain regions and at protein level.
Caveats
Animal models are, or at least have been, key tools in the studying the biological
mechanisms that underpin many psychiatric disorders and have aided in the develop-
ment of clinically effective treatments (Lewis and Lieberman, 2000). Despite this
there has also been much debate about whether they are truly useful (McArthur
and Borsini, 2006). Perhaps the major concern with regards to psychiatric research
using mice is whether emotionality can be behaviourally assessed affectively. Several
experimental models of depression, for example those focussing on chronic stress,
result in reduced sucrose consumption (Kompagne et al., 2008, Rygula et al., 2005).
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This supports the idea that sucrose consumption has surface validity when looking at
anhedonia. The mice were re-housed in a previous rat room, in a situation that was
out of our control for the duration of the behavioural testing. This may have induced
stress that confounded our results. The fact that we still observed a significant
change in the LCA in the NON-TG and TG mice and not in the other tests makes
this test result valid. In order to fully validity it would be important to perform
these behavioural assessments again in a less stressful environment.
Conclusion
The findings of this chapter have offered evidence that the non-genetic maternal
care phenotype described in chapter 4 and the biomolecular changes which likely
contribute to the maternal behavioural phenotype described in chapter 5 have lasting
consequences on the behavioural trajectory of the offspring. The research presented
points to two major causal factors behind the offsprings behavioural phenotype, it
indicates that either the shared in utero environment or post natal care influences
this area of development. The research however does not allow for these two factors
to be deciphered between as the main contributor and due to the phenotype of the
NON-TG mice it is possible to be a combination of the two. In order to be able
to distinguish between the postnatal care phenotype or the in utero environment
phenotype it would be important to carry out some cross fostering studies on the
pups.
Summary of Findings
• Neither the EPM and OF assays uncovered a group specific anxiety phenotype.
• PPI and ASR were no different between the groups.
• LCA identified a specific group effect in hedonic response to 4% and 16%
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sucrose in the TG mice compared to WT mice.
• NON-TG litter mates also displayed a reduced hedonic response with 4%
sucrose in the LCA test compared to WT mice.
• The LCA of 0.1% saccharin confirmed the findings by identifying differing
responses to this solution that mirrored the responses of all the groups at 4%
sucrose. TG mice had the greatest reduction in LCS compared to WT mice
and then NON-TG mice.
• qPCR analysis of dopamine receptors and opioid receptors in the ventral
striatum showed that these genes were not significantly altered in expression.
• Similarly qPCR of the hypothalamus showed no genotype specific changes in
gene expression of the opioid receptors.
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7General Discussion
The placenta is fundamental in maintaining the pregnant state in mammals and
serves numerous roles in ensuring that the appropriate physiological and behavioural
adaptations occur in the mother throughout pregnancy and in preparation for birth
(John and Hemberger, 2012). It expresses many imprinted genes whose altered
expression are associated with various developmental phenotypes in the offspring
including LBW and IUGR (Bressan et al., 2009, John, 2013, Tunster et al., 2013).
The elevated expression of the imprinted gene Phlda2 has been shown to result in
the asymmetric late fetal growth restriction of mice and regulate extra-embryonic
energy stores (Tunster et al., 2010, 2014). Understanding the role Phlda2 has in
modulating the SpT endocrine lineage of the mouse placenta (Tunster et al., 2015,
2016) was instrumental in the development of the hypothesis that: “The placenta
plays a vital in the development of the maternal instinct via this key endocrine
compartment and this is modulated by an imprinted gene”. The key discoveries from
each chapter during this study are summarised in the tables at the beginning of each
section. These findings have answered questions concerning this hypothesis and also
raised several questions that are discussed in the following pages.
Hugo Creeth Placental Endocrine Lineage Analysis
7.1 Placental Endocrine Lineage Anal-
ysis
Key Findings (Chapter 3)
• Phlda2 acts exclusively to constrain the expansion of the
SpT compartment of the mature mouse placenta.
• Phlda2 negatively regulates the expression of a number of
key placental hormones, including the Prls.
• ELISA analysis of levels of the Prls and prolactin were
inconclusive, but both did show an increase in the blood of
WT(KO) dams.
This chapter describes the role Phlda2 plays in regulating the SpT lineage and the
SpT’s role in modulating the Prls. The evidence that the imprinted gene Phlda2 has
this specific function and that this directly impacts the levels of a key set of hormones
that are known to play roles in the maternal adaptations to pregnancy. Some of
which bind directly to the Prlr, this begs the question whether other imprinted genes
may play a similar role? Recent research by Tunster et al. (2016) has identified
another maternally expressed gene, Ascl2, within the same mechanistically distinct
imprinted domain that acts on the SpT. This takes the number of genes identified
by the John lab acting on the SpT to three, Phlda2, Ascl2 and Cdkn1c. Phlda2 and
Ascl2 repress the expansion of this lineage (Figure 7.1) whilst Cdkn1c is required
for this lineage to develop normally (Salas et al., 2004, Tunster et al., 2015, 2010,
2011, 2014). These findings, combined with numerous experiments highlighting a
role for lactogenic hormones and the Prlr in programming maternal care in rodents
(Bridges and Freemark, 1995, Bridges et al., 1990, Lucas et al., 1998, Walker et al.,
2012), suggested that imprinted genes expressed in the placenta might regulate the
extent to which dams care for their young.
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Figure 7.1: Ascl2 and Phlda2 Expression. Schematic summarising the cell autonomous and
non-cell autonomous functions of Phlda2 and Ascl2 on the SpT. Taken from Tunster et al. (2016).
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7.2 Maternal Behavioural Characteri-
sation
Key Findings (Chapter 4)
• Altered Phlda2 expression in the fetal placenta leads to
abnormal pup retrieval and nest building in WT dams.
• Altered Phlda2 expression in the fetal placenta disrupts
normal circadian nesting and feeding behaviour WT dams.
The results of the maternal behavioural characterisation defined a distinct behavioural
phenotype across the three cohorts. The behaviours that were altered depended on
the tests that were used and the interpretation of the results. In some respects the
initial tests used were basic, however it was necessary to first establish whether there
were alterations in mothering behaviours in mice and rodents in general (Deacon, 2006,
Franks et al., 2011). The traditional measures of maternal behaviour postnatally,
such as pup retrieval and nest building are considered informative in relation to
the mechanisms of maternal behaviour (Gammie, 2005). Therefore these tests were
considered the appropriate starting point for this study. They have previously been
used in genetic and non-genetic models looking at maternal behaviours in mice and
rats. Stressed dams have been shown to retrieve their pups more rapidly and be
very aggressive towards an intruder compared to non-stressed dams (Meek et al.,
2001). Whilst studies on a mouse model of the Oxtr reported that these dams took
longer to retrieve pups (Takayanagi et al., 2005). It is important to discuss the strain
differences that are known between mice laboratory mice. Champagne et al. (2007)
investigated differences in the maternal behaviours of 129, BL6 and Swiss mice using
very similar protocols that were implemented during this study (Figure 7.2). There
significant differences in baseline behaviour between the three strains that were tested.
It was noted that 129 mice didn’t show any decline in normal levels of postpartum
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care for the first 6 days after parturition (Champagne et al., 2007). This was key to
the decision to perform the testing within the first week after birth on the 129 mice.
BL6 and Swiss mice both show a decline in normal care in the first 6 days after birth.
Understanding strain differences is therefore important when interpreting data on
maternal care and choosing when to perform specific tests. Pseudopregnant mice can
display maternal nest-building behaviour, however their nests tended to be smaller
but qualitatively identical to those constructed by pregnant animals (Gandelman
et al., 1979). This raises issues concerning how certain we can be regarding the extent
of the influence of the placenta in initiating this behaviour. It would therefore be
beneficial if this research was repeated to perform the assessments on WT dams
and also pseudopregnant females. Similarly, although care was taken to minimise
confounding factors in the pup retrieval task and nest building, by accounting for
litter size and modifying the original nest building protocol described by Deacon
(2006), it would be useful to assess the general quality of nests longitudinally over
the entire pregnancy period. Some studies have similarly combined the two maternal
behavioural tests and used more pups for the pup retrieval task. Champagne et al.
(2007) scattered three pups and original nest building material within the home cage
on the day of birth and scored the success of both retrieval and nest building.
Voci and Carlson (1973) showed that prolactin and progesterone infusions improved
nest building behaviour. The prediction that was originally formulated based on
research into prolactin, specifically work by Voci and Carlson (1973) and Bridges
and Freemark (1995), was that dams possessing a placenta that showed a higher
expression of Prls and therefore posessessing theoretically greater placental signalling
(WT(KO) dams) would be “better”, and display a more developed maternal instinct
than those dams with a WT or TG placenta. The findings of the pup retrieval and
nest building demonstrated that on the surface WT(KO) dams displayed behaviour
that was contrary to what was anticipated, by building nests less and retrieving pups
slower than both other cohorts.
Upon taking a closer look at the Ethovision data and video recordings it became
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clear it was necessary to further explore the maternal phenotypes and look at the
grooming, feeding and general nurturing behaviour in each of these cohorts both
within a specific test period and over the course of the assessment. Meek et al.
(2001) reported that stressed dams raising stressed pups exhibited high levels of
nursing and grooming. Therefore the discovery that the WT(KO) dams showed a
similar phenotype during the nest building task, may imply that these mice have
a predisposition to stress or may possess an anxiety phenotype. Unfortunately
the EPM was inconclusive and therefore it would be necessary to perform a more
thorough characterisation of the anxiety profile of these mothers, pre- and post-
natally. Despite this it became clear that WT(KO) dams presented a more pup
focussed nurturing phenotype compared to WT(TG) dams that carried out the more
basic maternal behavioural tasks similarly well, or better than WT(WT) dams.
As previously mentioned infusion of prolactin decreases the latency to initiation
of maternal behaviour in steroid-primed rats (Bridges et al., 1990). The increased
signalling of the Prls from the WT(KO) dams placenta may be an example of the
decreased latency for mothers to initiate postpartum care. This evidence demonstrates
the importance of utilising several behavioural assays and observations to fully
understand the behaviours of a mouse model. It demonstrated that dams can
prioritise behaviours dependent on their environment (Aubert et al., 1997), or that
hormones help differentially prime specific behaviours. The decision to perform
these maternal behavioural tests and observations between PND 2-4 was based
around previous studies that used this time period. Other studies that have observed
differences in maternal care behaviour have looked at later timepoints or more
prolonged stages and daily manual scoring (Champagne et al., 2007, Chourbaji et al.,
2011). This would be something that could be worth investigating, through the
use of Ethovision tracking and videoing longitudinally. This would prove useful in
stopping any bias or disruption caused by the observer entering the room to score
manually, and potentially skewing the results.
Perhaps two of the main questions that come to light from this study are: (1) is
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Figure 7.2: Mouse Strain Differences in Maternal Behaviour. Pie charts demonstrating
the strain differences between 129, BL6 and Swiss mice. Adapted from Champagne et al. (2007).
maternal behaviour a direct result of the pregnancy and aberrant placenta? (2) Or
does the pups genotype have a consequence upon the behavioural outcomes of the
dams? In the study by Takayanagi et al. (2005), infant Oxtr KO males emitted fewer
ultrasonic vocalisations than wild-type litter mates in response to social isolation.
This presented the idea that the transgenic offspring in this study may potentially
have vocal deficits that could result in differential maternal nurturing behaviour.
The developmental findings of the offspring outcome study (Chapter 6) offer some
evidence that there are no motor or anxiety deficits in TG pups. They are initially
growth restricted, which may illicit a different response from the dams. The KO
pups have not been behaviourally characterised within this research and this would
be important to assess. An effective way to test whether the pups genotype plays a
role in the observed maternal behaviour would be to perform a cross fostering study.
This would allow dams to foster pups of different genotypes postnatally after being
exposed to a different placenta during gestation and the results collected. Meek
et al. (2001) performed a cross fostering study during their research and this helped
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distinguish the effects of the maternal phenotype as well as the effects upon the
offsprings development.
It is possible that the varying levels of Prls may impact upon the lactation of
the dams. Prls are known to be important in mammary development and milk
production helping to maintain lactation after it has been initiated by prolactin
(Flietstra and Voogt, 1996). The suppression of prolactin by bromocriptine rapidly
causes a reduction in milk secretion (Forsyth and Wallis, 2002). Src KO mice show a
failure in milk secretion but not mammary development due to a failure in expression
of the Prlr and subsequent downstream signalling (Watkin et al., 2008). The role
that the Prls play in maintaining lactation make it plausible that milk secretion
and/or milk quality may be affected. This could potentially explain the reduced
nursing behaviours exhibited by the WT(TG) dams, which are thought to have
reduced levels of Prls. The fact that the offspring don’t differ in weight after catch
up from the IUGR, may suggest this not to be the case. Behaviourally, a cross
fostering study would help decipher any lactation differences; physiologically, the
mammary glands should be fully appraised and milk quality tested for each of the
cohorts of dams using whole mounting and oxytocin induced milk ejection followed
by the appropriate biomolecular assays (Plante et al., 2011). If less prolactin and
Prls are transferred to the offspring could this impact on the offsprings development?
Prolactin has been shown to be involved in the development of neuroendocrine,
immunological and reproductive systems of the young (Melo et al., 2009). Melo et al.
(2009) showed that deficiency in prolactin intake during development of female rats
negatively affected the maternal care provision they provided when they themselves
became mothers. This would be interesting to assess in the female offspring from
this study. Future experiments to address the issues highlighted in this section could
involve the use of the newly available Prlr conditional KO (Brown et al., 2016).
Using the Prlr conditional KO to attempt to restore maternal care through the
genetic normalisation of signalling via the Prlr would allow us to determine the
extent to which placental Phlda2 regulates maternal care via the maternal Prlr.
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7.3 Maternal Biomolecular Character-
isation
Key Findings (Chapter 5)
• Microarray analysis highlight distinct global differences in
gene expression levels between the three cohorts of dams in
both the hippocampus and the hypothalamus at E16.5.
• Altered placental Phlda2 expression leads to changes in
gene expression in maternal brain.
• Altered placental Phlda2 expression leads to changes in
maternal neurogenesis.
• HPLC analysis showed no significant differences in neuro-
transmitter levels or in there metabolites across the three
groups at E16.5.
The maternal biomolecular chapter identified changes in the maternal brain that
preceded the behavioural changes identified (Chapter 4). The microarray analysis
highlighted distinct differences in many of genes between the three cohorts with
genes that were up regulated in the WT(TG) brains and down regulated in the
brains of WT(KO) and vice versa. These differences led to a more detailed look at
the pathways linked to the gene changes seen in the hypothalamus and hippocampus
across the groups. The hypothalamus showed an enrichment in Olfr genes, that were
involved in olfactory transduction. Previous work by Del Punta et al. (2002) has
linked a cluster of the vomeronasal receptor genes to a deficit in pheromone responses
by mice. Pheromones themselves have been linked to increased neurogenesis and
improved maternal care in mice (Larsen et al., 2008). The fact that there are
hundreds of Olfr’s that have no known ligands, begs the question whether any of
these receptors have a role in a similar pathway or whether they are not relevant
at all (Zhang and Firestein, 2002). Are these Olfr’s ultimately responding to the
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pheromones of the pups causing the dams to respond in different ways with their care
towards the offspring? It was an initial surprise that these receptors were present in
the hypothalamus, however there is an established link between the olfactory system
and the hypothalamus with projections from the olfactory bulb branching into the
hypothalamus (Yoon et al., 2005).
The hippocampal gene expression highlighted genes that were associated with be-
havioural disorders, including schizophrenia and feeding behaviour, as well as some
linked to the dopaminergic and serotonergic system. These key genes appeared to
be down regulated in both the WT(TG) and WT(KO) conditions in comparison to
the WT(WT) dams. This was confirmed through qPCR indicating that the gene
expression patterns are seemingly not associated with gene dosage relationships. We
know that placental hormones are produced by offspring, but act on receptors of
mothers. As such, placental hormones and maternal receptors are prime candidates
for the expression of parent-offspring conflict (Haig, 1993, 1996). Prolactin-dependent
signalling occurs as the result of ligand-induced dimerisation of the Prlr. Several alter-
natively spliced transcript variants encoding different membrane-bound and soluble
isoforms have been described for the Prlr gene, which may function to modulate the
endocrine and autocrine effects of prolactin in tissues, including the brain. Prolactin
(like GH) has two separate binding sites, the first has a high affinity, the second
site has a low affinity for the Prlr. These sites each interact with a Prlr forming a
functional receptor dimer that activates a signalling cascade (Freeman et al., 2000,
Langenheim et al., 2006). The pathways include the Ras/Raf/MAPK kinase/Erk (Das
and Vonderhaar, 1996) and phosphatidylinositol 3-kinase/Akt signalling pathways.
It is through these pathways that the Prlr induces cell differentiation, proliferation
and survival (Shillingford et al., 2002). Once the first site has bound it initiates the
binding of the second site, when a disruptive mutation of prolactin binding site 2 was
investigated, it stopped Prlr activation. This is because the Prlr only becomes active
when the trimeric complex forms (Bole-Feysot et al., 1998, Goffin et al., 1996). This
understanding has given rise to the idea that perhaps the gene expression profiles
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exhibited in the cohorts may be a result of a “bounce back” effect. If this were the
case it would give a reason for both the inverted U and U profiles. More explicitly
this may be explained through promotor occupancy, when there is a low amount of
Prls in the system then the Prlr is not activated as much. In contrast, as the levels
of Prls increase, activation of the receptor increases. Theoretically therefore if levels
reach a certain threshold then the Prlr’s become occupied by the over abundance of
Prls resulting in the inactivation of the Prlr’s and mimicking the effect of low levels
of the ligands.
A recent study by a group at Cardiff University investigating steroid sulfatase
deficiency as a means to understand the brain pathway of PP identified the CCN
family of genes as potential candidates (Humby et al., 2016). NOV/CCN3 was
identified in their study and is interesting due to a number of factors that may
warrant further research in this study. NOV when over expressed is associated
with abnormal maternal behaviour which can be reversed through antipsychotic
administration (Humby et al., 2016). It is known that NOV is located on human
chromosome 8, just below the linkage peak that has been implicated in bipolar
affective disorder and PP (Jones, 2007). Disrupted calcium signalling is linked to
bipolar disorder and PP (Riley and Watt, 1985), the protein encoded by NOV
is involved in calcium signalling (Lombet et al., 2003). It is also a regulator of
angiogenesis in the placenta, as has been shown by its aberrant expression in cases
of pre-eclampsia (Winterhager and Gellhaus, 2014). The findings of this study by
this group looked at whole brain expression levels, which makes the significant up
regulation (p-value = 0.001) of the gene in WT(TG) dams hippocampus interesting
and may offer support to NOV being a key candidate gene in PP.
Through this study we discovered a decrease in BrdU labelled cells within the SVZ
for both the WT(TG) and WT(KO) dams. This was contrasted with the cell counts
in the SGZ for WT(KO) dams, where there was an increase in BrdU labelled cells.
The decrease in positively labelled cells at this stage in the SVZ conflicted with our
prediction that an increase in circulating Prls would cause an increase in maternal
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neurogenesis. Shingo (2003) investigated the levels of neurogenesis at E7.5 and E14.5
followed by P0, P7 and P14. They chose these time points based on the reasoning
that mammals experience a surge in prolactin concentrations during the first half of
pregnancy before they steadily decrease until term, and then rise again postpartum
during lactation (Freeman et al., 2000). This led to Shingo (2003) hypothesising
that due to the Prlr ’s high expression adjacent to the SVZ and in the choroid
plexus of the forebrain, that the Prlr expression could be involved with pregnancy
mediated neurogenesis. Their evidence that neurogenesis decreased 50% at E7.5
in the forebrain of mice with a 50% decrease in the Prlr gene dosage supports the
involvement of the receptor in mediating maternal neurogenesis (Shingo, 2003). They
saw a gradual decrease in BrdU labelled cells onwards from this stage before they
peaked again at P7. Based on there findings it was less surprising that at E16.5 we
didn’t see as higher numbers of BrdU labelled cells as Shingo (2003). The decision
to chose E16.5 as our time point was because it is the period of maximal placental
signalling, with relation to the SpT and the circulating Prls (Soares, 2004). Despite
this E16.5 has failed to be previously regarded, therefore it would probably have
been wise to perhaps assess 129 WT dams and pseudopregnant dams baseline levels
of neurogenesis to gain a fuller characterisation of this phenomenon at this stage.
It is possible the decrease in BrdU cells seen in the WT(KO) dams may be due
to promotor occupancy of the Prlr, thus the decrease in BrdU labelled cells could
be explained through the reduction in signals to the Prlr’s that are mediating
neurogenesis. The next question is whether the cells labelled for BrdU are indeed
new neurons or another type of brain cell such as an astrocyte or glial cell. DCX and
Nestin labelling was performed in separate assays. In this case we saw a reduction in
DCX and Nestin labelled cells in the WT(KO) dams SVZ but not in the WT(TG)
SVZ. DCX labels migrating neurons and Nestin labels neural stem cells. The nearly
50% decrease in both of these cell types at E16.5 suggests that neurogenesis is
reduced.
New neurons can take up to 4 weeks to become functionally active at which point
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the doubling of olfactory interneurons can significantly enhance olfactory function
in mice (Rochefort et al., 2002). Consequently to truly determine the importance
of these differences in neurogenesis would require a longitudinal study to look at
the functional relevance of the new neurons. The use of the Prlr conditional KO
could help with determining the ambiguity of the ELISAs and offer preliminary
support to the hypothesis that the Prls are functionally relevant in mediating the
changes in the maternal transcriptome via signalling through the Prlr in the maternal
brain. A longitudinal study that utilises the Prlr conditional KO would allow for
the assessment what the impact new neurons born during late gestation may have
upon the second pregnancy of these dams.
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7.4 Offspring Outcome
Key Findings (Chapter 6)
• The EPM, OF, PPI and ASR assays didn’t uncover any
behavioural differences between the groups.
• Offspring from WT(TG) mothers showed a decreased hedo-
nic response in the LCA that was partially independent of
genotype.
• The were no changes in gene expression of the opioid or
dopamine receptors in the VS or hypothalamus of either
group of offspring.
The final experimental chapter focussed upon the outcomes of the pups raised by
dams that were exposed to TG placenta. The results showed that the underlying
phenotypic responses were intact between the groups. The key finding was that both
TG and NON-TG litter mates displayed a disturbance in their hedonic responses at
4% sucrose solution in the LCA assay. This was also apparent in the TG offspring
at the 16% sucrose level. Both showed differences in the test using saccharin.
This observation highlighted a distinct non-genetic mechanism to this phenotype,
because NON-TG offspring are genetically WT. It is known that natural variations
in maternal care are often observed between laboratory environments among inbred
and outbred rodents. These natural variations are used as a predictors of offspring
neurobiology and behaviour (Champagne et al., 2007, 2003). This approach has been
more thoroughly explored in rats, but emerging data from studies in mice illustrate
that there are persistent effects on emotionality as a consequence from variations
in maternal care (Coutellier et al., 2009b). Use of systematic and methodological
approaches to observe home cage maternal care toward offspring is essential in studies
examining the direct impact of maternal care on offspring development (Franks et al.,
2011). Our model provided the perfect platform to assess this and try and decipher
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the differential effects that maternal care, genotype and the in utero environment
has upon the offspring.
The mothers in this chapter were not subjected to any behavioural assessments
during this study. This was so that any outcomes displayed by the offspring could be
attributed to the individual differences in baseline maternal nurturing given during
the post partum period before weaning. It should be noted that despite no noticeable
physiological differences between the pups, there is the potential that the behavioural
phenotype displayed by the TG and NON-TG offspring could be a consequence
of the altered genotypes of the TG offspring and not a direct result in maternal
care. The programming effects of altered placental imprinted gene expression on
later life adult behaviour have been demonstrated before for Igf2 (Mikaelsson et al.,
2013). Phlda2 is known to restrict fetal growth (Tunster, 2009, Tunster et al., 2014),
theoretically the TG pups physiological phenotype could have caused the mothers
to react differently toward them and their NON-TG litter mates. This factor was
not controlled for during this study, meaning that using cross fostering would be
required to help determine whether the pup genotypes played a role in developmental
outcomes. It would also be useful to assess levels of vocalisations by the offspring,
as decreased calling has been linked to social isolation in pups (Takayanagi et al.,
2005). Similarly there is some evidence that litter composition can play a role on
the development of the offspring (Crews et al., 2004), therefore it is possible that
litter composition could play a part in maternal development too.
It is possible that the developing fetal brain could have been primed in utero, in
preparation for the external environment occupied by the mother. Prenatal adversity
is a well known phenomenon that results in functional alterations within systems
controlled by imprinted gene dosage, these include metabolic function (Entringer,
2013), fetal growth (Baibazarova et al., 2013, Tunster et al., 2016) and behaviour
(Bale et al., 2010b, McNamara and Isles, 2014). This has formally been reviewed by
Bateson et al. (2004) and in chapter 1. In addition the TG pups suffer from IUGR,
in humans IUGR preterm infants at 16 days display decreased hedonic responding
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to a sucrose solution (Ayres et al., 2012).
Although care was taken to maintain the in cage environments the same for the newly
weaned offspring, there is the possibility that differences in in-cage environments
post weaning could act as a causal factor to the identified phenotype (Tucci et al.,
2006). In particular, it is important to note that before testing and post weaning of
the offspring, there were issues with the animal house at Cardiff University. Meaning
that the mice had to be re-housed in a room that was formerly a rat room, which
has been shown to increase stress responses in mice (Adamec et al., 2004). Although
initially thought not to be an issue there was an increase in so called “crunching” of
food by several cages of mice, which is thought to be a behavioural response to stress
as well as increased in cage fighting. This aggressive behaviour was particularly
prevalent in the cages of TG mice. There has been much work that has linked stress
to adverse behavioural responses in rodents (Champagne and Meaney, 2006, Meaney,
2001). Mice prefer to be housed alone as it reduces their stress levels, something
which is opposite to rats Campos et al. (2013). These factors mean the findings
reported in the LCA are valid, although along with the other behavioural assays the
results may have been confounded by the environment, therefore they would need to
be repeated in order to validate the results. Furthermore, it would be informative for
a larger number of sucrose concentrations to be used and to measure serum levels of
cortisol to help account for the affects of stress.
The actual lick cluster sizes performed by the mice were comparatively small in
contrast to published rat data (Wright et al., 2013), however evidence from an
increasing number of mouse trials indicate this to be be normal in the 129 strain
(Dwyer, personal communications). Despite these weaknesses it is important to
note that Champagne et al. (2003) illustrated that maternal behaviour, particularly
in licking/grooming, act to regulate the development of endocrine, emotional and
cognitive responses to stress in pups. It is therefore not inconceivable that any stress
responses observed in the TG and NON-TG mice may be due to a maladaptation
of the pups to stress during development. The epigenetic profile of the pups that
231
Hugo Creeth Final Remarks
are exposed to altered maternal care would be an exciting area to look at, as the
multifunctional roles and the flexibility of epigenetic marks have led to the suggestion
that imprinted genes may contribute to the fetal programming of adverse outcomes
(Keverne, 2010). Experimental animal models have previously demonstrated that
early-life stress can leave a mark on the offspring epigenome, with alterations reported
in offspring exposed to prenatal stress (Mueller and Bale, 2008), maternal separation
(Kundakovic and Champagne, 2015) and low levels of maternal postnatal care (Szyf
et al., 2005). It is therefore exciting to see behavioural changes in the offspring of
WT dams exposed to TG placenta, it would be important to investigate whether
this care results in epigenetic changes that lead to alter gene expression and account
for the behavioural changes seen in the offspring.
The increased aggression that was observed in the TG mice cages was interesting
and should be further assessed. There has recently been observations that varia-
tions in PHLDA2 expression in the placenta of humans, is linked to an increased
aggression in human infants scored using the CICS scoring system (Janssen, personal
communications). This is another exciting area that needs further work. The fact
that this model allows the multigenerational assessment of the potential impact that
an aberrant placenta may have upon maternal care and the subsequent outcomes of
the offspring highlight the importance of gaining a better understanding of this area
of study.
7.5 Final Remarks
There are still questions regarding the mechanisms that underpin the phenotypes
described for both the dams and the offspring, but this model provides a novel
and intriguing system that combines the deficits seen in the maternal care with the
direct consequences this care has upon the offsprings development. It is the first
ever demonstration that a placental defect can alter maternal care behaviour in a
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WT mother and that this behaviour can influence the future behaviour of the WT
offspring exposed to the same environment. Meaning that this model is unique in
that it gives the ability to understand a potential non-genetic mechanism behind the
postnatal behavioural phenotypes of the dams that stems from a placental origin.
So how does this research translate to the human condition? Throughout this thesis
the link between IUGR, LBW and maternal psychiatric conditions has been discussed.
The origin of maternal mood disorders is still an enigma, however the co-occurrence
of these disorders with IUGR and LBW provided a novel hypothesis that the switch
that initiates them may not have a genetic origin. Recent research has implicated the
imprinted gene PEG3 with prenatal depression in humans, changes in the expression
of PHLDA2 didn’t reach significance in this particular study by Janssen et al. (2016),
the ever increasing knowledge of imprinted genes roles in the placenta mean that
there are likely other genes that have similar roles to play. Similarly these imprinted
genes are known to be influenced by the environment including low protein diet.
Understanding the placental origins of these conditions and discovering whether
environmental factors can play a role in their expression may help improve the
clinical understanding of these disorders and ultimately lead to their prevention and
treatment.
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a b s t r a c t
Imprinted genes, which are expressed from a single parental allele in response to epigenetic marks ﬁrst
established in the germline, function in a myriad of processes to regulate mammalian development.
Recent work suggests that imprinted genes may regulate the signalling function of the placenta by
modulating the size of the endocrine compartment. Here we provide in vivo evidence that this hy-
pothesis is well founded. Elevated expression of the imprinted Pleckstrin homology-like domain, family a,
member 2 (Phlda2) gene drives a reduction of the spongiotrophoblast endocrine compartment, dimin-
ished placental glycogen and asymmetric foetal growth restriction. Using both loss-of-function and gain-
in-expression mouse models, here we further show that Phlda2 exclusively modulates the spongio-
trophoblast compartment of the placenta without signiﬁcantly altering the composition of the tropho-
blast giant cell endocrine lineages that share a common progenitor with this lineage. Additionally, we
show that Phlda2 loss-of-function placentae contain nearly three times more placental glycogen than
non-transgenic placentae. Remarkably, relative to a fully wild type scenario, wild type placentae also
accumulate excessive glycogen. While loss-of-function of Phlda2 increased both placental weight and
placental glycogen, the weight of both mutant and non-transgenic fetuses was lower than that found in a
fully wild type scenario indicating that excessive glycogen accumulation comes at the cost of foetal
growth. This work ﬁrstly highlights a novel signalling function for the spongiotrophoblast in stimulating
the global accumulation of placental glycogen. Furthermore, this work suggests that Phlda2 manipulates
the placenta's demands for maternal resources, a process that must be tightly regulated by epigenetic
marks to ensure optimal foetal growth.
Crown Copyright & 2015 Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Genomic imprinting is an epigenetic phenomenon which
drives the preferential expression of certain genes from one par-
ental allele (John and Surani, 1996). The ﬁnding that some pater-
nally silenced genes restrain foetal growth while some maternally
silenced genes are growth promoting led to the suggestion that
imprinting may have evolved in response to the different energetic
contributions that male and female mammals make to their off-
spring (Moore and Haig, 1991) and the effectively antagonistic
selective pressure acting on the mother–offspring relationship
(Moore, 2011). However, another conﬂict exists in mammals be-
cause maternal resources are utilised by both the growing foetus
and the developing extra-embryonic tissues. In some mammals
these supporting tissues can consume more than half the maternal
resources allocated to a pregnancy (Fowden, 1997; Carter, 2000)
introducing the potential for competition between their energetic
requirements and that of the growing foetus.
In mice, a signiﬁcant number of imprinted genes functionally
converge to regulate placental growth and development (Tunster
et al., 2013). The mature mouse placenta supports foetal growth
from approximately embryonic day (E) 9.5 until birth and is or-
ganised into the histologically distinct labyrinth zone, junctional
zone and maternal decidua interspersed with trophoblast giant
cells (TGCs) lining the maternal tissues and vasculature at speciﬁc
sites (Rai and Cross, 2014). While the function of the labyrinth in
placental transport is well established, the function of the spon-
giotrophoblast and the glycogen cell lineages, which reside within
the junctional zone, has yet to be fully determined experimentally.
Placental glycogen, which accumulates in the glycogen cells of the
junctional zone from mid-gestation, may provide a store of easily
mobilisable energy late in gestation to support the ﬁnal stages of
foetal growth (Coan et al., 2006) supported by numerous mouse
models in which limited glycogen stores are associated with foetal
growth restriction (Lefebvre, 2012). The function of the
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spongiotrophoblast lineage is less well understood but several
placental lactogens (Prls) and pregnancy-speciﬁc glycoproteins
(Psgs) are expressed from this lineage some of which have been
shown to act on the mother to induce the physiological changes
required for a successful pregnancy (Samaan et al., 1968; Bhatta-
charyya et al., 2002; Muller et al., 1999; Kammerer and Zimmer-
mann, 2010; Wu et al., 2008). While this lineage is required for
foetal viability (Guillemot et al., 1994; Ono et al., 2006), fetuses can
survive to term with very little spongiotrophoblast (Oh-McGinnis
et al., 2011). A reduced spongiotrophoblast has been linked to
foetal growth restriction in several studies (Oh-McGinnis et al.,
2011; Hitz et al., 2005; Zheng-Fischhofer et al., 2007; Withington
et al., 2006; Tunster et al., 2010) while an expanded spongio-
trophoblast may drive delayed parturition associated with foetal
and maternal death (Denda et al., 2011). Loss of function of several
maternally expressed imprinted genes results in an expansion of
the spongiotrophoblast lineage (John and Hemberger, 2012), most
recently Sirh7/Ldoc1 (Naruse et al., 2014), suggesting that the pa-
ternal genome has selectively silenced genes that limit spongio-
trophoblast-speciﬁc functions. However, while there are a number
of mouse mutants in which alterations in the spongiotrophoblast
lineage have been reported, these defects commonly occur
alongside alterations in additional placental lineages. In particular,
the glycogen cell lineage and four of the six distinct TGC lineages
which share a common progenitor with the spongiotrophoblast
(Rai and Cross, 2014; Hu and Cross, 2010; Simmons et al., 2007;
Gasperowicz et al., 2013) confounding their functional assessment.
Pleckstrin homology-like domain family A member 2 (Phlda2) is a
maternally expressed gene that maps to the imprinted domain on
mouse distal chromosome 7, which encodes a PH domain-only
protein (Frank et al., 1999; Qian et al., 1997). Prior to the formation
of the mature mouse placenta, Phlda2 is expressed most strongly
in the ectoplacental cone and the visceral endoderm of the yolk
sac (Frank et al., 1999; Dunwoodie and Beddington, 2002; Takao
et al., 2012). The ectoplacental cone contains the trophoblast spe-
ciﬁc protein alpha (Tpbpa)-positive progenitors that give rise to the
spongiotrophoblast, the glycogen cells and four of the six TGC
subtypes of the mature placenta (Rai and Cross, 2014; Simmons
et al., 2007, 2008; Gasperowicz et al., 2013). Loss-of-function of
Phlda2 results in an enlarged placenta with an expanded junc-
tional zone and more placental glycogen but without foetal over-
growth (Frank et al., 2002). Elevated expression, at two-fold the
endogenous level, results in placental stunting, a loss of the
spongiotrophoblast lineage and reduced placental glycogen accu-
mulation but without an alteration in the representation of the
glycogen cell lineage or the parietal trophoblast giant cells which
line the maternal decidua (Tunster et al., 2010; Salas et al., 2004).
Additionally, elevated Phlda2 drives a late, asymmetric foetal
growth restriction (Tunster et al., 2014). Taken together, these data
suggested that Phlda2 acts indirectly to restrain foetal growth by
limiting the expansion of the spongiotrophoblast lineage, which is
required to stimulate glycogen accumulation. However, the effects
of elevated Phlda2 gene dosage on all the TGCs lineages has not
been reported. Moreover, a characterisation of the placental
lineages in the context of loss-of-function has not been performed.
To further investigate the role of Phlda2 in regulating the placental
endocrine lineages, glycogen accumulation and foetal growth, we
performed an examination of the placental lineages in the different
Phlda2 gene dosage mouse models and biochemically quantiﬁed
placental glycogen at different stages of development in response to
loss-of-function of Phlda2. Remarkably, in addition to the anticipated
over accumulation of placental glycogen in response to loss-of-
function of Phlda2, we noted a similar phenotypes in non-transgenic
placenta sharing the uterine environment. Rather than supporting
enhanced foetal growth, these stores came to the detriment of foetal
growth identifying a novel role for Phlda2 in regulating maternal
resource allocation between the placenta and the foetus.
2. Materials and methods
2.1. Mouse strains and genotyping
Animal studies and breeding were approved by the Universities
of Cardiff Ethical Committee and performed under a UK Home Of-
ﬁce project license (RMJ). All mice were housed under standard
conditions throughout the study on a 12 h light–dark cycle with
lights coming on at 06.00 h with a temperature range of 21 °C72
with free access to water (tap water) and standard chow. The Phlda2
targeted allele (Frank et al., 2002) was crossed into the 129S2/SvHsd
(Harlan, 129) strain background for þ8 generations. The single copy
Phlda2 transgenic line Phlda2þ /þBACx1 (Tunster et al., 2014) was
maintained on the 129 background by paternal transmission. Phlda2
deﬁcient fetuses were generated by crossing Phlda2þ / females
with wild type males. Phlda2þ / females were crossed with
Phlda2þ /þBACx1 males to generate four genotypes: Phlda2þ /þ (non-
transgenic; 1X), Phlda2 /þ (maternal KO; 0X), Phlda2þ /þBACx1
(single copy Phlda2 transgene; 2X) and Phlda2 /þBACx1 (single copy
transgene plus maternal KO; 1X). 129 wild type colonies were
maintained alongside the transgenic colonies. For recipient transfer
experiments, 2-cell embryos were surgically transferred into E0.5
wild type 129 recipients mated with vasectomised males.
2.2. Quantitative RNA analysis
RNA was extracted from whole placenta following careful re-
moval of membranes and umbilicus. Quantitative PCR of reverse
transcribed RNA (RT-qPCR) was performed and analysed as de-
scribed (Tunster et al., 2010; Schmittgen and Livak, 2008). RNA
was hybridised to Affymetrix Mouse Gene 2.0 ST chips. Data was
analysed essentially as described (Zhang et al., 2009) and using
Partek Genomic suite. Genes signiﬁcantly up in Phlda2 /þ ) (0X)
and signiﬁcantly down in Phlda2þ /þBACx1 (2X) E16.5 whole pla-
centa were tested for enrichment of gene ontology molecular
function and biological process using the Database for Annotation,
Visualisation and Integrated Discovery (DAVID). Microarray data
available in GEO repository accession *******.
2.3. In situ hybridisation and histological analyses
Placentas were ﬁxed overnight in phosphate-buffered 4% paraf-
ormaldehyde, parafﬁn-embedded and 6 μm sections taken through
the midline. Riboprobe preparation and in situ hybridisation were
performed as previously described (Tunster et al., 2010, 2012).
2.4. Weighing studies and biochemical determination of placental
glycogen concentration
Foetal and placental wet weights were taken at the stated time
points after a discernable plug and normalised. Genotyping data
was obtained from yolk sac DNA as previously described (Frank
et al., 2002; John et al., 2001). Glycogen was extracted from whole
placenta, and resuspended in 1 ml of H2O and assayed according
to the method of Lo et al. (1970) at a dilution of 1 in 2.
2.5. Statistical analyses
Statistical signiﬁcance (probability values) was determined
using the Student's t-Test (two tailed distribution and two sample
unequal variance) for comparisons between knockout and control
littermates. Comparisons with the fully wild type scenario were
undertaken using ANOVA with Bonferroni correction.
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3. Results
3.1. Phlda2 supresses the expansion of the spongiotrophoblast
without altering the representation of the TGC lineages
A characterisation of placental lineages in response to loss of
Phlda2 function was undertaken after breeding the original line
carrying a targeted deletion of Phlda2 onto a 129S2/SvHsd (129)
genetic background. Phlda2 /þ (maternal KO; 0X) placenta ex-
pressed Tpbpa, a gene expressed by both the spongiotrophoblast
and the glycogen cell lineage (Lescisin et al., 1988), at 2.20-fold
(70.26; p¼3.77104) the normal level (Fig. 1A, and Table S1).
Prl8a8, a gene expressed exclusively in spongiotrophoblast cells
(Simmons et al., 2008), was elevated by 2.10-fold (70.15;
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Fig. 1. Phlda2 restrains the expansion of the spongiotrophoblast lineage without signiﬁcantly altering other trophoblast cell lineages. A. RT-qPCR analysis of placental lineage
markers mRNA levels between E14.5 Phlda2þ /þ(non-transgenic; 1X) and Phlda2 /þ(0X) placentae from littermates examined on the 129 genetic background. B. In situ
hybridisation with Prl3d (Pl1) of midline sections from E10.5 Phlda2þ /þ(1X), Phlda2 /þ(0X), Phlda2 /þBACx1(2X) and Phlda2 /þBACx1 (1X) 129 placenta. C. In situ hybridisation
of midline sections E14.5 placenta with Tpbpa, Prl8a8, Prl3b1 (Pl2) and Prl2c (Plf) (scale bar¼200 μm). Prl2c also shown at a higher magniﬁcation illustrating similar staining
of the canal and the spiral artery TGC (scale bar¼100 μm). For the RT-qPCR analysis, N¼4 placenta per genotype (2 vs 2 from 2 independent litters); error bars represent
SEM. Statistical signiﬁcance calculated using t-test. NSP40.05, *Po0.05, **Po0.01, and ***Po0.005.
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p¼8.787105) and FMS-like tyrosine kinase 1 (Flt1), a marker of
the junctional zone (Breier et al., 1995) was elevated by 2.31-fold
(70.51; p¼0.00551). Expression of glycogen cell markers (Gjb3/
Cx31 and Pcdh12) and traditional markers of the labyrinth was
comparable to wild type (Fig. 1A). These data were reciprocal to
our ﬁndings in the gain-in-expression Phlda2model (Tunster et al.,
2010, 2014) conﬁrming the inverse relationship between Phlda2
gene dosage and the spongiotrophoblast but not the glycogen cell
lineage. Some markers of the TGC lineages, Tle3 and Ctsq, were
expressed normally whereas Prl2c (Plf) and Prl3b1, which are ex-
pressed in both the spongiotrophoblast and TGCs, were elevated in
response to loss-of-function of Phlda2 (Fig. 1A) suggesting that
some TGC lineages may also be altered in this model. To further
reﬁne the analysis, four placental genotypes were generated from
crosses between Phlda2þ / females and males carrying a single
copy of a transgene spanning the Phlda2 locus: Phlda2þ /þ (non-
transgenic; 1X), Phlda2 /þ (maternal KO; 0X), Phlda2þ /þBACx1
(single copy Phlda2 transgene; 2X) and Phlda2 /þBACx1 (single
copy transgene plus maternal KO; 1X). In situ hybridisation per-
formed with Prl3d, an exclusive marker of the parietal TGC lineage
at E10.5 (Simmons et al., 2008), excluded any gross alterations in
this lineage (Fig. 1B). Hybridisation with Tpbpa and Prl8a8 at E14.5
further highlighted the inverse relationship between Phlda2 gene
dosage and the spongiotrophoblast with an expansion of this
lineages occurring in response to the decreasing expression of
Phlda2. Hybridisation with Prl2b1 and Prl2c, which identify the
canal, sinusoidal and spiral artery TGCs (Simmons et al., 2007),
was similar irrespective of Phlda2 gene dosage (Fig. 1C) indicating
that these lineages were relatively unaffected by the loss-of-
function of Phlda2. These data identiﬁed Phlda2 as a gene that acts
exclusively to constrain the expansion of the spongiotrophoblast
lineage without signiﬁcantly altering the cellular composition of
other trophoblast lineages which share a common progenitor.
3.2. Phlda2 regulates the expression of several placental hormones
The spongiotrophoblast expresses a number of Prls (Simmons
et al., 2008), genes that encode placental lactogens that act on the
mother during pregnancy to induce changes required for a suc-
cessful pregnancy (John, 2013). Several Prl members were elevated
in the Phlda2 /þ (maternal KO; 0X) placenta and reduced in the
Phlda2þ /þBACx1 (2X) placenta (Fig. 2A,Table S1). The spongio-
trophoblast is also a major source of pregnancy speciﬁc glyco-
proteins (Psgs), another large gene family important for pregnancy
(McLellan et al., 2005). RT-qPCR analysis of the most abundantly
expressed Psgs during mid gestation, Psg17, Psg18, Psg19 and Psg21
(Fig. 2B), and in situ hybridisation with Psg17 (Fig. 2C) revealed a
reciprocal relationship between Phlda2 expression and the Psgs.
In situ hybridisation (Figs. 1B, C and 2C) and RT-qPCR analyses
(Table S1) on double transgenic placenta carrying both the trans-
gene and the maternally inherited targeted Phlda2 allele (1X)
formally assigned these changes to Phlda2.
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Fig. 2. Phlda2 indirectly suppresses the expression of key placental hormones. A. RT-qPCR comparison of Prls at E14.5 between Phlda2þ /þ(1X), Phlda2 /þ(0X),
Phlda2 /þBACx1(2X) and Phlda2 /þBACx1(1X) 129 placentae. B. RT-qPCR comparison of Psgs at E14.5. C. In situ hybridisation of midline sections E14.5 placentae with Psg17
(scale bar¼200 μm). For the RT-qPCR analysis, N¼4 placenta per genotype (2 vs 2 from 2 independent litters); error bars represent SEM. Statistical signiﬁcance calculated
using t-test. NSP40.05, *Po0.05, **Po0.01, and ***Po0.005.
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A more objective analysis of gene expression changes was
performed using an Affymetrix mouse microarray to proﬁle gene
expression on E16.5 Phlda2þ /þ (1X), Phlda2 /þ (0X) and
Phlda2þ /þBACx1 (2X) placenta (N¼3–4 of each genotype, two in-
dependent litters for each genotype). Data was initially analysed at
the genome wide level using a Bioconductor package Limma
(Linear Model for Microarray data Analysis) written in R statistical
software to identify differentially expressed genes between all
pair-wise comparisons of the groups (Fig. 3A and B). Database for
Annotation, Visualisation and Integrated Discovery (DAVID) was
used to generate molecular function and biological processes
pathway data on the unselected dataset highlighting signiﬁcant
changes in genes involved in cell cycle, cytokine–cytokine inter-
actions and sphingolipid metabolism (Table S2). Genes both sig-
niﬁcantly up in Phlda2 /þ placenta and signiﬁcantly down in
Phlda2þ /þBACx1 E16.5 whole placenta likely represent the spon-
giotrophoblast transcriptome (Fig. 3C, and Table S3). A dataset of
these UP DOWN genes was further analysed by DAVID giving a
functional annotation clustering analysis output which highlighted
cytoskeleton pathways, cell division pathways and the protein
Fig. 3. Microarray analysis identiﬁes the transcriptomic signature of the spongiotrophoblast. A. Three-dimensional principle components analysis plot clustering placental
gene expression with genotypes. B. Heat map showing genes signiﬁcantly altered in relations to changes in Phlda2 gene dosage. The colour represents the expression level of
the gene. Red represents high expression, while green represents low expression. The expression levels are continuously mapped on the colour scale provided at the bottom
of the ﬁgure. Phlda2 /þ(0X) and Phlda2þ /þBACx1(2X) placenta show a reciprocal pattern of expression. C. Enrichment for placental hormones after pathways analysis of genes
signiﬁcantly UP in Phlda2 /þ (129)(0X) and signiﬁcantly DOWN in Phlda2þ /þBACx1(2X) placenta (pr0.05) presumed to originate within the spongiotrophoblast. Supplemental
Table 1 list the DAVID results and the UP DOWN annotated probe sets with a signiﬁcant differences in gene expression at PZ0.05.
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superfamily prolactin/lactogen/growth hormone cluster (Cluster
3 Enrichment Score: 4.25) (Tables S4 and S5). Within cluster
3 were a number of placental prolactins known to be expressed
within the spongiotrophoblast (Simmons et al., 2008) and secretin,
also highly expressed within the spongiotrophoblast (Knox et al.,
2011) (Table S6). This data, together with our RT-qPCR and in situ
analyses (Figs. 1 and 2), conﬁrmed Phlda2 as a major rheostat for
placental hormone gene expression.
3.3. Excessive accumulation of placental glycogen in Phlda2-deﬁ-
cient placenta
Phlda2-deﬁciency results in a transient foetal growth restric-
tion in C57BL/6 (BL6) mice (Frank et al., 2002; Salas et al., 2004).
Given the less favourable foetal:placental ratio in 129 mice
(Tunster et al., 2012), we asked whether foetal overgrowth might
manifest on this genetic background. Phlda2 /þ fetuses were si-
milar in weight to their 129 non-transgenic counterparts at E14.5,
E16.5 and E18.5 (Fig. 4A). Phlda2 /þ placenta weighed more than
non-transgenic at each time point with a maximal increase of 50%
at E16.5 (p¼7.42108) (Fig. 4B). Phlda2-deﬁciency resulted in a
lower F:P ratios (Fig. 4C) particularly evident at E16.5 with a
change in ratio from 8.870.26 to 6.470.30 (73.1% of control;
p¼2.75106).
Phlda2-deﬁciency resulted in increased Periodic Acid Schiff
(PAS) staining for glycogen (Tunster et al., 2010; Frank et al., 2002).
When we biochemically determined the amount of glycogen
stored in the 129 placenta, Phlda2-deﬁciency resulted in greater
stores of placental glycogen, as anticipated, with a maximal dif-
ference in total glycogen at E16.5 of 2.3-fold (129; Fig. 4D). These
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differences were maintained when placental weights were taken
into account (Fig. 4E).
3.4. Global foetal growth restriction
Given the function of Phlda2 in restraining the spongio-
trophoblast lineage and thus, indirectly, the production of pla-
cental hormones, loss-of-function of Phlda2 might promote the
accumulation of placental glycogen and potentially support the
increased growth of both the loss-of-function fetuses and their
non-transgenic counterparts sharing the intrauterine environ-
ment. The within litter comparison would not necessary exclude
this possibility. To address this, data on Phlda2-deﬁcient fetuses
and their non-transgenic littermates were compared to those from
fully wild type litters at E18.5 collected concurrently using the
parent strain. Remarkably, rather than an anticipated increase in
foetal weights, we observed a 15% reduction in weight of both
Phlda2 /þ and Phlda2þ /þ compared to fully wild type litters
(Fig. 5A). Non-transgenic placentae were similar in weight to fully
wild-type placentae (Fig. 5B). Consequently the F:P ratios for both
the Phlda2-deﬁcient scenario and the non-transgenic scenario
were both signiﬁcantly different to the fully wild-type scenario
(Fig. 5C). Remarkably, while placental glycogen stores from non-
transgenic placenta at E18.5 contained signiﬁcantly less glycogen
per gram of placenta than the Phlda2-deﬁcient placenta, they
contained more glycogen overall than the fully wild type placenta
(Fig. 5D). Phenotypes in the non-transgenic samples sharing the
intrauterine environment with the transgenic individuals high-
lighted a global effect on the entire litter as a result of localised
loss-of-function of Phlda2.
The litters we examined were carried by dams inheriting the
targeted Phlda2 allele, albeit paternally and thus the inactive allele.
While Phlda2 is imprinted strongly in the placenta and extra-
embryonic membranes, functional imprinting is less well main-
tained in embryonic and adult tissues (Qian et al., 1997). To for-
mally exclude a haploinsufﬁciency phenotype in the dams, Phlda2-
deﬁcient embryos and their non-transgenic controls were trans-
ferred into wild-type recipient mothers. The weights of both
Phlda2 /þ (KO) and non-transgenic fetuses were signiﬁcantly
lighter when compared to fully wild-type litters (Fig. 6A).
Phlda2 /þ (KO) placental weights were signiﬁcantly increased
(Fig. 6B) and the F:P ratio was lower (Fig. 6C). Importantly, whe-
ther examined as total glycogen or as glycogen per gram of pla-
centa, the Phlda2 /þ (KO) and non-transgenic values were sig-
niﬁcantly higher than fully wild-type control values (Fig. 6D and
E). These data excluded a maternal genotype-effect and identiﬁed
a novel function for the spongiotrophoblast in promoting the
global accumulation of placental glycogen.
Phlda2-/+ (0X)  
Phlda2+/+ (1X; 
non-transgenic 
littermates)  
Phlda2+/+ (1X; 
fully wild type)  
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
Fe
ta
l w
ei
gh
t (
g)
 
0 
40 
80 
120 
P
la
ce
nt
al
 w
ei
gh
t (
m
g)
 
0 
5 
10 
15 
20 
F:
P 
R
at
io
 *** *** 
NS 
*** 
*** 
*** 
G
ly
co
ge
n 
(m
g/
g)
 
%
 o
f f
ul
ly
 w
ild
 ty
pe
0 
50 
100 
150 
200 
250 
*** 
*
0 
50 
100 
150 
200 
250 *** 
 NS 
G
ly
co
ge
n 
(m
g)
 
%
 o
f f
ul
ly
 w
ild
 ty
pe
1X 1X 0X 
Phlda2 
1X 1X 0X 
Phlda2 
1X 1X 0X 
Phlda2 
1X 1X 0X 
Phlda2 
1X 1X 0X 
Phlda2 
Fig. 5. Phlda2 deﬁciency drives global foetal growth restriction. A. Weights of non-transgenic and Phlda2 /þ(0X) fetuses compared with true 129 wild type values (wild type
fetuses carried by wild type females). Both genotypes weigh less than fully wild type fetuses. B. Weights of non-transgenic and Phlda2 /þ(0X) placenta compared with true
129 wild type values. Phlda2 /þ (129)(0X) placenta weigh considerably more than fully wild type placenta. C. Comparison of F:P ratios between non-transgenic,
Phlda2 /þ (129)(0X) and true 129 wild type. Both the non-transgenic and the Phlda2 /þratios are signiﬁcantly different to the fully wild type ratio. D. Direct biochemical
determination of glycogen in Phlda2þ /þ and Phlda2 /þ(0X) placenta at E18.5 as a percentage of true 129 wild type values expressed as total amount (mg) and as a
proportion of placental weight (mg/g placenta). Phlda2 /þ(0X) placenta and the non-transgenic placenta both contain signiﬁcantly more glycogen than fully wild type
placenta on the 129 genetic background when placental weights are taken into account. Numbers of samples given in Supplemental Table S8. Error bars represent SEM.
Statistical signiﬁcance calculated using one way ANOVA with Bonferroni correction for multiple comparisons: NSP40.05, *Po0.05, **Po0.01, and ***Po0.005.
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4. Discussion
Here we show that the imprinted Phlda2 gene acts in a lineage-
speciﬁc manner to exclusively modulate the size of the spongio-
trophoblast compartment of the mature mouse placenta. Phlda2 is
the ﬁrst gene described which has this speciﬁc function allowing
the in vivo assessment of the function of this lineage. Using both
loss-of-function and gain-in-expression models we show that, via
the spongiotrophoblast, Phlda2 negatively regulates the expression
of a number of key placental hormones. We show that an
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expanded spongiotrophoblast compartment, driven by loss-of-
function of Phlda2, drives an inappropriate accumulation of pla-
cental glycogen both locally, in the genetically modiﬁed in-
dividuals, and also globally in individuals that were genetically
wild type. This work identiﬁes a novel signalling function for the
spongiotrophoblast. The presence of foetal growth restriction in
both the genetically modiﬁed individuals and their non-transgenic
counterparts further suggests that Phlda2 balances resource allo-
cation between the foetus and the placenta, a process that must be
precisely regulated for optimal foetal growth.
Phlda2 is the only gene to date which acts to limit the size of
the spongiotrophoblast compartment of the mouse placenta
without signiﬁcantly altering the contribution of additional pla-
cental lineages that share a common progenitor (Rai and Cross,
2014). This suggests that Phlda2 acts in placental development
after these lineage decisions are made but before Phlda2 expres-
sion subsides (Fig. 7). This unique speciﬁcity for the spongio-
trophoblast allowed us to explore the function of the spongio-
trophoblast. One key ﬁnding from this study was that an expanded
spongiotrophoblast drove the excessive accumulation of placental
glycogen both directly, within the loss-of-function placenta, and
also indirectly in the non-transgenic placenta sharing the uterine
environment. To our knowledge, this is the ﬁrst example of a gene
modiﬁcation affecting the phenotype in wild type conceptuses of
the same litter. However, very few studies make the comparison
with fully wild type data. These data suggest that the spongio-
trophoblast produces a signal that acts locally and at a distance to
stimulate glycogen accumulation. The spongiotrophoblast ex-
presses a number of placental prolactins (Simmons et al., 2008)
and pregnancy speciﬁc glycoproteins (McLellan et al., 2005).
Consequently, by changing the size of the spongiotrophoblast
compartment, Phlda2 indirectly and negatively regulates the ex-
pression of several placental hormones. Many of these placental
hormones act on the maternal system to channel nutrients to the
foetus and ensure a healthy and successful pregnancy (Samaan
et al., 1968; Bhattacharyya et al., 2002; Muller et al., 1999; Kam-
merer and Zimmermann, 2010; Wu et al., 2008). One explanation
for our ﬁndings is that an increased signal (Phlda2 loss-of-func-
tion) leads to increased nutrient availability potentially explaining
increased placental glycogen in both genotypes. However, we
observed foetal growth restriction of both the Phlda2 KO fetuses
and their non-transgenic, genetically wild-type littermates. We
could discount a haploinsufﬁciency phenotype in the dams, which
carry the paternal targeted allele, because embryos transferred
into wild-type recipients also displayed both foetal growth re-
striction and excessive placental glycogen of both genotypes
(Fig. 6). Another explanation is that the defect lies at the level of
foetal uptake of glucose or the ability to transport it across the
placenta to the foetus such that placental glycogen accumulates
because it is not utilised. A third explanation is that the spongio-
trophoblast produces a signal demanding nutrients to support
placental growth. When the signal is too high, as in the Phlda2
loss-of-function model, it outcompetes the demand signal from
the foetus resulting in the diversion of maternal resources away
from supporting foetal growth and towards supporting placental
growth. This latter explanation is plausible as the placenta is a
highly metabolic organ consuming maternal energy in order to
support the active transport of nutrients to the foetus and also the
production and secretion of vast quantities of placental hormones
(John, 2013). In mammals, more than half of the total uterine
glucose and oxygen uptake is channelled to the uteroplacental
tissues (Fowden, 1997; Carter, 2000). A larger placenta, observed
in the Phlda2 loss-of-function model, would require a greater
proportion of maternal resources that might occur to the detri-
ment of foetal growth. While further work is required to de-
termine the precise mechanism driving foetal growth restriction in
this model, this study has demonstrated that a precisely regulated
dose of Phlda2 is essential for optimal foetal growth with both
loss-of-function and gain-in-expression driving foetal growth re-
striction in mice.
Phlda2 does not appear to follow the straightforward rules
applied to a substantial number of imprinted genes whereby pa-
ternally expressed genes promote placental and foetal growth
whereas maternally expressed genes restrain placental and foetal
growth. Phlda2 resides within a complex imprinted domain
spanning several maternally expressed genes including Cdkn1c, a
potent embryonic growth restriction gene (Andrews et al., 2007;
Tunster et al., 2011). Neither loss-of-function of Phlda2 nor loss-of-
function of Cdkn1c alone in mice results in the increase in birth
weight predicted by the genomic conﬂict theory. It may be that
loss of function of such critically important genes has too severe an
impact on foetal development. Alternatively, the combined al-
teration may be required to generate larger offspring. Our data
from mouse models would predict an increase in foetal weight,
due to reduced Cdkn1c expression, alongside an increase in the
signalling function of the placenta, due to reduced Phlda2 ex-
pression, thus retaining the balance between foetal growth and
placental demands on maternal resources. Co-imprinting of these
two genes, which occurred after marsupials diverged for Eutherian
mammals (Suzuki et al., 2005, 2011), may consequently have
played an important role in the evolution of modern day mammals
that give birth to relatively mature offspring.
In conclusion, we have shown that Phlda2 modulates the sig-
nalling function of the placenta to limit the accumulation of pla-
cental glycogen and placental growth. While this does not provide
a facile explanation for paternal silencing of Phlda2, our work
highlights the complex relationship between the mother, the
foetus and the placenta whose requirements must be carefully
balanced for an optimal reproductive success.
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a b s t r a c t
Imprinted genes are expressed primarily from one parental allele by virtue of a germ line epigenetic
process. Achaete-scute complex homolog 2 (Ascl2 aka Mash2) is a maternally expressed imprinted gene
that plays a key role in placental and intestinal development. Loss-of-function of Ascl2 results in an
expansion of the parietal trophoblast giant cell (P-TGC) lineage, an almost complete loss of Trophoblast
speciﬁc protein alpha (Tpbpa) positive cells in the ectoplacental cone and embryonic failure by E10.5.
Tpbpa expression marks the progenitors of some P-TGCs, two additional trophoblast giant cell lineages
(spiral artery and canal), the spongiotrophoblast and the glycogen cell lineage. Using a transgenic model,
here we show that elevated expression of Ascl2 reduced the number of P-TGC cells by 40%. Elevated Ascl2
also resulted in a marked loss of the spongiotrophoblast and a substantial mislocalisation of glycogen
cells into the labyrinth. In addition, Ascl2-Tg placenta contained considerably more placental glycogen
than wild type. Glycogen cells are normally located within the junctional zone in close contact with
spongiotrophoblast cells, before migrating through the P-TGC layer into the maternal decidua late in
gestation where their stores of glycogen are released. The failure of glycogen cells to release their stores
of glycogen may explain both the inappropriate accumulation of glycogen and fetal growth restriction
observed late in gestation in this model. In addition, using in a genetic cross we provide evidence that
Ascl2 requires the activity of a second maternally expressed imprinted gene, Pleckstrin homology-like
domain, family a, member 2 (Phlda2) to limit the expansion of the spongiotrophoblast. This “belts and
braces” approach demonstrates the importance of genomic imprinting in regulating the size of the
placental endocrine compartment for optimal placental development and fetal growth.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Genomic imprinting is a remarkable process whereby certain
genes are preferentially silenced on one parental allele as a con-
sequence of epigenetic events initiated in the germ line (Surani,
1998). Imprinted genes have been shown to functionally converge
on biological processes that, while not exclusive to mammals,
were likely important for the relative dominance of mammals on
Earth today, including placentation, advanced maturity at birth
and high maternal care (Kaneko-Ishino and Ishino, 2010; Keverne,
2013; Renfree et al., 2013; Moore, 2011; Cleaton et al., 2014; Peters,
2014). The majority of studies on imprinted genes rely on loss-of-
expression models. However, imprinting is a mechanism that ex-
clusively modulates gene dosage. Examining models in which gene
dosage is increased may further contribute to our understanding
of genomic imprinting.
Achaete-scute complex homolog 2 (Ascl2 aka Mash2) was one of
the ﬁrst imprinted genes to be knocked out in mice (Guillemot
et al., 1995). These studies demonstrated that fetal survival beyond
E10.5 requires the maternal Ascl2 allele (Guillemot et al., 1995,
1994). Loss of function restricted to the embryo had no overt
consequence during gestation highlighting a requirement for
placental Ascl2 in the transition to the mature chorioallantoic
placenta (Tanaka et al., 1997). The mature mouse placenta is or-
ganised into the histologically distinct labyrinth zone, junctional
zone and maternal decidua, all of which are interspersed with
trophoblast giant cells (TGCs) (John and Hemberger, 2012; Rai and
Cross, 2014). Loss-of-function of Ascl2 resulted in an expansion of
one TGC type, the parietal (P-) TGCs. These normally form a single
layer of cells located beneath the maternal decidua surrounding
large lakes of maternal blood leading into the uterine veins, that
becomes somewhat discontinuous as development proceeds (Rai
and Cross, 2014). In Ascl2/þ placenta there were multiple layers
of P-TGCs (Guillemot et al., 1994; Tanaka et al., 1997). Four other
distinct TGC types exist which are deﬁned by their characteristic
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gene expression proﬁles and their position with respect to ma-
ternal circulation (Rai and Cross, 2014; Simmons et al., 2007, 2008;
Gasperowicz et al., 2013). The spiral artery (SpA-) TGCs are located
within the maternal decidua lining the maternal blood system on
entry to the placenta; the canal (C-) TGCs line the maternal blood
canals as they pass through the junctional zone; the sinusoidal
TGCs (S-TGCs) are in direct contact with the maternal blood spaces
within the labyrinth and the recently discovered channel (Ch-)
TGCs line the maternal blood spaces located just beneath the de-
cidua where maternal blood drains into the venous sinuses to be
returned to the maternal circulation (Rai and Cross, 2014; Sim-
mons et al., 2007, 2008; Gasperowicz et al., 2013). These additional
lineages were not examined in Ascl2/þ placenta as these fail too
early in development, but the original report (Guillemot et al.,
1994) noted an almost complete lack of expression of Trophoblast
speciﬁc protein alpha (Tpbpa). Tpbpa is expressed in the progenitor
cells of 50% of the P-TGCs, all the SpA-TGCs and C-TGCs, as well as
the glycogen cell and spongiotrophoblast lineages that form the
bulk of the junctional zone (Hu and Cross, 2011). Another mouse
model (Del7A1/þ) in which Ascl2 levels were reduced by 50%, al-
lowed survival to term and the assessment of a later placental
phenotype (Oh-McGinnis et al., 2011). Del7A1/þ placenta possessed
a similarly expanded P-TGC layer alongside a reduced spongio-
trophoblast and a complete loss of the glycogen cell lineage (Oh-
McGinnis et al., 2011; Lefebvre et al., 2009). Del7A1/þ involves
maternal inheritance of a 280 kb deletion physically adjacent to
Ascl2 and spanning the maternally expressed Tyrosine hydroxylase
(Th) gene. Consequently, these placenta lack Th expression after
maternal transmission of this deletion. Del7A1/þ placenta also ex-
press Pleckstrin Homology-Like Domain, Family A, Member 2
(Phlda2) at two-fold the normal level (Data summarised in Sup-
plemental Table 1). Phlda2 maps to the same imprinted domain at
Ascl2 and Th (Fitzpatrick et al., 2002). We have previously shown
that two-fold expression of Phlda2 results in a 50% loss of the
spongiotrophoblast lineage (Tunster et al., 2010, 2014, 2015).
Consequently the loss of spongiotrophoblast in the Del7A1/þ pla-
centa may be a direct consequence of reduced Ascl2 expression or
increased Phlda2 expression.
These in vivo studies highlighted a potential role for Ascl2 as a
dosage-sensitive cellular switch between the spongiotrophoblast/
glycogen cell lineages and the P-TGC lineage. Consistent with a
role in lineage choice, Ascl2 is expressed in the ectoplacental cone
and extra embryonic ectoderm at E7.5 where the placental pro-
genitors reside with expression restricted to the diploid tropho-
blast cells, and later diploid trophoblast cells located in the la-
byrinthine and spongiotrophoblast layers (Guillemot et al., 1994.,
1993). This model would be consistent with the ﬁnding that ec-
topic expression of Ascl2 can inhibit the normal differentiation of
Rcho-1 cells, a rat choriocarcinoma cell line, towards a TGC-like
fate (Kraut et al., 1998; Cross et al., 1995; Hughes et al., 2004).
However, ectopic expression of Ascl2 in trophoblast stem (TS) cells,
which can differentiate into a number of trophoblast lineages,
resulted in decreased expression of both Prl3d, a marker of TGCs,
and Tpbpa, a gene expressed in the progenitors of a number of
lineages including the spongiotrophoblast, suggesting that Ascl2
could function to repress more than one placental lineage (Hughes
et al., 2004; Takao et al., 2012). The consequences of increased
expression of Ascl2 in vivo on placental development have not
been fully explored. A P1 transgene spanning the genomic locus
expressing Ascl2 at 4–7 fold the endogenous level was shown to
rescue embryonic lethality associated with maternal inheritance of
the Ascl2 targeted allele, but no overt consequence for placental or
fetal weight were reported (Rentsendorj et al., 2010). To in-
vestigate the effect of Ascl2 overexpression on placental develop-
ment and fetal growth, we made use of an existing line of mice
carrying a bacterial artiﬁcial chromosome (BAC) spanning the
Ascl2 locus previously used to explore the relevance of elevated
Ascl2 in intestinal tumorigenesis (Reed et al., 2012). We observed a
reciprocal relationship between Ascl2 expression and P-TGC
number as anticipated, but a marked loss of spongiotrophoblast
arguing against a role for Ascl2 as a simple cell fate switch.
2. Materials and methods
2.1. Mouse strains and genotyping
All animal studies and breeding was approved by the Uni-
versities of Cardiff ethical committee and performed under a UK
Home Ofﬁce project license (RMJ). Mice were housed in a con-
ventional unit on a 12-h light–dark cycle with lights coming on at
06.00 h with a temperature range of 21 °C 72 with free access to
tap water and standard chow unless otherwise stated. The Ascl2
BAC transgenic line (Ascl2-Tg; Genome Systems BAC225J16) de-
scribed previously (Reed et al., 2012) was primarily studied on the
C57BL/6 (BL6) strain background. Some experiments were per-
formed when the transgene was bred into 129S2/SvHsd (G6; 129).
The Phlda2 targeted allele (Frank et al., 2002) was maintained by
paternal transmission on the BL6 genetic background.
2.2. Weighing studies
Embryonic and placental wet weights were taken following
careful dissection to remove the yolk sac, umbilicus and excess
decidua prior to RNA extraction at the stated time points after a
discernable plug. Genotyping data was obtained from yolk sac
DNA using primers CACATACGTTCCGCCATTCC and CCACTT-
CAACGTAACACCGC to amplify from the BAC.
2.3. Quantitative RNA analysis
Quantitative PCR of reverse transcribed RNA (QRT-PCR) was
performed as described (Tunster et al., 2010) with additional pri-
mers (Supplemental Table 2).
2.4. In situ hybridisation and histological analyses
Placentas were ﬁxed overnight in phosphate-buffered 4% par-
aformaldehyde, parafﬁn-embedded and 10 mm sections taken
through the midline. Haematoxylin and eosin (H&E) staining, ri-
boprobe preparation, in situ hybridizations and PAS staining were
performed as previously described (Tunster et al., 2010; John et al.,
2001). Biochemical determination of glycogen was performed on
fresh snap-frozen placenta as previously described (Tunster et al.,
2010; John et al., 2001). Measurements were taken from midline
sections obtained by cutting a number of serial sections and jud-
ging overall thickness as previously described (Tunster et al.,
2010). For counting P-TGC, sections were analysed without
knowing the genotype, with independent repeat blind counts.
2.5. Statistical analyses
Statistical signiﬁcance (Probability values) was determined
using the Student's t-Test (two tailed distribution and two sample
unequal variance). The signiﬁcance in the difference in observed
over the expected appearance of a particular genotype was de-
termined using the Chi-squared Test.
3. Results
The previously described transgenic line (Reed et al., 2012)
carries a bacterial artiﬁcial chromosome physically encompassing
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the Ascl2 locus (Fig. 1A). E9.5, E10.5 and E12.5 Ascl2-Tg transgenic
placenta were found to express Ascl2 at 6-fold the wild type
level (Fig. 1B, Supplemental Table 3). The transgene spanned a
second gene, Tspan32, not expressed in the placenta (Gartlan et al.,
2010; Nicholson et al., 2000) and not ectopically expressed from
the transgene (Supplemental Fig. 1). In situ hybridisation with an
Ascl2 riboprobe demonstrated the correct localisation of the Ascl2
signal within Ascl2-Tg placenta to a subset of diploid cells in the
ectoplacental cone and chorion at E10.5 and restricted expression
within a subset of cells within the junctional zone at E12.5
(Fig. 1C). Previously, adenovirus driven overexpression of Ascl2 at
10-fold the normal level was found to down-regulate expression of
both Tpbpa and Prl3d1 in trophoblast stem cells cultured under
stem cell conditions, alongside reduced expression of Phlda2 (Ta-
kao et al., 2012) (Supplemental Table 1). The spatio-temporally
accurate elevated expression of Ascl2 in this animal model pro-
vided a tool to explore the consequences of similarly increased
Ascl2 dosage on placental development in vivo.
At E10.5, P-TGC form a distinct and histologically recognisable
single cell layer between the maternal decidua and the developing
chorio-allantoic placenta. Haematoxylin staining of E10.5 Ascl2-Tg
midline placental sections revealed a marked loss of the giant,
polyploid cells lining the maternal decidua (Fig. 2A). In situ hy-
bridisation with Prl3d (Pl1), exclusively expressed in the P-TGC
lineage at this time point (Jackson et al., 1986) identiﬁed these
polyploid cells as P-TGCs (Fig. 2B). Counting of these cells in
midline sections revealed a signiﬁcant 40% loss of P-TGCs at
E10.5 (36.377.1 versus 19.871.9; 10 WT v 16 Ascl2-Tg placental
sections from 5 litters; p¼0.0120; Fig. 2C, Supplemental Table 4).
Consistent with the loss of P-TGCs, RT-QPCR revealed a signiﬁcant
30% reduction in expression of Prl3d at E9.5 and E10.5 (Fig. 2D).
Expression of Prl3b1 (aka Pl2), a second gene expressed in P-TGC at
E9.5 and E10.5 (Simmons et al., 2008), was also markedly reduced,
by 70% and 40% respectively (Fig. 2D, Supplemental Table 4).
Hand1 and Prl2c, genes expressed in all or most of the TGC lineages
(Simmons et al., 2008; Scott et al., 2000), were not signiﬁcantly
altered suggesting the defect was not attributable to the loss of
other emergent TGC lineages. The loss of P-TGC was reciprocal to
the phenotype reported in response to reduced Ascl2 expression
(Guillemot et al., 1994; Tanaka et al., 1997). Markers associated
with the emerging spongiotrophoblast and glycogen cell lineages
were also measured (Fig. 2E). Tpbpa, expressed in the precursors of
the spongiotrophoblast, the glycogen cells, S-TGC, SpA-TGC and
50% of the P-TGC (Hu and Cross, 2011), was expressed at near
normal levels (Fig. 2E). Blimp1, Rgs5, Pcsk6 and Prl7b1, expressed in
the precursors of the glycogen cells, the SpA-TGC and the C-TGC
(Mould et al., 2012) or exclusively in the SpA TGC (Mould et al.,
2012) were expressed at near normal levels. Protocadherin 12
(Pcdh12), one of the earliest markers of the glycogen cell lineage
(Bouillot et al., 2006), was expressed at wild type levels at E9.5 but
elevated at E10.5, by 1.5-fold (Fig. 2E, Supplemental Table 4).
To further investigate the effects of the Ascl2 transgene on the
placental lineages, Ascl2-Tg placenta were histologically examined
at E14.5. H&E staining revealed an unexpected, distinct and dra-
matic loss of the junctional zone, where the glycogen and spon-
giotrophoblast cells normally reside (Fig. 3A). In situ hybridisation
with Tpbpa, exclusively expressed in both the spongiotrophoblast
and the glycogen cells (Lescisin et al., 1988), further highlighted
the dramatic loss of cells from the junctional zone (Fig. 3B). In situ
hybridisation with Psg17, an exclusive marker of the spongio-
trophoblast (Kromer et al., 1996), suggested a substantial loss of
this lineage from the junctional zone (Fig. 3C). In situ hybridisation
with Prl3b1, expressed in the spongiotrophoblast, C-TGC, P-TGC
and S-TGCs at E14.5 (Simmons et al., 2008), was also consistent
with a signiﬁcant loss of the spongiotrophoblast lineage from the
junctional zone, and further identiﬁed a degradation of the inter-
face between the junctional zone and maternal decidua consistent
with the loss of P-TGC from this region (Fig. 3D). What little re-
mained of the junctional zone stained for Periodic acid Schiff
(PAS), which distinguishes glycogen cells (Adamson et al., 2002),
suggesting that the junctional zone was primarily composed of
this cell type (Fig. 3E). There was an overall 40% decrease in
junctional zone area (Fig. 3F; Supplemental Table 5) and an in-
creased number of junctional zone-like clusters of cells present in
the labyrinth. While clusters were apparent in both WT and Ascl2-
Fig. 1. Spatially and temporally accurate (entopic) overexpression of Ascl2 in the
mouse placenta. (A) Schematic of the BAC transgene. Top line shows a genomic
map of the IC2 region on distal mouse chromosome 7. Hatched region marks the
KvDMR1 that is methylated only on the maternal allele. Arrows indicate direction of
transcription. Below is a map of the BAC transgene containing the Ascl2 gene. Filled
boxes represent imprinted genes (not to scale). (B) Placental RT-QPCR results for
Ascl2 in transgenic placenta at E9.5, E10.5 and E12.5. N¼4 placenta per genotype (2
versus 2 from 2 independent litters); error bars represent SEM. Statistical sig-
niﬁcance calculated using t-test. **Po0.01, ***Po0.005. (C) In situ hybridisation of
midline placental sections with Ascl2 riboprobe reveals similar spatial localisation
of mRNA in control and Ascl2-Tg placentas at E10.5 and E12.5. Scale bars¼200 mm.
Data for Fig. 2 in Supplemental Table 2.
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Tg placenta, the number present in the labyrinth of Ascl2-Tg pla-
centa was 7-fold greater than WT (Fig. 3G; Supplemental Table 5).
The size of the clusters was similar between the two genotypes
(Fig. 3H; Supplemental Table 5) and they were Tpbpaþve/
Psg17ve/Prl3b1ve/Ascl2þve/PASþve (Fig. 3B–E, I; right pa-
nels). This analysis identiﬁed them as mislocalised glycogen cells.
At E18.5, just prior to term, the junctional zone was similarly
disorganised with clusters of mislocalised glycogen cells ob-
servable in the labyrinth of Ascl2-Tg placentae (Fig. 4A–C). As
quantiﬁed by area measurements of midline sections, the 12%
decrease in junctional zone at E18.5 was not signiﬁcantly different
to WT and there was small (11%) but signiﬁcant increase in la-
byrinth (Fig. 4D, Supplemental Table 6).
As a proxy for the representation of the different lineages, a RT-
QPCR analysis was performed (Fig. 5, Supplemental Table 7).
Tpbpa, Tpbpb and FMS-like tyrosine kinase 1 (Flt1), markers of the
junctional zone lineages at E14.5 (Henke et al., 2013; Hirashima
et al., 2003), were expressed at considerably lower levels in Ascl2-
Tg placenta compared to controls (Fig. 5A). Prl8a8, Prl3a1, Prl3c1,
Prl3a1, Prl7a2, Prl8a9, Psg17, Psg18, Psg19 and Psg21, all markers
exclusively or predominantly expressed in the spongiotrophoblast
(Simmons et al., 2008; McLellan et al., 2005), were expressed at
markedly lower levels in Ascl2-Tg placenta (Fig. 5B). Prl3b1, which
at E14.5 is expressed in P-TGC, C-TGC, S-TGC and spongiotropho-
blast (Simmons et al., 2008), was reduced (Fig. 5B). However two
other markers associated predominantly with the spongio-
trophoblast, Prl8a1 (SpT and P-TGCs) and Prl8a6 (SpT and C-TGCs)
(Simmons et al., 2008), were expressed at wild type levels. These
data essentially supported a loss of the spongiotrophoblast
lineage.
Markers of the glycogen cell lineage were also assessed
(Fig. 5C). Pcdh12 and Gap junction protein, beta 3 (Gjb3/Cx31), a
marker of glycogen cell maturation (Zheng-Fischhofer et al., 2007),
were expressed at near normal levels, however Prl7b1 and Prl2a1,
expressed predominantly but not exclusively in glycogen cells
(Simmons et al., 2008), were both signiﬁcantly elevated (Fig. 5C).
Prl7b1 is a marker of migrating glycogen cells and is also expressed
in SpA-TGC and C-TGC at E14.5, while Prl2a1 is expressed in P-TGC,
SpA-TGC and C-TGC, in addition to the glycogen cell lineage
(Simmons et al., 2008). Glucan (1,4-alpha-), branching enzyme 1
(Gbe1), involved in glycogen branching, was elevated. However,
Prl6a1, expressed in glycogen cells and SpA-TGCs, and other gly-
cogen metabolism enzymes, glycogenin (Gyg), glycogen synthase 1
(gys) and UDP-glucose pyrophosphorylase 2 (Ugp2), were not sig-
niﬁcantly elevated. These data supported a change in the nature of
the glycogen cell lineage rather than a signiﬁcant alteration in the
cellular contribution of this lineage to the placenta.
An analysis of the markers Hand1, Tle3 and Prl2c, genes ex-
pressed in all or most of the TGC lineages (Simmons et al., 2008;
Gasperowicz et al., 2013; Scott et al., 2000), and Ctsq, expressed in
just the S-TGC and Ch-TGC lineages (Rai and Cross, 2014), sug-
gested a near normal representation of these lineages (Fig. 5D).
Flk1, Dlx3, Tfeb, Syna, Synb, Gcm1 and Cebpa, all genes primarily or
exclusively expressed in the labyrinth at E14.5 (Simmons et al.,
2008; Hirashima et al., 2003; Steingrimsson et al., 1998; Berghorn
et al., 2005; Anson-Cartwright et al., 2000) were also expressed at
Fig. 2. A reduction in the parietal trophoblast giant cell lineage. (A) Haematoxylin staining of midline placental sections at E10.5. Parietal trophoblast giant cells (P-TGC) are
indicated by dashed lines. Scale bars¼500 mm. (B) In situ hybridisation with a Prl3d (Pl1) riboprobe, which speciﬁcally marks P-TGCs at E10.5. Scale bars¼500 mm. (C) P-TGC
number per section at E10.5. N¼26. (D) Relative expression levels of key markers of P-TGC at E9.5 and E10.5. Prl3d1, Prl3b1 (aka Pl2), Prl2c (aka Plf) and Hand1 are all
expressed the P-TGC lineage at this time point. (E) Relative expression levels of markers of the emerging spongiotrophoblast (Tpbpa), glycogen cell (Pcdh12, Prl7b1), S-TGC,
SpA-TGC and C-TGC (Blimp1, Rgs5, Pcsk6, Prl7b1) lineages at E9.5 and E10.5. For the RT-qPCR analysis, N¼4 placenta per genotype (2 versus 2 from 2 independent litters);
error bars represent SEM. Statistical signiﬁcance calculated using t-test. NSP40.05, *Po0.05. Data for Fig. 2 in Supplemental Table 3.
S.J. Tunster et al. / Developmental Biology 418 (2016) 55–6558
levels similar to controls (Fig. 5E). Together, these data were con-
sistent with a substantial loss of the spongiotrophoblast and
P-TGCs with limited consequence for the other placental lineages.
The loss of spongiotrophoblast was very marked in the Ascl2-Tg
placenta. Previously we have shown a direct relationship between
the spongiotrophoblast and the amount of stored placental gly-
cogen late in gestation, both of which were associated with fetal
growth restriction (Tunster et al., 2010, 2014, 2015; Salas et al.,
2004). To assess the consequences of elevated Ascl2, fetuses and
placenta were collected at E12.5, E14.5, E16.5 and E18.5. The
observed ratios between Ascl2-Tg and non-transgenic fetuses were
not signiﬁcantly different to the expected ratios indicating no loss
of viability (Critical value 3.841 with p¼0.05 and DoF¼1; E12.5:
2.083, E14.5: 0.049, E16.5: 0.170 and E18.5: 0.865). Ascl2-Tg fetuses
were not signiﬁcantly different in weight to controls at E12.5,
E14.5, and E16.5 but at E18.5 there was a 6% (p¼0.00521) reduc-
tion in wet weight (Fig. 6A, Supplemental Table 8). Ascl2-Tg pla-
centae were signiﬁcantly lighter than controls at E12.5 and E14.5,
by 17% (p¼0.00898) and 11% (p¼9.29105) respectively, but
weights had recovered at E16.5 and E18.5 (Fig. 6B). As a
Fig. 3. A substantial loss of the spongiotrophoblast and mislocalisation of glycogen cells at E14.5. (A) HþE staining at E14.5 illustrating loss of the junctional zone. (B) In situ
hybridisation with a Tpbpa riboprobe, which speciﬁcally marks the spongiotrophoblast and glycogen cell lineages in the junctional zone, at E14.5. (C) In situ hybridisation
with a Psg17 riboprobe, which is expressed in just the spongiotrophoblast at E14.5. (D) In situ hybridisation with a Prl3b1 riboprobe, which is expressed in the P-TGC, C-TGC,
S-TGC and the spongiotrophoblast at E14.5, showing a degraded interface between the junctional zone and maternal decidua. (E) PAS staining of glycogen cells in the
junctional zone at E14.5. Three right hand images highlighting mislocalisation of glycogen cells in the labyrinth. (F) Midline section areas (mm2) occupied by the junctional
zone and labyrinth, and total area of both at E14.5. (G) Number of Tpbpaþve/Psg17ve/Prl3b1ve/PASþve/Ascl2þve clusters present in the labyrinth. (H) Total and average
area (mm2) occupied by Tpbpaþve/Psg17ve/Prl3b1ve/PASþve/Ascl2þve clusters in the labyrinth. (I) In situ hybridisation with an Ascl2 riboprobe, demonstrating
mislocalised cells express Ascl2. Scale bars¼1000 mm (two images on left); 350 mm (middle and adjacent right image) and 150 mm (far right image).
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consequence, the Fetal:Placental (F:P) ratios were higher at E12.5
and E14.5 and lower at E18.5 (Fig. 6C). A biochemical determina-
tion of glycogen was performed at E14.5, E16.5 and E18.5. At E18.5,
there was a substantial (þ61%; mg) increase in the total amount of
glycogen present in Ascl2-Tg placenta (Fig. 6D). When expressed
relative to placental weight (mg/g), glycogen was signiﬁcantly in-
creased at both E16.5 (þ25%; p¼0.0458) and E18.5 (þ58%;
p¼0.00277).
Fetal growth restriction was very modest (6%) in comparison to
the placental defect. Our analysis of a different mouse model
(transgenic overexpression of Phlda2) with a similar substantial
loss of spongiotrophoblast revealed a fetal growth restriction
phenotype apparent on a 129 strain background and absent on a
BL6 background (Tunster et al., 2010, 2014, 2015) potentially ex-
plained by the less permissive F:P ratio in 129 mice (Tunster et al.,
2012). Ascl2-Tg was examined after 46 generations of
backcrossing into 129. In initial studies, few plugged females were
pregnant when checked at E14.5 (Supplemental Table 9). When
the line was switched to a more nutrient-rich diet in a barrier unit,
pregnancy success rates improved (Supplemental Table 9) but
there was no difference in fetal weight between Ascl2-Tg fetuses
and WT littermates at E18.5 under these more favourable condi-
tions (Supplemental Table 10).
The dramatic reduction of the spongiotrophoblast lineage was
consistent with data demonstrating that ectopic expression of
Ascl2 in TS cells represses the expression of Tpbpa (Takao et al.,
2012) (Supplemental Table 1). However, a signiﬁcant loss of the
spongiotrophoblast lineage in vivo has been reported in associa-
tion with a 50% reduction in the expression of Ascl2 in Del7A1/þ
placenta (Oh-McGinnis et al., 2011). In this complex model, Phlda2
was expressed at two-fold higher than normal (Supplemental
Table 1). We have previously shown that two-fold elevation in the
expression of Phlda2 results in a substantial (50%) reduction of the
spongiotrophoblast (Tunster et al., 2010, 2014, 2015). Together
these data suggest that Ascl2 could regulate the spongiotropho-
blast indirectly via Phlda2. Phlda2 and Ascl2 co-localise to a subset
of cells with the developing chorio-allantoic placenta potentially
marking progenitors of the spongiotrophoblast (Oh-McGinnis
et al., 2011; Takao et al., 2012) (Fig. 7A). Ectopic expression of Ascl2
in TS cells results in lower expression of Phlda2 (Takao et al., 2012)
(Supplemental Table 1). In vivo, a similar elevation in Ascl2 did not
result in signiﬁcantly lower expression of Phlda2 (Fig. 7B). To ge-
netically test the relationship between Ascl2 and Phlda2, double
transgenic placenta carrying both the Ascl2 transgene and a ma-
ternally inherited targeted Phlda2 allele (Phlda2-/þ;Ascl2-Tg) were
generated. Both the Phlda2 loss-of-function placenta and the
double transgenic placenta possessed a markedly expanded junc-
tional zone, as evidenced by Tpbpa staining of E14.5 placental
sections (Fig. 7C). In the absence of Phlda2, Ascl2 was detectable by
in situ indicating that Ascl2 expression was not dependent on
Phlda2 (Fig. 7D). While is possible that the dominance of the
Phlda2 phenotype is a consequence of earlier events, these data are
consistent with Ascl2 acting via Phlda2 to suppress the expansion
of the spongiotrophoblast lineage (Fig. 8).
4. Discussion
Ascl2 is a gene expressed from the maternal allele in the pla-
centa. Previous studies in mice examining the consequences of
reduced expression of Ascl2 have suggested a pivotal role for this
gene in repressing the expansion of the parietal trophoblast giant
cell lineage (Guillemot et al., 1995, 1994; Tanaka et al., 1997; Oh-
McGinnis et al., 2011). Here, we have conﬁrmed this directly in an
Ascl2 over expression model. We also highlight a novel role for the
Ascl2 in repressing the expansion of the spongiotrophoblast, a
function that depends on expression of a second maternally ex-
pressed imprinted gene, Phlda2. We previously reported that two-
fold expression of Phlda2 resulted in a loss of the spongiotropho-
blast associated with a signiﬁcant reduction in placental glycogen,
which led us to hypothesise a role for the spongiotrophoblast in
driving the accumulation of these stores (Tunster et al., 2010).
Here, we observed a similar loss of spongiotrophoblast but co-
incident with increased stores of placental glycogen late in ge-
station. Moreover, glycogen cells were markedly mislocalised to
the labyrinth. One interpretation of this data is that the mis-
localisation of the glycogen cells, in response to the loss of both
the P-TGC and the spongiotrophoblast, precludes the utilisation of
these stores resulting in late fetal growth restriction.
We have now identiﬁed three maternally expressed genes lo-
cated in a single, mechanistically distinct imprinted domain
(Fitzpatrick et al., 2002) that all act on the spongiotrophoblast
Fig. 4. Persistence of junctional zone phenotype at E18.5. (A) HþE staining at E18.5
illustrating loss of the junctional zone. Lower panels are higher magniﬁcation of the
regions indicated. (B) In situ hybridisation with a Tpbpa riboprobe, which speciﬁ-
cally marks the spongiotrophoblast and glycogen cell lineages, at E18.5. Lower
panels are higher magniﬁcation of the regions indicated. (C) PAS staining for gly-
cogen cells at E18.5. Lower panels are higher magniﬁcation of the regions indicated.
(D) Midline section areas (mm2) occupied by the junctional zone and labyrinth, and
total area of both at E18.5. Scale bars A–C¼1000 mm (upper panels); 400 mm (lower
panels).
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lineage of the mouse placenta. Ascl2 and Phlda2 repress the ex-
pansion of this lineage while Cdkn1c is required for this lineage to
develop normally (Tunster et al., 2010, 2014, 2015, 2011; Salas
et al., 2004). Additionally, Ascl2 and Cdkn1c are functionally im-
portant for the P-TGC and S-TGCs lineages, respectively. There is
some evidence that the IC2 imprinted domain encompassing these
Fig. 5. Lineage analysis reveals a marked loss of the spongiotrophoblast and an increased representation of the glycogen cell lineage. (A) Quantitation of junctional zone
markers Tpbpa, Tpbpb and Flt1 at E14.5. (B) Quantitation of genes exclusively or predominantly expressed in the spongiotrophoblast at E14.5. (C) Quantitation of genes
exclusively or predominantly expressed in the glycogen cell lineage at E14.5. (D) Quantitation of genes exclusively or predominantly expressed in the TGC lineages at E14.5.
(E) Quantitation of genes exclusively or predominantly expressed in the labyrinth at E14.5. For the RT-qPCR analysis, N¼4 placenta per genotype (2 vs. 2 from 2 independent
litters); error bars represent SEM. Statistical signiﬁcance calculated using t-test. NSP40.05, *Po0.05, **Po0.01, ***Po0.005. Data for Fig. 5 in Supplemental Table 4.
Fig. 6. Placental and fetal growth restriction but increased placental glycogen. (A) Transgenic versus non-transgenic fetal wet weights at E12.5 (WT N¼29; Ascl2-Tg N¼19),
E14.5 (WT N¼42; Ascl2-Tg N¼40), E16.5 (WT N ¼25; Ascl2-Tg N¼28) and E18.5 (WT N¼41; Ascl2-Tg N ¼33). (B) Transgenic versus wild type placental wet weights at the
same time points. (C) Fetal:Placental (F:P) ratios at the same time points. (D) Biochemical determination of placental glycogen at E14.5, E16.5 and E18.5 expressed as the total
amount of glycogen (mg) E. Biochemical determination of placental glycogen at E14.5, E16.5 and E18.5 expressed in relation to placental weight (mg/g). Data for Fig. 6 in
Supplemental Table 5.
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genes became imprinted after marsupials diverged from Eutherian
mammals (Suzuki et al., 2005, 2011.). It may be signiﬁcant that a
key difference between marsupials and Eutherians is the extent to
which extra embryonic tissues support growth in utero with the
Eutherian newborn being substantially larger at term, relative to
the size of the mother, and distinctly more mature than the
Fig. 7. Ascl2 requires Phlda2 to repress the expansion of the spongiotrophoblast lineage. (A) In situ hybridisation of sequential midline sections of wild type placenta at E10.5
with Ascl2 and Phlda2 riboprobes. The two genes are co-expressed in subset of cells at the base of the developing junctional zone (ﬁlled arrowheads) but not those located
near the P-TGC layer (white arrow). Scale bars 100 mm. (B) Quantitation of Phlda2 mRNA at E9.5, E10.5 and E14.5. (C) In situ hybridisation of midline sections of non-
transgenic, Ascl2-Tg, Phlda2/þ and Phlda2/þ; Ascl2-Tg double transgenic placenta with the junctional zone marker Tpbpa at E14.5. D. In situ hybridisation of midline
sections of non-transgenic, Ascl2-Tg, Phlda2/þ and Phlda2 /þ; Ascl2-Tg double transgenic placenta with an Ascl2 riboprobe at E14.5. Scale bars in C and D ¼1000 mm (upper
panels); 400 mm (lower panels).
Fig. 8. Summary of gene expression data in relation to placental lineages. Genes indicated in red are signiﬁcantly down and genes indicated in green are signiﬁcantly
elevated in Ascl2-Tg placenta. Ascl2 requires Phlda2 to repress the expansion of the spongiotrophoblast lineage.
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marsupial newborn. There are a number of maternally expressed
imprinted genes, including Esx1, Cited1, Plac1 and Nrk (maternally
expressed by virtue of their location on the paternally inactive
X-chromosome), that repress the spongiotrophoblast lineage and
at least two paternally expressed imprinted genes, Peg3 and Peg10,
predicted to increase the size of this compartment (John, 2013).
This convergence suggests that this lineage is a major site of par-
ental genomic conﬂict. The spongiotrophoblast is a major site of
production of placental lactogens (Simmons et al., 2008). Some
members of this extensive gene family (Prl3d and Prl3b1) have
been shown to induce the changes in the mother required for a
successful pregnancy (Bhattacharyya et al., 2002; Muller et al.,
1999). The spongiotrophoblast also manufactures pregnancy-spe-
ciﬁc glycoproteins (PSGs) which are another family of highly si-
milar secreted proteins thought to contribute in the protection of
the semiallotypic fetus from the maternal immune system, and
which also remodel placental and maternal vasculature (Kam-
merer et al., 2010; Wu et al., 2008). Essentially the spongio-
trophoblast is a hormone factory and the considerable drain on
maternal resources required to sustain the production of these
placental hormones may be why this lineage is so tightly regulated
by imprinting. Alternatively, this regulation may reﬂect the func-
tion of these hormones in pregnancy. Placental hormones are
manufactured in large quantities during pregnancy and act on the
maternal system to direct resources to support fetal growth. While
it remains to be determined whether such changes in gene ex-
pression in the placenta have a consequence for maternal phy-
siology in this model, this data provides further evidence that the
maternal and paternal genomes are involved in a continuing battle
over the endocrine function of the mouse placenta.
We have previously shown that the maternally expressed
Phlda2 gene limits the expansion of the spongiotrophoblast
alongside placental stunting, a loss of placental glycogen and fetal
growth restriction (Tunster et al., 2010, 2014, 2015). Similarly,
elevated Ascl2 also resulted in fetal growth restriction but, in
contrast to the Phlda2 transgenic model, placental glycogen stores
were markedly increased in the near term placenta when fetal
growth restriction was apparent. Moreover, there was a marked
appearance of clusters of glycogen cells in the labyrinth at a time
when these cells are normally migrating into the decidua. Ex-
pression of some glycogen cell markers, such as the marker of
migrating glycogen cells Prl7b1, was altered but the majority of
markers were expressed at similar levels to WT suggesting mis-
localisation from the junctional zone. A milder mislocalisation of
junctional zone cells was also apparent in our Phlda2 over-
expression model where there was also a loss of spongiotropho-
blast (Tunster et al., 2010) suggesting that the spongiotrophoblast
is important for maintaining the glycogen cells within the junc-
tional zone. Mislocalisation of glycogen cells in the Ascl2-Tg model
was considerably more severe than in our Phlda2 model suggest-
ing that the loss of P-TGC may further contribute to this pheno-
type. The presence of excess glycogen and fetal growth restriction
is not consistent with the suggestion that placental glycogen is
required to support late fetal growth (Coan et al., 2006). However,
these data can be reconciled if the release of glycogen into the
maternal system was prevented as a consequence of the mis-
localisation of glycogen cells into the labyrinth.
Fetal growth restriction was very modest (6%) on the BL6
background despite the rather dramatic loss of both P-TGC and
spongiotrophoblast cells. BL6 placenta have a higher F:P ratio and
are thought to have a greater reserve capacity to support fetal
growth compared to the 129 strain. We had great difﬁculty
breeding Ascl2-Tg into 129. Under standard conditions in a con-
ventional unit few plugged females were pregnant at E14.5. When
the line was rederived into a barrier unit where the mice were
maintained on an enriched diet, the pregnancy success rate
improved sufﬁciently to assess fetal growth but under these con-
ditions we observed no fetal growth restriction. The use of dif-
ferent diets under a different health status confounds the inter-
pretation of this data. Notably, targeted loss of function of the
placental lactogens Prl4a1 and Prl7b1 had no overt phenotypic
consequence under normal husbandry conditions but pregnancies
failed under stressed conditions (Ain et al., 2004; Bu et al., 2016).
There are 22 members of the Prl gene family (Simmons et al.,
2008). These data suggests an inherent redundancy in the func-
tions of members of the Prl family such that overt fetal compli-
cations manifest only when adverse conditions are combined with
reduced expression.
Both loss-of-function (Guillemot et al., 1995) and over-
expression of Ascl2 in vivo (Figs. 2D, and 5A) results in fewer cells
expressing Tpbpa. Ectopic overexpression of Ascl2 in TS cells also
resulted in low Tpbpa (Takao et al., 2012). These data suggest that
Ascl2 is both required for the development of Tpbpaþve lineages
and restrains their proliferation. In the Del7A1/þ model, in which
placenta express Ascl2 at 50% normal, at E9.5 placenta initially
appeared to have an increased number of cells expressing Tpbpa.
By E15.5 very few cells expressed this marker (Oh-McGinnis et al.,
2011). The Del7A1/þ model involves a 280 kb deletion of the IC1–
IC2 interval directly or indirectly disrupting the expression of
three imprinted genes in this region: Ascl2 (50%), Phlda2 (200%)
and Th (0%) (Oh-McGinnis et al., 2011). We have previously shown
that just two-fold expression of Phlda2 alone can reduce the size of
the spongiotrophoblast lineage by 50% (Tunster et al., 2010, 2014,
2015). The ﬁndings in these different models can be reconciled if
the spongiotrophoblast phenotype in the Del7A1/þ model is due to
elevated Phlda2 rather than a direct consequence of elevated Ascl2.
Previous studies have suggested a direct relationship between
Ascl2 and Phlda2 (Data summarised in Supplemental Table 1).
Ascl2 is co-expressed with Phlda2 in a subset of cells in the ecto-
placental cone at E7.5, E9.5 (Oh-McGinnis et al., 2011; Takao et al.,
2012) and E10.5 (Fig. 7A) where progenitors of the spongio-
trophoblast reside. Adenoviral-driven overexpression of Ascl2 in
trophoblast stem cells resulted in a 60% reduction in the expres-
sion of Phlda2 under stem cell culture conditions (Takao et al.,
2012). Conversely, knockdown of Ascl2 expression in TS cells (Ta-
kao et al., 2012) or reduced expression in vivo (Oh-McGinnis et al.,
2011) resulted in increased Phlda2 expression. In this current
study, we did not observe a statistically signiﬁcant reduction in
Phlda2 expression in vivo in response to overexpression of Ascl2.
When we genetically tested the relationship between Ascl2 and
Phlda2 by combining overexpression of Ascl2 with loss-of-ex-
pression of Phlda2, this resulted in a markedly expanded spon-
giotrophoblast similar to loss of expression of Phlda2 alone. This
tells us that, while both elevated Phlda2 (Tunster et al., 2010, 2014,
2015) and elevated Ascl2 repress the spongiotrophoblast, Ascl2 can
only do so in the presence of Phlda2 (Fig. 7C). These data are
consistent with Ascl2 functioning upstream of Phlda2 to control
the expansion of the spongiotrophoblast in a progenitor cell type
(Fig. 8).
In conclusion, we have demonstrated that overexpression of
the imprinted Ascl2 gene has considerable consequences for pla-
cental development, speciﬁcally for the P-TGC and spongio-
trophoblast lineages both of which express pregnancy-related
hormones. Either as a consequence of the reduced function of the
endocrine compartment or the failure in the appropriate migra-
tion of glycogen cells, elevated Ascl2 resulted in a late fetal growth
restriction. The presence of three imprinted genes within a single
mechanistically distinct imprinted domain that all act to regulate
placental lineages critical for the endocrine function of the pla-
centa suggest that the imprinting of this domain was key to the
switch to prolonged gestation and greater maturity at birth ob-
served in Eutherian mammals.
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